Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	ATP hydrolysis activity	ABCA1 ABCA2 ABCA3 ERCC6 KIF28P CHD6 DDX41 KIF16B ATP1A1 ATP1A3 ATP12A ATP2B1 ATP5F1A MCM8 MYO5B MYO9B DHX33 IQCA1L ABCD4 DYNC1H1 ABCC10 NSF RFC1 DNAH7 KIF3A	4.80e-06	441	408	25	GO:0016887
GeneOntologyMolecularFunction	ATP-dependent activity	ABCA1 ABCA2 ABCA3 ERCC6 UBA1 SHPRH KIF28P CHD6 DDX41 MRE11 KIF16B ATP1A1 ATP1A3 ATP12A ATP2B1 ATP5F1A MCM8 MYO5B MYO9B DHX33 IQCA1L ABCD4 DYNC1H1 ABCC10 NSF ZNFX1 RFC1 DNAH7 KIF3A	2.78e-05	614	408	29	GO:0140657
GeneOntologyMolecularFunction	ribonucleoside triphosphate phosphatase activity	ABCA1 ABCA2 ABCA3 ERCC6 TUFM KIF28P CHD6 DDX41 RGS5 KIF16B GFM2 RAB40C ATP1A1 ATP1A3 ATP12A GFM1 ATP2B1 ATP5F1A MCM8 MYO5B MYO9B DHX33 IQCA1L ABCD4 RAB40B RAB2A DYNC1H1 ABCC10 ADSS1 NSF RFC1 DNAH7 KIF3A	6.11e-05	775	408	33	GO:0017111
GeneOntologyMolecularFunction	ionotropic glutamate receptor binding	PICK1 CACNG4 MYO5B DLG3 SHANK1 NSF GRIP1	8.55e-05	52	408	7	GO:0035255
GeneOntologyMolecularFunction	small GTPase binding	ABCA1 FGD1 RIC1 RAB11FIP2 KIF16B TBC1D13 DOCK7 RAB11FIP4 MYO5B MYCBP2 MYO9B HPS4 IPO5 DOCK3 DMXL2 NSF KIF3A CDC42EP1	1.18e-04	321	408	18	GO:0031267
GeneOntologyMolecularFunction	pyrophosphatase activity	ABCA1 ABCA2 ABCA3 ERCC6 TUFM KIF28P CHD6 DDX41 RGS5 KIF16B GFM2 RAB40C ATP1A1 ATP1A3 ATP12A GFM1 ATP2B1 ATP5F1A MCM8 MYO5B MYO9B DHX33 IQCA1L ABCD4 RAB40B RAB2A DYNC1H1 ABCC10 ADSS1 PRUNE2 NSF RFC1 DNAH7 KIF3A	1.23e-04	839	408	34	GO:0016462
GeneOntologyMolecularFunction	hydrolase activity, acting on acid anhydrides	ABCA1 ABCA2 ABCA3 ERCC6 TUFM KIF28P CHD6 DDX41 RGS5 KIF16B GFM2 RAB40C ATP1A1 ATP1A3 ATP12A GFM1 ATP2B1 ATP5F1A MCM8 MYO5B MYO9B DHX33 IQCA1L ABCD4 RAB40B RAB2A DYNC1H1 ABCC10 ADSS1 PRUNE2 NSF RFC1 DNAH7 KIF3A	1.26e-04	840	408	34	GO:0016817
GeneOntologyMolecularFunction	hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides	ABCA1 ABCA2 ABCA3 ERCC6 TUFM KIF28P CHD6 DDX41 RGS5 KIF16B GFM2 RAB40C ATP1A1 ATP1A3 ATP12A GFM1 ATP2B1 ATP5F1A MCM8 MYO5B MYO9B DHX33 IQCA1L ABCD4 RAB40B RAB2A DYNC1H1 ABCC10 ADSS1 PRUNE2 NSF RFC1 DNAH7 KIF3A	1.26e-04	840	408	34	GO:0016818
GeneOntologyMolecularFunction	GTPase binding	ABCA1 FGD1 RIC1 RAB11FIP2 KIF16B TBC1D13 DOCK7 RAB11FIP4 MYO5B MYCBP2 MYO9B HPS4 IPO5 DOCK3 DMXL2 NSF KIF3A CDC42EP1 GRIP1	1.68e-04	360	408	19	GO:0051020
GeneOntologyMolecularFunction	guanyl-nucleotide exchange factor activity	FGD1 RIC1 DENND4C DOCK7 KNDC1 MYCBP2 HPS4 DOCK3 PSD3 DENND11 ARFGEF3 EGF TIAM1 SPATA13	3.03e-04	231	408	14	GO:0005085
GeneOntologyMolecularFunction	nucleoside-triphosphatase regulator activity	FGD1 ARHGAP8 RIC1 RGS5 DENND4C TBC1D13 ARHGAP6 DOCK7 KNDC1 MYCBP2 MYO9B ARHGAP11A NF1 HPS4 IPO5 DOCK3 PSD3 RALGAPA2 DENND11 ARFGEF3 EGF TIAM1 SPATA13	3.33e-04	507	408	23	GO:0060589
GeneOntologyMolecularFunction	GTPase regulator activity	FGD1 ARHGAP8 RIC1 RGS5 DENND4C TBC1D13 ARHGAP6 DOCK7 KNDC1 MYCBP2 MYO9B ARHGAP11A NF1 HPS4 IPO5 DOCK3 PSD3 RALGAPA2 DENND11 ARFGEF3 EGF TIAM1 SPATA13	3.33e-04	507	408	23	GO:0030695
GeneOntologyMolecularFunction	ATPase-coupled transmembrane transporter activity	ABCA1 ABCA2 ABCA3 ATP1A1 ATP1A3 ATP12A ATP2B1 ABCD4 ABCC10	4.01e-04	109	408	9	GO:0042626
GeneOntologyBiologicalProcess	regulation of modification of postsynaptic structure	BAIAP2 MYO5B PTK2 DIP2A NF1 TIAM1	3.11e-06	22	404	6	GO:0099159
GeneOntologyBiologicalProcess	regulation of modification of synaptic structure	BAIAP2 MYO5B PTK2 DIP2A NF1 TIAM1	1.76e-05	29	404	6	GO:1905244
GeneOntologyCellularComponent	glutamatergic synapse	CSMD2 BAIAP2 PICK1 VPS26B APBB1 GABBR2 PPP2R1B CADPS CACNG4 CTNND2 CADPS2 ATP2B1 FRMPD4 LZTS3 MYO5B PTK2 DIP2A NF1 PLPPR4 PTPRS DLG3 GRIN3A ADGRL3 SHANK1 PRUNE2 FZD3 L1CAM PSD3 LAMA5 GRIK4 KIF3A GRIP1 TIAM1 PCDH8	3.02e-05	817	408	34	GO:0098978
GeneOntologyCellularComponent	synaptic membrane	ERBB3 CSMD2 CHRNA5 BAIAP2 PICK1 APBB1 GABBR2 STX19 CACNG4 ATP1A3 CADPS2 ATP2B1 PLPPR4 PTPRS KCNJ3 DLG3 GRIN3A DMD ADGRL3 SHANK1 FZD3 L1CAM GRIK4 GRIP1 TIAM1 PCDH8	8.80e-05	583	408	26	GO:0097060
GeneOntologyCellularComponent	filopodium	FAT1 BAIAP2 APBB1 CRP MYO9B B4GALT1 DMD DYNC1H1 FZD3 SPATA13	1.52e-04	123	408	10	GO:0030175
GeneOntologyCellularComponent	lamellipodium	FAT1 PIK3CA FER FGD1 BAIAP2 CARMIL1 APBB1 SNX2 MYO9B CTTNBP2NL PTK2 NHS DMD SPATA13	1.83e-04	230	408	14	GO:0030027
GeneOntologyCellularComponent	somatodendritic compartment	ZC3H14 TRPC5 CHRNA5 BAIAP2 USH2A PICK1 ENC1 APBB1 APOB STAU2 KNDC1 CACNG4 CTNND2 ATP1A3 ATP2B1 LYPD6 FRMPD4 LZTS3 MYO5B PTGER3 PTK2 DIP2A NF1 PTPRK PTPRS DLG3 KDR TACR3 GRIN3A DMD RAB2A DYNC1H1 KNG1 SHANK1 FZD3 NSF L1CAM GRIK4 KIF3A GRIP1 TIAM1 PCDH8	3.01e-04	1228	408	42	GO:0036477
GeneOntologyCellularComponent	intercalated disc	XIRP1 PIK3CA SLC4A1 ATP1A1 PTK2 NRAP DSG2	3.57e-04	68	408	7	GO:0014704
GeneOntologyCellularComponent	cell leading edge	FAT1 PIK3CA FER FGD1 BAIAP2 USH2A JCAD CARMIL1 APBB1 GAS7 ATP2B1 SNX2 MYO9B CTTNBP2NL PTK2 PTPRK NHS TACR3 DMD PSD3 TIAM1 SPATA13	3.66e-04	500	408	22	GO:0031252
GeneOntologyCellularComponent	actin-based cell projection	PDZD7 FAT1 BAIAP2 USH2A ENPP7 APBB1 CRP MYO9B CDH23 B4GALT1 DMD DYNC1H1 DPEP1 FZD3 SPATA13	3.99e-04	278	408	15	GO:0098858
GeneOntologyCellularComponent	neuronal cell body	TRPC5 CHRNA5 BAIAP2 USH2A ENC1 APBB1 APOB STAU2 KNDC1 CTNND2 ATP1A3 ATP2B1 LYPD6 MYO5B PTGER3 PTPRK PTPRS DLG3 KDR TACR3 GRIN3A DMD RAB2A DYNC1H1 KNG1 FZD3 L1CAM GRIK4 KIF3A GRIP1 TIAM1	5.02e-04	835	408	31	GO:0043025
GeneOntologyCellularComponent	cell-cell contact zone	XIRP1 PIK3CA SLC4A1 ATP1A1 PTK2 NRAP DSG2 TIAM1	5.07e-04	94	408	8	GO:0044291
Domain	HIF-1	HIF1A HIF3A EPAS1	1.01e-05	3	405	3	PF11413
Domain	HIF_alpha_subunit	HIF1A HIF3A EPAS1	1.01e-05	3	405	3	IPR021537
Domain	ARM-type_fold	TRRAP PLAA PIK3CA ASPM APOB AP3B1 VIRMA SCYL2 PPP2R1B TTI1 CTNND2 STAG2 SMG1 PDCD4 NF1 IPO5 DOCK3 ZNFX1 HUWE1 RALGAPA2 ARFGEF3	1.76e-05	339	405	21	IPR016024
Domain	Kelch-typ_b-propeller	ENC1 KBTBD2 KBTBD4 KBTBD6 KLHL11 KLHL5 KLHL25	1.77e-04	55	405	7	IPR015915
Domain	P-type_ATPase_IIC	ATP1A1 ATP1A3 ATP12A	1.93e-04	6	405	3	IPR005775
Domain	BACK	ENC1 KBTBD2 KBTBD4 KBTBD6 KLHL11 KLHL5 KLHL25	3.07e-04	60	405	7	SM00875
Domain	ATPase_P-typ_TM_dom	ATP1A1 ATP1A3 ATP12A ATP2B1	3.22e-04	16	405	4	IPR023298
Domain	-	ATP1A1 ATP1A3 ATP12A ATP2B1	3.22e-04	16	405	4	1.20.1110.10
Domain	BACK	ENC1 KBTBD2 KBTBD4 KBTBD6 KLHL11 KLHL5 KLHL25	3.41e-04	61	405	7	IPR011705
Domain	BACK	ENC1 KBTBD2 KBTBD4 KBTBD6 KLHL11 KLHL5 KLHL25	3.41e-04	61	405	7	PF07707
Domain	Cation_ATPase_C	ATP1A1 ATP1A3 ATP12A ATP2B1	4.14e-04	17	405	4	PF00689
Domain	ATPase_P-typ_cation-transptr_C	ATP1A1 ATP1A3 ATP12A ATP2B1	4.14e-04	17	405	4	IPR006068
Domain	P-loop_NTPase	ABCA1 ABCA2 ABCA3 ERCC6 TUFM NLRC4 MYO15B ASPM SHPRH CHD6 DDX41 TPST1 KIF16B GFM2 RAB40C GFM1 ATP5F1A MCM8 MYO5B MYO9B DHX33 ABCD4 DLG3 RAB40B CAMTA1 RAB2A DYNC1H1 ABCC10 ADSS1 NSF ZNFX1 RFC1 DNAH7 KIF3A	4.41e-04	848	405	34	IPR027417
Domain	Actin-binding_Xin_repeat	XIRP1 XIRP2	4.69e-04	2	405	2	IPR012510
Domain	XIN	XIRP1 XIRP2	4.69e-04	2	405	2	PS51389
Domain	DM15	LARP1 LARP1B	4.69e-04	2	405	2	IPR006607
Domain	CAPS	CADPS CADPS2	4.69e-04	2	405	2	IPR033227
Domain	HIF-1a_CTAD	HIF1A EPAS1	4.69e-04	2	405	2	PF08778
Domain	HIF-1_TAD_C	HIF1A EPAS1	4.69e-04	2	405	2	IPR014887
Domain	DM15	LARP1 LARP1B	4.69e-04	2	405	2	SM00684
Domain	XIRP1/XIRP2	XIRP1 XIRP2	4.69e-04	2	405	2	IPR030072
Domain	Xin	XIRP1 XIRP2	4.69e-04	2	405	2	PF08043
Domain	UPF0028	PNPLA6 PNPLA7	4.69e-04	2	405	2	PS01237
Domain	Cation_ATPase_N	ATP1A1 ATP1A3 ATP12A ATP2B1	5.24e-04	18	405	4	PF00690
Domain	Cation_ATPase_N	ATP1A1 ATP1A3 ATP12A ATP2B1	5.24e-04	18	405	4	SM00831
Domain	-	ENC1 KBTBD2 KBTBD4 KBTBD6 KLHL11 KLHL25	5.69e-04	48	405	6	2.120.10.80
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	PATZ1 PTER PANK2 KMT2A FNIP1 BAIAP2 DDX41 DYRK2 JCAD AMPD2 NAA15 IFT74 CARMIL1 RAB11FIP2 APBB1 WDR26 VIRMA DENND4C TET1 DOCK7 ANKRD17 SSH2 ATP2B1 SNX2 EMC1 MYCBP2 ITPRID2 LUZP1 MPRIP FSIP2 NF1 MAST4 SVIL NHS MTCL1 DSG2 PARP8 ZNF629 PSD3 LARP1 CEP192 LARP1B DNAH7 CDC42EP1 GRIP1 ARFGEF3 FAM171A1 ZNF106 TIAM1 SPATA13	3.27e-20	861	416	50	36931259
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	HIF1A KCNH8 TRRAP ALX4 AFMID SHC2 ERI3 SHPRH FNIP1 PLA2G6 MACROH2A2 SEMA6A CHD6 BAIAP2 ARHGAP8 RIC1 FAM149A PSAT1 CARMIL1 ENC1 RBM39 SFMBT2 ARHGAP6 PPP2R1B PPP2R2C NAXD KNDC1 ANKRD17 CROCC ATP2B1 STAG2 SNX2 CYB5A MCM8 MYCBP2 PTK2 STT3A ITPK1 B4GALT1 TLK1 PTPRB PNPLA6 COQ8A PTPRS SPIN1 KCNJ3 KATNIP RAB40B CAMTA1 RPS6KL1 ADSS1 PRUNE2 UACA RBM4 LARP1 CEP192 HUWE1 ARFGEF3 ZNF532 NACC2 PNPLA7 KAT6B VPS13B	2.79e-18	1489	416	63	28611215
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	TUFM CRACD UBA1 NMT2 CDIPT KMT2A BAIAP2 CARMIL1 COPS3 AP3B1 VIRMA PRPF40A RBM39 SLC4A1 PPP2R2C MLIP CADPS MRPL48 PDE4DIP DOCK7 KNDC1 SSH2 ATP1A1 CTNND2 ATP1A3 CROCC ATP2B1 ATP5F1A SNX2 LZTS3 MYO5B ALDH1L1 LUZP1 MPRIP DIP2A NF1 PNPLA6 PLPPR4 PTPRS SVIL DLG3 DMD RAB2A DYNC1H1 KNG1 SHANK1 IPO5 GPD2 DMXL2 NSF L1CAM PSD3 LARP1 ZNFX1 KIF3A	2.72e-14	1431	416	55	37142655
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	CSMD3 CRACD FNIP1 CHD6 PPM1E VIRMA LRIG3 CADPS PDE4DIP DOCK7 RAB11FIP4 CROCC RUBCN FRMPD4 AVL9 DLG3 KATNIP MTCL1 CAMTA1 DYNC1H1 ADGRL3 PSD3 CEP192 DENND11 ARFGEF3 GPCPD1 VPS13B SPATA13	1.45e-13	407	416	28	12693553
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	BIRC6 CEMIP2 ADH5 UBA1 PIK3R1 MACROH2A2 BAIAP2 JCAD PSAT1 RNF169 PPM1E PTPN23 SMPD4 CACHD1 AP3B1 PPM1B PCF11 IGBP1 PDP1 TTI1 SSH2 ATP2B1 ATP5F1A EMC1 MYO5B MYCBP2 ITPRID2 LUZP1 TDRD3 TRMT10C UBXN4 PTPRB PTPRK PTPRS SVIL NHS DMD GPD2 PSD3 CEP192 HUWE1 CDC42EP1 FAM171A1 TIAM1 TMF1	1.77e-13	1049	416	45	27880917
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	ERBB3 ABCA2 AKAP17A KIAA0319L LRP1B CREBZF PIK3R1 NMT2 ARIH2 CCDC15 CHD6 BAIAP2 PICK1 JCAD IFT74 ENC1 APBB1 GAS7 CACHD1 WDR26 SCYL2 ZNF7 P4HTM CADPS PDE4DIP NECAB3 RAB11FIP4 CTNND2 CADPS2 ATP5F1A MYCBP2 PTK2 MPRIP TRIM66 DIP2A PTPRK NECAB1 HPS4 ZNF841 DYNC1H1 SHANK1 IPO5 DOCK3 DMXL2 ZNFX1 HUWE1 KIF3A TIAM1 ZNF532	1.07e-12	1285	416	49	35914814
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	MRPS31 PLPPR3 BIRC6 LRP1B UBA1 PLAA BAIAP2 AKAP7 JCAD AMPD2 NAA15 RAB11FIP2 APBB1 GABBR2 WDR26 RBM39 CADPS STAU2 PDE4DIP DOCK7 KNDC1 CTNND2 GFM1 CYB5A EMC1 FRMPD4 LZTS3 MYCBP2 TRMT10C UBXN4 NF1 PLPPR4 KCNJ3 DLG3 ADGRL3 SHANK1 DOCK3 DMXL2 PSD3 ZNFX1 HUWE1 ARFGEF3 CELSR2 PCDH8	1.10e-11	1139	416	44	36417873
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	PATZ1 UBA1 BAIAP2 AMPD2 ZNF618 GABBR2 WDR26 VIRMA PDE4DIP DOCK7 ANKRD17 SSH2 CTNND2 PROX1 LZTS3 MYCBP2 PTK2 LUZP1 MPRIP TDRD3 NF1 PLPPR4 PTPRS SVIL DLG3 MTCL1 CDC73 RAB2A DYNC1H1 SHANK1 DMXL2 UACA NSF ZNFX1 HUWE1 KIF3A FAM171A1 CELSR2 PCDH8 SPATA13	1.15e-11	963	416	40	28671696
Pubmed	Transcriptome analysis of mouse stem cells and early embryos.	ABCA1 BIRC6 CRACD ASPM FGD1 CHD6 MRE11 COL6A3 KIF16B PDP1 STAU2 PDE4DIP ATP2B1 STAG2 IQCA1L NHS SGO2 DLG3 IPO5 RBM4 LAMA5 RALGAPA2 ZNF106 NACC2	1.90e-11	363	416	24	14691545
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	ELOA2 CSMD2 PTER CDIPT MACROH2A2 CHD6 FAM149A ZNF823 JCAD KIF16B APBB1 AP3B1 VIRMA ANKRD36B ANKRD17 CEP295 CTNND2 ATP2B1 STAG2 SMG1 CDS2 NF1 COQ8A MTCL1 RBM4 MUC16 ZNFX1 RFC1 DNAH7 LIG3 BBS7	5.94e-11	638	416	31	31182584
Pubmed	A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome.	ERBB3 ABCA1 AKAP17A TUFM CEMIP2 CHD6 FLT4 APOB RBM39 PPM1B SCYL2 CNPY3 PCNX1 ATP1A1 CTSD SMG1 DIP2A NF1 PTPRB KDR PID1 MUC16 GRIK4 DNAH7	3.76e-10	420	416	24	28065597
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	ABCA2 CEMIP2 KIF16B SMPD4 CACHD1 KBTBD2 LRIG3 TET1 ANKRD17 UNK PCNX1 SMG1 IFT140 EMC1 ARHGAP11A CTTNBP2NL UBXN4 MAST4 PLPPR4 NUAK1 COQ8A HPS4 LARP1 LAMA5 ZNF532 KAT6B	1.71e-09	529	416	26	14621295
Pubmed	The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2.	KIAA0319L CEMIP2 FAT1 PIK3CA SEMA6A BAIAP2 CARMIL1 KIF16B APBB1 SMPD4 APOB MEAK7 SLC4A2 STXBP6 DOCK7 ATP1A1 ATP2B1 SPAG1 NF1 DLG3 UACA DSG2 PSD3 RALGAPA2 CDC42EP1 CELSR2 VPS13B	1.76e-09	569	416	27	30639242
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	ERBB3 TUFM CEMIP2 PHKA2 DNAJC10 KMT2A SLC25A17 RIC1 RC3H2 NAA15 AP3B1 SLC4A2 DOCK7 ANKRD17 RUBCN SMG1 EMC1 MCM8 C15orf39 PTK2 DIP2A COQ8A DMXL2 ZNF629 LARP1 LAMC2 ZNFX1 KLHL11 LIG3	1.77e-09	650	416	29	38777146
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	ERCC6 AKAP17A PATZ1 MECOM TRRAP TUFM FAT1 DNAJC10 PIK3R1 ASPM MACROH2A2 DDX41 MRE11 ZNF618 GAS7 WDR26 PRPF40A SLC4A1 LRIG3 CADPS ANKRD17 CEP295 KDM1B PROX1 IFT140 MCM8 LUZP1 TRIM66 PNPLA6 BRCA1 ACTL8 COQ8A UACA DSG2 RBBP6 ZNF629 RALGAPA2 CDC42EP1 KAT6B	2.97e-09	1116	416	39	31753913
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	FNIP1 RC3H2 DENND4C STAU2 DOCK7 UNK SNX2 CTTNBP2NL LUZP1 TDRD3 MAST4 NHS MTCL1 CEP192 LARP1B ARFGEF3	5.67e-09	209	416	16	36779422
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	ABCA2 KIAA0319L LRP1B CHRNA5 CEMIP2 FAT1 UBA1 DNAJC10 CDIPT TPST1 ITGA11 CACHD1 SLC4A2 P4HTM CNPY3 TTI1 ATP1A1 CTSD ATP2B1 SNX2 EMC1 MYCBP2 ERAP1 STT3A B4GALT1 IGSF10 BPNT2 NF1 PTPRK PTPRS SVIL NPR1 DSG2 RBM4 L1CAM LAMA5 KLHL11 CELSR2 LRP11 MFSD5	7.05e-09	1201	416	40	35696571
Pubmed	Comparative interactome analysis of α-arrestin families in human and Drosophila.	ZC3H14 ABCA3 DNAJC10 SLC25A17 KIF16B MEAK7 PRPF40A GET4 DOCK7 NF1 PTPRS SVIL DMD DSG2 RBBP6 LARP1 LAMA5 HUWE1 ARFGEF3	9.88e-09	313	416	19	38270169
Pubmed	A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.	CEMIP2 PIK3CA PIK3R1 SEMA6A CARMIL1 RAB11FIP2 CACHD1 STXBP6 ATP1A1 ATP2B1 MPRIP NHS DLG3 DMD UACA DSG2 PSD3 RALGAPA2 CDC42EP1 GRIP1 FAM171A1 CELSR2	1.04e-08	421	416	22	36976175
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	MRPS31 PATZ1 UBA1 PANK2 PIK3R1 BAIAP2 DDX41 DYRK2 MRE11 AMPD2 DIABLO IFT74 CARMIL1 RAB11FIP2 COPS3 AP3B1 WDR26 DENND4C SCYL2 DOCK7 TTI1 CCDC144A IFT140 SPAG1 MYO5B MYCBP2 CDH23 C15orf39 LUZP1 MPRIP TLK1 NF1 KATNIP RAB2A DYNC1H1 NSF LARP1 RFX3 KIF3A TIAM1 BBS7 ZW10	1.10e-08	1321	416	42	27173435
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	CDO1 TRRAP UBA1 KMT2A DDX41 MRE11 RNF169 CARMIL1 VIRMA PRPF40A PCF11 ANKRD17 UNK STAG2 SNX2 MYCBP2 ITPRID2 CTTNBP2NL TLK1 NF1 PNPLA6 SVIL GCFC2 UACA RBBP6 LARP1 HUWE1 RFC1 ZNF106 KAT6B	2.26e-08	774	416	30	15302935
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	ABCA2 KIAA0319L TRRAP BIRC6 ADCY7 FAT1 PLA2G6 RIC1 PICK1 GET4 PCNX1 PCNX3 MYCBP2 MYO9B C15orf39 MPRIP DIP2A TDRD3 FAM20C TLK1 PNPLA6 NUAK1 PTPRS GPC2 DYNC1H1 ABCC10 DOCK3 L1CAM LAMA5 CEP192 HUWE1 RALGAPA2 OVOL1 KLHL25 CELSR2 MFSD5 SPATA13	2.33e-08	1105	416	37	35748872
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	MRPS31 KIAA0319L BIRC6 TUFM CEMIP2 FAT1 BAIAP2 APBB1 APOB KBTBD2 AP3B1 PCF11 LRIG3 IGBP1 DOCK7 ATP1A1 ATP5F1A UBXN4 BRCA1 DLG3 DYNC1H1 DSG2 MUC16 CEP192 HUWE1 DNAH7 ANKRD46 CDC42EP1 ARFGEF3 TMF1	2.46e-08	777	416	30	35844135
Pubmed	Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV.	ERBB3 CEMIP2 FAT1 PSAT1 SMPD4 APOB MEAK7 PRPF40A SLC4A2 LRIG3 GET4 PDE4DIP NR5A2 TTI1 ATP12A GFM1 SNX2 CYB5A STT3A B4GALT1 FAM20C NF1 PTPRS RAB2A ABCC10 GPD2 NSF RBM4B HUWE1 DENND11 CELSR2 TMTC4 LRP11 TMF1 ZW10 MFSD5	2.62e-08	1061	416	36	33845483
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	MRPS31 ZC3H14 ERCC6 AKAP17A TRRAP TUFM CRACD NMT2 KMT2A CHD6 BAIAP2 MRE11 RNF169 AP3B1 VIRMA PCF11 STAU2 ANKRD17 UNK KDM1B CTNND2 CROCC STAG2 ATP5F1A EMC1 PCNX3 DHX33 ITPRID2 CTTNBP2NL LUZP1 MPRIP TDRD3 TRMT10C UBXN4 PNPLA6 BRCA1 DLG3 UACA DSG2 NSF RBBP6 RBM4B LAMA5 TMF1	4.68e-08	1497	416	44	31527615
Pubmed	CYLD Regulates Centriolar Satellites Proteostasis by Counteracting the E3 Ligase MIB1.	PATZ1 KDM1B ATP5F1A PTK2 MPRIP PNPLA6 MTCL1 DYNC1H1 IPO5 UACA NSF LARP1 HUWE1 RFC1	4.81e-08	182	416	14	31067453
Pubmed	C5orf51 is a component of the MON1-CCZ1 complex and controls RAB7A localization and stability during mitophagy.	KIAA0319L CEMIP2 PIK3R1 FNIP1 RIC1 VPS26B KIF16B APBB1 DENND4C SLC4A2 LRIG3 SNX2 EMC1 UBXN4 GPD2 DMXL2 DSG2 ANKRD46 ARFGEF3 FAM171A1 TMF1 ZW10 VPS13B	5.84e-08	504	416	23	34432599
Pubmed	Why do cellular proteins linked to K63-polyubiquitin chains not associate with proteasomes?	CRACD FAT1 P4HTM ZNF792 SPAG1 MUC16 CEP192 HUWE1 LARP1B DNAH7 KLHL11 BRF1 TIAM1	1.55e-07	170	416	13	23314748
Pubmed	The interactome of CLUH reveals its association to SPAG5 and its co-translational proximity to mitochondrial proteins.	ZC3H14 AKAP17A PTER PHKA2 IFT74 PDP1 STAU2 ANKRD17 GFM1 ATP5F1A DYNC1H1 LARP1 LIG3 ZNF106	1.87e-07	203	416	14	35012549
Pubmed	A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins.	TRRAP BIRC6 F13A1 ERI3 FGD1 BAIAP2 RAB11FIP2 DENND4C SCYL2 LRIG3 MRPL48 STAU2 CNPY3 ATP2B1 SNX2 SMG1 SPAG1 EMC1 CDS2 STT3A PNPLA6 ABCD4 UACA DSG2 CEP192 RALGAPA2 TMF1	2.17e-07	719	416	27	35337019
Pubmed	mTORC1 activity regulates post-translational modifications of glycine decarboxylase to modulate glycine metabolism and tumorigenesis.	ZC3H14 DNAJC10 DDX41 JCAD PRPF40A RBM39 ITPRID2 LUZP1 MPRIP SVIL UACA DSG2 RBBP6 ZNF629 LARP1 LARP1B	2.46e-07	274	416	16	34244482
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	ZC3H14 TRRAP TUFM UBA1 KMT2A MRE11 IFT74 APBB1 PTPN23 AP3B1 PRPF40A SCYL2 TET1 DOCK7 SNX2 MYCBP2 LUZP1 MPRIP DYNC1H1 DSG2 RBBP6 LARP1 HUWE1	2.66e-07	549	416	23	38280479
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	MECOM BIRC6 CEMIP2 MEX3A CHD6 BAIAP2 RNF169 SMPD4 DENND4C SLC4A2 ZNF792 UNK CEP295 CROCC GFM1 MYCBP2 STT3A TDRD3 UBXN4 GCFC2 RBM4 MFSD9 LARP1 HUWE1 ZNF106 BBS7 TMF1	3.16e-07	733	416	27	34672954
Pubmed	Prediction of the coding sequences of unidentified human genes. XVIII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	KIF16B CACHD1 MEAK7 SFMBT2 ANKRD36B CADPS2 UACA CEP192 HUWE1 ZNF532	3.93e-07	101	416	10	10997877
Pubmed	MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development.	ZC3H14 HIF1A ERCC6 PANK2 MEX3A CLN5 SEMA6A RC3H2 ATP2B1 PROX1 MYCBP2 DYNC1H1 FZD3 RBBP6 LARP1 HUWE1 KIF3A CELSR2	4.04e-07	358	416	18	32460013
Pubmed	Protein-protein interactions between large proteins: two-hybrid screening using a functionally classified library composed of long cDNAs.	ABCA2 SEMA6A CACHD1 CADPS CADPS2 IFT140 FRMPD4 MYO5B KATNIP UACA ZNFX1	5.11e-07	130	416	11	12421765
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	BIRC6 CHD6 PTPN23 CADPS PCNX1 SMG1 MYCBP2 ERAP1 TLK1 CAMTA1 PRUNE2 DMXL2 PSD3 KAT6B	6.51e-07	225	416	14	12168954
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	BIRC6 FAT2 MYO15B RIC1 RNF169 ZNF618 GAS7 PTPN23 MEAK7 PCF11 SSH2 MYO5B TRIM66 TLK1 GRIN3A DOCK3 PRUNE2 DMXL2 UACA ZNF629 RALGAPA2	6.77e-07	493	416	21	15368895
Pubmed	Impaired OTUD7A-dependent Ankyrin regulation mediates neuronal dysfunction in mouse and human models of the 15q13.3 microdeletion syndrome.	PLPPR3 BAIAP2 PDE4DIP KNDC1 CACNG4 FRMPD4 LZTS3 PLPPR4 DLG3 ADGRL3 SHANK1 DOCK3 ARFGEF3	8.43e-07	197	416	13	36604605
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	ZC3H14 TRRAP TUFM UBA1 MACROH2A2 DDX41 MRE11 PRPF40A RBM39 DOCK7 ATP1A1 ATP2B1 STAG2 ATP5F1A SNX2 EMC1 MYO5B MYCBP2 MYO9B ITPRID2 NF1 SVIL DYNC1H1 IPO5 GPD2 DSG2 NSF RBM4B RBM4 HUWE1 LIG3 BBS7	9.63e-07	1024	416	32	24711643
Pubmed	Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors.	ERBB3 ELOA2 ETFDH F13A1 TUFM ZBP1 FAT1 DNAJC10 CDIPT MMP11 SLC25A17 AMPD2 HSD17B7 KIF16B PTPN23 PRPF40A RBM39 GFM2 CRP SLC4A2 NAXD ATP1A1 GFM1 ATP2B1 ATP5F1A CYB5A EMC1 ERAP1 CDS2 LUZP1 STT3A UBXN4 PTPRK RAB2A IPO5 GPD2 NSF LAMA5 CELSR2 PNPLA7	1.01e-06	1451	416	40	30550785
Pubmed	A ubiquitin-based effector-to-inhibitor switch coordinates early brain, craniofacial, and skin development.	COL6A3 ENC1 COPS3 KBTBD2 KBTBD4 KBTBD6 KLHL11 KLHL5 KLHL25	1.04e-06	87	416	9	37495603
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	MRPS31 CSMD2 BIRC6 TUFM ADRA1D MYO15B CDIPT PKHD1 CHD6 NCR1 MRE11 UBQLNL ZNF618 CEP295 ARHGAP11A ITGAE CTTNBP2NL IGSF10 DIP2A TDRD3 FAM20C MTCL1 DYNC1H1 LARP1 HUWE1 LIG3	1.14e-06	736	416	26	29676528
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	F13A1 ADH5 AFMID PLAA PIK3R1 RXFP2 SHLD2 MRE11 AMPD2 ENC1 PTPN23 APOB AP3B1 TET1 ANKRD17 CEP295 KDM1B ATP2B1 STAG2 ATP5F1A DZIP1L CDS2 C5orf34 COQ8A SPIN1 KCNJ3 CAMTA1 RAB2A CEP192 HUWE1 TGM4 KLHL5 VPS13B	1.15e-06	1084	416	33	11544199
Pubmed	Decreased lymphatic HIF-2α accentuates lymphatic remodeling in lymphedema.	HIF1A FLT4 PROX1 EPAS1	1.36e-06	8	416	4	32673288
Pubmed	A candidate spermatogenesis gene on the mouse Y chromosome is homologous to ubiquitin-activating enzyme E1.	PHEX UBA1 DMD EDA	1.36e-06	8	416	4	1749428
Pubmed	Phosphorylation switches protein disulfide isomerase activity to maintain proteostasis and attenuate ER stress.	DNAJC10 DDX41 SMPD4 AP3B1 STAU2 ATP1A1 STT3A FAM20C BPNT2 UBXN4 IPO5 CDC42EP1	1.40e-06	174	416	12	32149426
Pubmed	Tumor suppressor BAP1 nuclear import is governed by transportin-1.	MRPS31 TUFM ADH5 PHKA2 UBA1 DDX41 MRE11 PSAT1 NAA15 COPS3 AP3B1 WDR26 PRPF40A RBM39 STAU2 DOCK7 ANKRD17 ATP1A1 CTSD ATP5F1A SNX2 MYCBP2 LUZP1 SPIN1 SVIL DYNC1H1 IPO5 NSF RBM4 LARP1 HUWE1 RFC1 LIG3 ZW10	1.47e-06	1149	416	34	35446349
Pubmed	E-cadherin interactome complexity and robustness resolved by quantitative proteomics.	ERBB3 CEMIP2 BAIAP2 JCAD MRE11 CARMIL1 DENND4C SCYL2 IGBP1 STXBP6 ATP2B1 SNX2 SPAG1 ITPRID2 LUZP1 MPRIP SVIL NHS UACA DSG2 LARP1 CDC42EP1	1.62e-06	565	416	22	25468996
Pubmed	Systematic analysis of human protein complexes identifies chromosome segregation proteins.	FANCC PHKA2 UBA1 PLAA ASPM CCDC15 DDX41 HSD17B7 NAA15 CARMIL1 COPS3 RBM39 PCF11 PPP2R1B IGBP1 STAG2 CTTNBP2NL B4GALT1 MPRIP BCLAF3 TLK1 SVIL SGO2 MTCL1 DYNC1H1 IPO5 NPR1 UACA DSG2 LARP1 CEP192 ZNF106 ZW10 VPS13B	1.65e-06	1155	416	34	20360068
Pubmed	Neurofibromatosis with male breast cancer--risk factor or co-incidence? Report of two rare cases.	NF1 BRCA1 BRCA2	1.70e-06	3	416	3	25267367
Pubmed	Expression and characterization of hypoxia-inducible factor (HIF)-3alpha in human kidney: suppression of HIF-mediated gene expression by HIF-3alpha.	HIF1A HIF3A EPAS1	1.70e-06	3	416	3	11573933
Pubmed	Cloning and characterization of human CADPS and CADPS2, new members of the Ca2+-dependent activator for secretion protein family.	CADPS CADPS2 DMD	1.70e-06	3	416	3	12659812
Pubmed	Tet1 facilitates hypoxia tolerance by stabilizing the HIF-α proteins independent of its methylcytosine dioxygenase activity.	HIF1A TET1 EPAS1	1.70e-06	3	416	3	29036334
Pubmed	Hypoxia-inducible factor (HIF)-3alpha is subject to extensive alternative splicing in human tissues and cancer cells and is regulated by HIF-1 but not HIF-2.	HIF1A HIF3A EPAS1	1.70e-06	3	416	3	20416395
Pubmed	Cockayne syndrome group B protein regulates fork restart, fork progression and MRE11-dependent fork degradation in BRCA1/2-deficient cells.	ERCC6 MRE11 BRCA1	1.70e-06	3	416	3	34871413
Pubmed	Pilot Study on the Effect of Patient Condition and Clinical Parameters on Hypoxia-Induced Factor Expression: HIF1A, EPAS1 and HIF3A in Human Colostrum Cells.	HIF1A HIF3A EPAS1	1.70e-06	3	416	3	39456823
Pubmed	HIF-1α overexpression in ductal carcinoma in situ of the breast in BRCA1 and BRCA2 mutation carriers.	HIF1A BRCA1 BRCA2	1.70e-06	3	416	3	23409121
Pubmed	Progress on hypoxia-inducible factor-3: Its structure, gene regulation and biological function (Review).	HIF1A HIF3A EPAS1	1.70e-06	3	416	3	25936862
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	MRPS31 CEMIP2 DNAJC10 PIK3R1 ASPM SEMA6A BAIAP2 NAA15 KIF16B APBB1 SMPD4 AP3B1 PRPF40A SLC4A2 PCF11 MRPL48 STAU2 ATP2B1 SNX2 EMC1 MYCBP2 ITPRID2 STT3A MPRIP DIP2A C5orf34 TRMT10C UBXN4 PNPLA6 DMXL2 UACA DSG2 NSF PSD3 CEP192 CDC42EP1 FAM171A1 TIAM1 BBS7 VPS13B	1.83e-06	1487	416	40	33957083
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	UBA1 MRE11 CARMIL1 PTPN23 CACHD1 AP3B1 PRPF40A DENND4C SCYL2 DOCK7 ANKRD17 ATP1A1 ATP2B1 ATP5F1A STT3A DYNC1H1 IPO5 GPD2 DSG2 NSF PSD3 LARP1 CDC42EP1 GRIP1 FAM171A1	1.85e-06	708	416	25	39231216
Pubmed	Interactome Analysis of Human Phospholipase D and Phosphatidic Acid-Associated Protein Network.	AP3B1 GFM2 CNPY3 ATP12A GFM1 SPAG1 EMC1 ERAP1 STT3A B4GALT1 PNPLA6 COQ8A GPD2 LRP11 PNPLA7	1.87e-06	282	416	15	35007762
Pubmed	Defining the membrane proteome of NK cells.	ABCA2 BIRC6 TUFM DNAJC10 PIK3R1 CDIPT DDX41 SLC25A17 NAA15 AP3B1 PRPF40A SLC4A2 STAU2 ANKRD17 ATP2B1 STAG2 ATP5F1A CYB5A MYCBP2 ERAP1 MYO9B CDS2 LUZP1 STT3A B4GALT1 BPNT2 NF1 PNPLA6 DYNC1H1 IPO5 LARP1 HUWE1 ZW10 MFSD5	2.11e-06	1168	416	34	19946888
Pubmed	A human MAP kinase interactome.	PIK3R1 CHD6 BAIAP2 ZNF823 GAS7 PTPN23 ANKRD17 IFT140 ITPRID2 PTK2 TLK1 HPS4 DMD SHANK1 RBBP6 RBM4B KIF3A CDC42EP1 ZNF106 EPAS1	2.11e-06	486	416	20	20936779
Pubmed	A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.	MRPS31 TUFM ZBP1 CRACD DNAJC10 KMT2A DDX41 PSAT1 SMPD4 COPS3 WDR26 RBM39 GFM2 PPP2R1B STAU2 DOCK7 ATP1A1 ATP2B1 STAG2 ATP5F1A SMG1 EMC1 ITPRID2 ARHGAP11A PDCD4 STT3A TRMT10C COQ8A DYNC1H1 IPO5 GPD2 UACA NSF LARP1 HUWE1 RFC1 ARFGEF3 LIG3 ZW10	2.11e-06	1440	416	39	30833792
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	BIRC6 BAIAP2 JCAD AMPD2 RAB11FIP2 DENND4C IGBP1 DOCK7 UNK CEP295 CTTNBP2NL LUZP1 NF1 MTCL1 PARP8 LARP1 CEP192 CDC42EP1 GRIP1	2.30e-06	446	416	19	24255178
Pubmed	Large-scale proteomics and phosphoproteomics of urinary exosomes.	PTER CEMIP2 ADH5 FAT1 UBA1 TMEM38A PKHD1 BAIAP2 COL6A3 PSAT1 PTPN23 NOX3 SLC4A1 SLC15A2 CROCC CTSD ATP5F1A MYO5B ALDH1L1 B4GALT1 FAM20C RAB2A DYNC1H1 KNG1 DPEP1 UACA LAMA5 HUWE1 KIF3A TGM4 EGF	2.33e-06	1016	416	31	19056867
Pubmed	Promoting anti-tumor immunity by targeting TMUB1 to modulate PD-L1 polyubiquitination and glycosylation.	AP3B1 SCYL2 DOCK7 ATP1A1 STT3A SPIN1 IPO5 HUWE1	2.40e-06	72	416	8	36376293
Pubmed	Characterization of genes encoding translation initiation factor eIF-2gamma in mouse and human: sex chromosome localization, escape from X-inactivation and evolution.	PHEX UBA1 DMD EDA	2.42e-06	9	416	4	9736774
Pubmed	The TRIM9/TRIM67 neuronal interactome reveals novel activators of morphogenesis.	PLPPR3 PIK3CA SLC25A17 UNK CTNND2 CDS2 LUZP1 TDRD3 PLPPR4 DLG3 KATNIP AZI2 GRIP1	2.61e-06	218	416	13	33378226
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	ZC3H14 UBA1 MEX3A CDIPT FER BAIAP2 MRE11 RC3H2 AP3B1 STAU2 DOCK7 ANKRD17 UNK ATP1A1 MYCBP2 PTK2 LUZP1 MPRIP TDRD3 BRCA1 UACA RBM4 ZNF629 LARP1 LARP1B	2.75e-06	724	416	25	36232890
Pubmed	Combinatorial CRISPR screen identifies fitness effects of gene paralogues.	ASPM KMT2A FNIP1 STXBP6 SMG1 CDS2 TLK1 PTPRS IPO5 GCFC2 LARP1 LARP1B	2.81e-06	186	416	12	33637726
Pubmed	Proteomic, functional, and domain-based analysis of in vivo 14-3-3 binding proteins involved in cytoskeletal regulation and cellular organization.	PIK3R1 FER SHPRH BAIAP2 RAB11FIP2 PRPF40A DOCK7 ATP5F1A MYCBP2 MPRIP SVIL DYNC1H1 LARP1 TIAM1	2.85e-06	255	416	14	15324660
Pubmed	Fibril treatment changes protein interactions of tau and α-synuclein in human neurons.	CRACD MACROH2A2 AMT IFT74 APBB1 PTPN23 AP3B1 PPP2R1B CADPS TTI1 STAG2 SMG1 STT3A SVIL CDC73 IPO5 DMXL2 LARP1 KIF3A GRIP1	3.04e-06	498	416	20	36634849
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	AKAP17A TRRAP TUFM DNAJC10 CDIPT MACROH2A2 CHD6 DDX41 ZNF618 SMPD4 PRPF40A RBM39 PCF11 MRPL48 STAU2 DOCK7 KDM1B PROX1 EMC1 MYCBP2 STT3A TRMT10C SPIN1 GPC2 DYNC1H1 GPD2 DMXL2 RBBP6 RBM4 ZNF629 LIG3 ZNF532	3.06e-06	1082	416	32	38697112
Pubmed	Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.	ZC3H14 HIF1A TUFM ADH5 PIK3CA PIK3R1 PSAT1 AP3B1 PRPF40A RBM39 PPM1B IGBP1 ANKRD17 ATP1A1 ATP1A3 ATP5F1A MYO5B MYO9B PDCD4 LUZP1 MPRIP SVIL NHS RAB2A DYNC1H1 ADSS1 IPO5 UACA NSF RBBP6 LARP1 HUWE1 RFC1 KIF3A LIG3	3.33e-06	1247	416	35	27684187
Pubmed	Functional proteomics mapping of a human signaling pathway.	ERCC6 CREBZF PHKA2 CHD6 MMP11 FLT4 PRPF40A SCYL2 PDE4DIP RUBCN SMG1 MYCBP2 MAST4 DYNC1H1 NPR1 RBBP6 RBM4 LAMA5 HUWE1 GRIP1 ZNF106 EPAS1	3.35e-06	591	416	22	15231748
Pubmed	The Hsp70-Hsp90 co-chaperone Hop/Stip1 shifts the proteostatic balance from folding towards degradation.	TUFM UBA1 DNAJC10 DDX41 MRE11 NAA15 PTPN23 AP3B1 WDR26 RBM39 SCYL2 ATP1A1 STAG2 SNX2 COQ8A CDC73 DYNC1H1 IPO5 DSG2 NSF RBM4 HUWE1 ZW10	3.41e-06	638	416	23	33239621
Pubmed	Tagging genes with cassette-exchange sites.	BIRC6 PLAA RNF169 NAA15 ENC1 AP3B1 PRPF40A RBM39 TET1 PTK2 TLK1 CDC73 NSF LARP1 BRF1 KAT6B	3.44e-06	335	416	16	15741177
Pubmed	The E3 ubiquitin ligase FBXL6 controls the quality of newly synthesized mitochondrial ribosomal proteins.	MRPS31 PATZ1 TUFM CDIPT FER MRE11 RC3H2 COPS3 RBM39 GET4 STAU2 ANKRD17 ATP1A1 SPAG1 PDCD4 STT3A IPO5 RBBP6 RBM4 ZNF629 HUWE1	3.48e-06	547	416	21	37267103
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	MECOM BIRC6 CHD6 IFT74 WDR26 SFMBT2 DENND4C TET1 DOCK7 ANKRD17 PROX1 MYCBP2 C15orf39 LUZP1 BRCA2 HUWE1 ZNF532 TMF1	3.65e-06	418	416	18	34709266
Pubmed	Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma.	ERBB3 CEMIP2 GAS7 DOCK7 ATP1A1 ATP2B1 PCNX3 DIP2A NF1 PTPRK PTPRS DMD UACA DSG2 PSD3 CDC42EP1 TIAM1	3.69e-06	377	416	17	38117590
Pubmed	Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.	MECOM SHPRH KMT2A MACROH2A2 CHD6 RNF169 IFT74 DENND4C IGBP1 DOCK7 KDM1B MYCBP2 ARHGAP11A PDCD4 LUZP1 BRCA1 SGO2 KBTBD6 ZNF629 HUWE1 RFC1 KIF3A LIG3	4.08e-06	645	416	23	25281560
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	MRPS31 TUFM UBA1 DDX41 MRE11 PSAT1 DIABLO BIRC3 APOB COPS3 AP3B1 PRPF40A RBM39 DOCK7 ATP1A1 GFM1 CTSD ATP2B1 STAG2 ATP5F1A SNX2 EMC1 STT3A TRMT10C NF1 SGO2 CDC73 RAB2A DYNC1H1 IPO5 GPD2 DSG2 NSF RBM4 LARP1 HUWE1 RFC1 LIG3	4.11e-06	1425	416	38	30948266
Pubmed	Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	FRMPD4 TRIM66 MAST4 DYNC1H1 DOCK3 PRUNE2 ZNF629 HUWE1 KAT6B	4.64e-06	104	416	9	9205841
Pubmed	Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.	MRPS31 MECOM TRRAP BIRC6 CRACD UBA1 MEX3A PIK3CA ARIH2 ASPM KMT2A MRE11 HSD17B7 VIRMA RBM39 IGBP1 GET4 SLC15A2 PRKAB1 NR5A2 ANKRD17 SSH2 ATP1A3 NKAIN3 ATP5F1A CCDC125 MCM8 TLK1 NF1 NUAK1 NHS RAB2A IPO5 ZNF629 ZNF106 BRF1	5.11e-06	1327	416	36	32694731
Pubmed	Genomic analysis of mouse retinal development.	HIF1A ABCA2 CREBZF FANCC FAM161A PIK3R1 KMT2A DYRK2 RNF169 RBM39 GET4 CADPS PDE4DIP PRKAB1 UNK CACNG4 CROCC PCNX3 ARHGAP11A PTK2 PTPRS KATNIP IMPG2 FZD3 ZNF629 PSD3 RFC1 KLHL25 BBS7 PNPLA7	5.34e-06	1006	416	30	15226823
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	MRPS31 ELOA2 TUFM PHEX DNAJC10 FAM161A ASPM PKHD1 KMT2A CHD6 PICK1 APOB SFMBT2 PCF11 MLIP CEP295 ATP1A1 ATP1A3 ATP12A CADPS2 ATP2B1 STAG2 ATP5F1A SMG1 SPAG1 MYO5B DZIP1L LUZP1 TLK1 UBXN4 BRCA1 DLG3 KDR DMD PARP8 LARP1 CCDC158 SPATA13	5.39e-06	1442	416	38	35575683
Pubmed	USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.	TUFM FAT2 ASPM DIABLO VIRMA PRPF40A RBM39 MPRIP KDR DMD RFC1 KLHL5 VPS13B	5.67e-06	234	416	13	36243803
Pubmed	Large-scale mapping of human protein-protein interactions by mass spectrometry.	CDO1 AKAP17A TRRAP TUFM FANCC PANK2 PIK3R1 CLN5 ASPM BAIAP2 DDX41 RAB11FIP2 SMPD4 COPS3 AP3B1 PRPF40A PPM1B GET4 PRKAB1 EMC1 MYCBP2 PDCD4 PTK2 MPRIP TLK1 NUAK1 PTPRS SGO2 DLG3 DYNC1H1 NSF LARP1 LIG3 TIAM1 ZW10	6.27e-06	1284	416	35	17353931
Pubmed	LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy.	TUFM DOCK7 ANKRD17 ATP1A1 MYO9B ITPRID2 MPRIP IPO5 UACA LARP1 ZNFX1 TIAM1	6.57e-06	202	416	12	33005030
Pubmed	Regulation of error-prone translesion synthesis by Spartan/C1orf124.	TUFM RBM39 ATP1A1 ATP5F1A DYNC1H1 HUWE1 RFC1	6.65e-06	59	416	7	23254330
Pubmed	Lactate dehydrogenase 5 expression in non-Hodgkin B-cell lymphomas is associated with hypoxia regulated proteins.	HIF1A KDR EPAS1	6.74e-06	4	416	3	19021062
Pubmed	Targeting the hypoxia-sensing pathway in clinical hematology.	HIF1A HIF3A EPAS1	6.74e-06	4	416	3	24371328
Pubmed	Coinheritance of BRCA1 and BRCA2 mutations with Fanconi anemia and Bloom syndrome mutations in Ashkenazi Jewish population: possible role in risk modification for cancer development.	FANCC BRCA1 BRCA2	6.74e-06	4	416	3	15726604
Pubmed	ADP-ribosylation factor 1 controls the activation of the phosphatidylinositol 3-kinase pathway to regulate epidermal growth factor-dependent growth and migration of breast cancer cells.	PIK3CA PIK3R1 EGF	6.74e-06	4	416	3	18990689
Pubmed	Conditional hypoxia inducible factor-1α induction in embryonic pulmonary epithelium impairs maturation and augments lymphangiogenesis.	HIF1A HIF3A EPAS1	6.74e-06	4	416	3	22094019
Pubmed	The action of HIF-3α variants on HIF-2α-HIF-1β heterodimer formation is directly probed in live cells.	HIF1A HIF3A EPAS1	6.74e-06	4	416	3	26160453
Pubmed	Lymphatic ontogeny and effect of hypoplasia in developing lung.	FLT4 PROX1 KDR	6.74e-06	4	416	3	20932899
Pubmed	DCIS in BRCA1 and BRCA2 mutation carriers: prevalence, phenotype, and expression of oncodrivers C-MET and HER3.	ERBB3 BRCA1 BRCA2	6.74e-06	4	416	3	26496879
Interaction	YWHAG interactions	AKAP17A PTER TRRAP CRACD UBA1 PANK2 PIK3R1 SHPRH KMT2A FNIP1 BAIAP2 DDX41 JCAD RC3H2 AMPD2 NAA15 DIABLO CARMIL1 RAB11FIP2 APBB1 VIRMA PRPF40A DENND4C TET1 DOCK7 ANKRD17 UNK SSH2 RUBCN ATP5F1A SNX2 MYCBP2 DZIP1L ITPRID2 PDCD4 PTK2 LUZP1 MPRIP NF1 MAST4 NUAK1 SVIL NHS KDR MTCL1 DYNC1H1 UACA DSG2 PARP8 ZNF629 PSD3 LARP1 CEP192 HUWE1 LARP1B DNAH7 CDC42EP1 GRIP1 FAM171A1 ZNF106 TIAM1 SPATA13	2.48e-11	1248	402	62	int:YWHAG
Interaction	YWHAH interactions	ZC3H14 ABCA2 UBA1 PANK2 PIK3CA KMT2A FNIP1 BAIAP2 JCAD AMPD2 DIABLO IFT74 CARMIL1 RAB11FIP2 APBB1 WDR26 VIRMA DENND4C TET1 DOCK7 ANKRD17 SSH2 RUBCN SNX2 CCDC125 EMC1 MYCBP2 ITPRID2 PDCD4 LUZP1 MPRIP NF1 MAST4 NUAK1 SVIL NHS MTCL1 UACA DSG2 PARP8 ZNF629 PSD3 LARP1 CEP192 HUWE1 LARP1B DNAH7 CDC42EP1 GRIP1 ARFGEF3 FAM171A1 ZNF106 TIAM1 SPATA13	9.29e-10	1102	402	54	int:YWHAH
Interaction	YWHAZ interactions	ERBB3 TUFM CRACD UBA1 PANK2 PIK3R1 KMT2A BAIAP2 JCAD AMPD2 DIABLO RAB11FIP2 AP3B1 VIRMA RBM39 DENND4C DOCK7 ANKRD17 UNK SSH2 ATP1A1 CTSD ATP2B1 RUBCN ATP5F1A CCDC125 MYCBP2 ITPRID2 LUZP1 MPRIP FSIP2 NF1 MAST4 BRCA1 SVIL NHS KATNIP RAB40B CDC73 DYNC1H1 DMXL2 UACA DSG2 NSF PARP8 ZNF629 PSD3 LARP1 CEP192 HUWE1 CDC42EP1 GRIP1 FAM171A1 TIAM1 SPATA13	1.64e-07	1319	402	55	int:YWHAZ
Interaction	C11orf52 interactions	CEMIP2 PIK3R1 CDIPT SEMA6A BAIAP2 CARMIL1 CACHD1 SLC4A2 SCYL2 DOCK7 ATP1A1 ATP2B1 STT3A DIP2A DLG3 UACA DSG2 PSD3 CDC42EP1 GRIP1 FAM171A1 TIAM1	3.30e-07	311	402	22	int:C11orf52
Interaction	YWHAE interactions	CRACD UBA1 PANK2 PIK3R1 KMT2A BAIAP2 JCAD RC3H2 AMPD2 DIABLO RAB11FIP2 BIRC3 VIRMA RBM39 DENND4C PPM1B TET1 DOCK7 ANKRD17 UNK SSH2 ATP1A1 RUBCN ATP5F1A CCDC125 MYCBP2 ITPRID2 PDCD4 LUZP1 MPRIP TLK1 NF1 MAST4 BRCA1 NUAK1 SPIN1 SVIL NHS CDC73 DYNC1H1 NRAP PARP8 ZNF629 PSD3 LARP1 HUWE1 CDC42EP1 GRIP1 FAM171A1 ZNF106 TIAM1 SPATA13	4.62e-07	1256	402	52	int:YWHAE
Interaction	SFN interactions	HIF1A KMT2A BAIAP2 JCAD AMPD2 CARMIL1 WDR26 VIRMA RBM39 DENND4C IGBP1 DOCK7 ANKRD17 SSH2 CTSD CCDC125 MYCBP2 ITPRID2 ARHGAP11A LUZP1 MPRIP MAST4 SVIL NHS CDC73 IPO5 DSG2 ZNF629 LARP1 CEP192 CDC42EP1 GRIP1 FAM171A1 TIAM1	1.40e-06	692	402	34	int:SFN
Interaction	KCTD13 interactions	TUFM CRACD UBA1 NMT2 CDIPT KMT2A BAIAP2 CARMIL1 COPS3 AP3B1 VIRMA PRPF40A RBM39 SLC4A1 PPP2R2C MLIP CADPS MRPL48 DOCK7 KNDC1 SSH2 ATP1A1 CTNND2 ATP1A3 CROCC ATP2B1 ATP5F1A SNX2 LZTS3 MYO5B ALDH1L1 LUZP1 MPRIP DIP2A NF1 PNPLA6 PLPPR4 PTPRS SVIL DLG3 DMD RAB2A DYNC1H1 KNG1 SHANK1 IPO5 GPD2 DMXL2 NSF L1CAM PSD3 LARP1 ZNFX1 KIF3A	2.09e-06	1394	402	54	int:KCTD13
Interaction	ARF6 interactions	KIAA0319L CEMIP2 PIK3R1 NMT2 CDIPT FGD1 FLT4 APBB1 SMPD4 CACHD1 AP3B1 DENND4C SLC4A2 PCF11 PDE4DIP DOCK7 RAB11FIP4 ATP1A1 ATP2B1 SNX2 UBXN4 DMD RAB2A DYNC1H1 DSG2 PSD3 DNAH7 CDC42EP1 ARFGEF3 TIAM1	2.46e-06	584	402	30	int:ARF6
Interaction	MKRN2 interactions	ZC3H14 HIF1A ERCC6 UBA1 PANK2 CLN5 SEMA6A RC3H2 STAU2 ATP2B1 PROX1 SMG1 TDRD3 BRCA1 DYNC1H1 FZD3 RBM4B RBM4 LARP1 CEP192 LARP1B KIF3A CELSR2	3.31e-06	385	402	23	int:MKRN2
Interaction	NR3C1 interactions	ELOA2 CSMD2 PTER TUFM CDIPT FNIP1 MACROH2A2 CHD6 FAM149A ZNF823 JCAD KIF16B APBB1 AP3B1 VIRMA ANKRD36B PDP1 ANKRD17 CEP295 ATP1A1 CTNND2 ATP2B1 STAG2 ATP5F1A SMG1 CDS2 NF1 COQ8A SVIL MTCL1 DOCK3 RBM4 MUC16 ZNFX1 RFC1 DNAH7 GRIP1 LIG3 BBS7 TMF1 EPAS1	5.63e-06	974	402	41	int:NR3C1
Interaction	EGLN3 interactions	HIF1A BIRC6 TUFM MEX3A PLAA ASPM JCAD MRE11 IKZF3 IFT74 APBB1 BIRC3 CACHD1 WDR26 PPM1B PCF11 PPP2R1B IGBP1 GET4 DOCK7 ANKRD17 CEP295 ATP1A1 GFM1 ATP5F1A SNX2 MYCBP2 C15orf39 STT3A TRMT10C PNPLA6 BRCA1 BRCA2 PTPRK COQ8A SGO2 MTCL1 DYNC1H1 IPO5 DMXL2 DSG2 NSF RBM4 CEP192 AZI2 HIF3A CDC42EP1 FAM171A1 ZNF106 EPAS1	5.82e-06	1296	402	50	int:EGLN3
Interaction	ARRDC4 interactions	ABCA3 KIF16B GET4 TRIM66 NF1 PTPRS SVIL DSG2 HUWE1 ARFGEF3	5.93e-06	83	402	10	int:ARRDC4
Interaction	YWHAQ interactions	PANK2 KMT2A BAIAP2 JCAD AMPD2 RAB11FIP2 VIRMA RBM39 DENND4C TET1 DOCK7 ANKRD17 SSH2 ATP5F1A SNX2 CCDC125 MYCBP2 ITPRID2 PDCD4 LUZP1 MPRIP NF1 MAST4 BRCA1 SVIL NHS RAB40B CDC73 DYNC1H1 UACA DSG2 PARP8 ZNF629 PSD3 LARP1 CEP192 LARP1B RFC1 DNAH7 CDC42EP1 GRIP1 FAM171A1 ZNF106 TIAM1 SPATA13	6.12e-06	1118	402	45	int:YWHAQ
Interaction	YWHAB interactions	TRRAP PANK2 FER KMT2A BAIAP2 RC3H2 AMPD2 RAB11FIP2 VIRMA DENND4C DOCK7 ANKRD17 UNK SSH2 ATP5F1A EMC1 MYCBP2 ITPRID2 LUZP1 MPRIP NF1 MAST4 NUAK1 SVIL NHS MTCL1 CDC73 DYNC1H1 IPO5 UACA DSG2 PARP8 ZNF629 PSD3 LARP1 CEP192 CDC42EP1 GRIP1 FAM171A1 ZNF106 TIAM1 SPATA13	6.39e-06	1014	402	42	int:YWHAB
Interaction	RHOQ interactions	CEMIP2 FAT1 PIK3CA PIK3R1 SEMA6A BAIAP2 CARMIL1 CACHD1 SLC4A2 SCYL2 ATP1A1 ATP2B1 NF1 PTPRK PTPRS DLG3 DSG2 NSF PSD3 RALGAPA2 CDC42EP1 ARFGEF3 FAM171A1 TIAM1	1.02e-05	442	402	24	int:RHOQ
Interaction	GJA1 interactions	KIAA0319L CEMIP2 PIK3CA PIK3R1 KIF16B APBB1 SMPD4 APOB CACHD1 DENND4C PPM1B SLC4A2 SCYL2 LRIG3 ATP1A1 ATP2B1 ATP5F1A PCNX3 UBXN4 RAB2A DPEP1 UACA DSG2 PSD3 FAM171A1 TIAM1 TMF1 VPS13B	1.85e-05	583	402	28	int:GJA1
Interaction	GLDC interactions	ZC3H14 DNAJC10 DDX41 JCAD AMT PRPF40A RBM39 ATP5F1A ITPRID2 LUZP1 MPRIP SVIL UACA DSG2 RBBP6 ZNF629 LARP1 LARP1B SPATA13	2.68e-05	321	402	19	int:GLDC
Interaction	VASP interactions	XIRP1 HIF1A FAT1 BAIAP2 IFT74 APBB1 PTPN23 VIRMA PRPF40A SCYL2 XIRP2 CTSD CTTNBP2NL SVIL NHS DSG2 CEP192 ARFGEF3	2.79e-05	294	402	18	int:VASP
Interaction	ELOB interactions	HIF1A ELOA2 IKZF1 ARIH2 KMT2A RC3H2 IKZF3 COPS3 RAB40C CNPY3 COQ8A RAB40B CDC73 DYNC1H1 IPO5 LARP1 HUWE1 KLHL25 EPAS1	3.45e-05	327	402	19	int:ELOB
Interaction	RHOB interactions	CEMIP2 FAT1 UBA1 PIK3R1 BAIAP2 CARMIL1 RAB11FIP2 KIF16B APBB1 CACHD1 SCYL2 DOCK7 ATP1A1 ATP2B1 SPAG1 PCNX3 MYO9B ARHGAP11A STT3A MPRIP DIP2A TRMT10C NF1 PTPRK PTPRS DLG3 RAB2A UACA DSG2 NSF PSD3 RALGAPA2 CDC42EP1 FAM171A1 TIAM1	3.47e-05	840	402	35	int:RHOB
Interaction	GRIN2B interactions	PLPPR3 SHC2 PIK3CA PIK3R1 CTNND2 NF1 PLPPR4 DLG3 GRIN3A ADGRL3 NSF PSD3 PCDH8	3.84e-05	170	402	13	int:GRIN2B
Interaction	LAMP1 interactions	MRPS31 KIAA0319L TRRAP CEMIP2 PHKA2 PLAA PIK3CA PIK3R1 BAIAP2 SMPD4 AP3B1 VIRMA DENND4C SLC4A2 ATP1A1 CTSD ATP2B1 EMC1 STT3A UBXN4 RAB2A DSG2 NSF PSD3 HUWE1 RALGAPA2 CDC42EP1 TIAM1 EPAS1	4.26e-05	644	402	29	int:LAMP1
Interaction	ST8SIA4 interactions	KIAA0319L TUFM FAT1 CACHD1 BPNT2 PTPRK ANKRD46 CELSR2 LRP11	4.50e-05	84	402	9	int:ST8SIA4
Interaction	RAB7A interactions	KIAA0319L TRRAP CEMIP2 PIK3R1 FNIP1 RIC1 VPS26B KIF16B APBB1 BIRC3 VIRMA RBM39 DENND4C SLC4A2 LRIG3 PPP2R1B CTSD ATP2B1 ATP5F1A SNX2 EMC1 ITPRID2 UBXN4 COQ8A RAB2A GPD2 DMXL2 DSG2 NSF HUWE1 ANKRD46 ARFGEF3 FAM171A1 TMF1 ZW10 VPS13B	4.50e-05	886	402	36	int:RAB7A
Interaction	TMPRSS13 interactions	LRIG3 EMC1 B4GALT1 BPNT2 PTPRK PTPRS GPC2 GCFC2 EGF LRP11	5.18e-05	106	402	10	int:TMPRSS13
Interaction	LYN interactions	ERBB3 CEMIP2 PIK3R1 KMT2A BAIAP2 CARMIL1 CACHD1 VIRMA DENND4C SLC4A1 DOCK7 ATP1A1 ATP2B1 EMC1 FRMPD4 CDH23 DHX33 PTK2 NF1 SVIL DMD RAB2A IPO5 PRUNE2 UACA DSG2 PSD3 CDC42EP1 FAM171A1 TIAM1 CBX6	5.38e-05	720	402	31	int:LYN
Interaction	CTNNB1 interactions	HIF1A TRRAP FANCC PIK3CA PIK3R1 ASPM FER KMT2A CHD6 PICK1 JCAD NAA15 COPS3 VIRMA RBM39 KBTBD4 NR5A2 UNK ATP1A1 CTNND2 CROCC ATP5F1A MYO5B PTK2 MPRIP BRCA1 PTPRK SVIL NHS KDR CDC73 DYNC1H1 UACA DSG2 HUWE1 KIF3A GRIP1 LIG3 EPAS1	6.38e-05	1009	402	39	int:CTNNB1
Interaction	GPR173 interactions	CDIPT APOB ATP1A3 ATP2B1 CDS2 CELSR2 CBX6	6.48e-05	51	402	7	int:GPR173
Interaction	CALM3 interactions	ERBB3 PHKA2 ASPM RC3H2 FLT4 DENND4C DOCK7 UNK ATP2B1 MYO5B MYO9B ITPRID2 CTTNBP2NL PDCD4 LUZP1 MPRIP SVIL KDR CDC73	6.56e-05	343	402	19	int:CALM3
Interaction	RAB5A interactions	CEMIP2 PIK3R1 KIF16B APBB1 PTPN23 SMPD4 CACHD1 VIRMA DENND4C PPM1B SCYL2 UNK ATP1A1 CTSD ATP2B1 RUBCN SNX2 EMC1 PTK2 UBXN4 KDR CDC73 RAB2A DYNC1H1 DMXL2 DSG2 GRIK4 ARFGEF3 TMF1 VPS13B	8.98e-05	706	402	30	int:RAB5A
Interaction	RPN1 interactions	ERBB3 ABCA3 MECOM TUFM DNAJC10 CLN5 KMT2A APBB1 BIRC3 PTPN23 SMPD4 VIRMA RBM39 SLC4A2 PPP2R1B STAU2 ATP1A1 ATP2B1 ATP5F1A CYB5A EMC1 STT3A FAM20C UBXN4 COQ8A NHS CDC73 RAB2A IPO5 DSG2 HUWE1 TIAM1 ZW10	9.82e-05	814	402	33	int:RPN1
Interaction	DYRK1A interactions	ERBB3 ABCA2 LRP1B CCDC15 JCAD RNF169 CACHD1 AP3B1 WDR26 VIRMA RBM39 DOCK7 KNDC1 NECAB3 LZTS3 MYCBP2 CTTNBP2NL LUZP1 MPRIP TRIM66 NF1 BRCA1 HUWE1 DENND11 CBX6	1.31e-04	552	402	25	int:DYRK1A
GeneFamily	Basic leucine zipper proteins\|BTB domain containing	PATZ1 ENC1 KBTBD2 KBTBD4 KBTBD6 KLHL11 KLHL5 KLHL25 NACC2	2.50e-04	134	281	9	861
GeneFamily	Patatin like phospholipase domain containing	PLA2G6 PNPLA6 PNPLA7	4.11e-04	10	281	3	466
GeneFamily	N-terminal EF-hand calcium binding proteins\|EF-hand domain containing	NECAB3 NECAB1	7.15e-04	3	281	2	663
GeneFamily	ATP binding cassette subfamily A	ABCA1 ABCA2 ABCA3	1.19e-03	14	281	3	805
GeneFamily	Fibronectin type III domain containing\|USH2 complex	PDZD7 USH2A	1.41e-03	4	281	2	1244
GeneFamily	Cadherin related	FAT1 FAT2 CDH23	2.15e-03	17	281	3	24
GeneFamily	Protein phosphatases, Mg2+/Mn2+ dependent	PPM1E PPM1B PDP1	2.15e-03	17	281	3	701
GeneFamily	Phospholipid phosphatase related	PLPPR3 PLPPR4	2.33e-03	5	281	2	1127
GeneFamily	Ring finger proteins\|Fanconi anemia complementation groups\|Protein phosphatase 1 regulatory subunits\|BRCA1 A complex\|BRCA1 B complex\|BRCA1 C complex	MRE11 BRCA1	2.33e-03	5	281	2	1336
GeneFamily	CD molecules\|Integrin alpha subunits	ITGA11 ITGA10 ITGAE	2.55e-03	18	281	3	1160
GeneFamily	PDZ domain containing	PDZD7 PICK1 FRMPD4 MAST4 DLG3 SHANK1 GRIP1 TIAM1	2.63e-03	152	281	8	1220
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	ABCA3 KCNH8 PDZD7 CSMD2 CSMD3 LRP1B FAT2 DYRK2 IKZF3 ENC1 GABBR2 SLC4A1 ANKRD36B PPP2R2C CADPS PDP1 PDE4DIP CACNG4 RAB11FIP4 SSH2 CTNND2 ATP1A3 ATP2B1 CCDC144A FRMPD4 LZTS3 MYCBP2 DHX33 FSIP2 MAST4 PLPPR4 NUAK1 PTPRK DLG3 GPC2 GRIN3A CAMTA1 ADGRL3 DOCK3 KBTBD6 L1CAM LAMA5 LAMC2 LARP1B KIF3A GRIP1 ARFGEF3 BRF1 PCDH8 SPATA13	2.62e-11	1106	414	50	M39071
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	ZC3H14 HIF1A MECOM TRRAP FAT1 NMT2 TPST1 ENC1 AP3B1 RBM39 PPM1B PCF11 STAU2 ANKRD17 ATP2B1 STAG2 SNX2 MYCBP2 AVL9 MYO9B CDS2 ARHGAP11A PTK2 TDRD3 TLK1 BRCA1 BRCA2 NUAK1 PTPRK MTCL1 DMD DMXL2 PSD3 FAM171A1 TIAM1 KAT6B VPS13B	3.81e-08	856	414	37	M4500
Coexpression	ZHANG_BREAST_CANCER_PROGENITORS_UP	MRPS31 PATZ1 TRRAP ADH5 PSAT1 VPS26B KIF16B PPM1B STXBP6 CTNND2 BCLAF3 BRCA1 SPIN1 SGO2 CDC73 ADGRL3 DSG2 CEP192 RFC1 RFX3 TMTC4 ZNF532	1.91e-06	434	414	22	M15150
Coexpression	ZHANG_BREAST_CANCER_PROGENITORS_UP	MRPS31 PATZ1 TRRAP ADH5 PSAT1 VPS26B KIF16B PPM1B STXBP6 CTNND2 BCLAF3 BRCA1 SPIN1 SGO2 CDC73 ADGRL3 DSG2 CEP192 RFC1 RFX3 TMTC4 ZNF532	3.20e-06	448	414	22	MM1044
Coexpression	GSE26669_CTRL_VS_COSTIM_BLOCK_MLR_CD8_TCELL_DN	CDO1 IKZF1 ADCY7 ARIH2 DYRK2 VPS26B ENC1 SNX2 PCNX3 CDS2 C5orf34 CLEC4F COQ8A SELENOO	3.99e-06	200	414	14	M4667
Coexpression	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP	DNAJC10 PIK3CA ASPM MRE11 RC3H2 PSAT1 ITGA11 NAA15 ENC1 BIRC3 PRPF40A RBM39 GFM2 SCYL2 ATP2B1 MCM8 ITPRID2 ARHGAP11A C5orf34 TLK1 UBXN4 BRCA2 SGO2 DSG2 RBBP6 L1CAM RFC1 RFX3 KLHL5	4.86e-06	721	414	29	M10237
Coexpression	GSE27896_HDAC6_KO_VS_WT_TREG_UP	ABCA3 PATZ1 MIER3 IKZF1 ADCY7 BAIAP2 RNF169 IKZF3 ITGA10 WDR26 ATP2B1 HDAC10 SPATA13	4.90e-06	176	414	13	M8248
Coexpression	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5	DYRK2 ZNF823 GABBR2 SFMBT2 TBC1D13 PDP1 NAXD CTNND2 ATP2B1 RUBCN SPAG1 ZNF275 FAM20C NF1 RAB2A PSD3 ARFGEF3 NACC2 LRP11 TMF1 VPS13B EPAS1	1.35e-05	491	414	22	M13661
Coexpression	NAKAYA_PBMC_FLUMIST_AGE_18_50YO_7DY_DN	HIF1A ABCA1 MIER3 PIK3R1 ARIH2 FNIP1 DYRK2 RC3H2 AMPD2 ENC1 BIRC3 SMPD4 KBTBD2 PPM1B PPP2R1B GET4 KBTBD4 PCNX1 RAB11FIP4 ITPRID2 PDCD4 B4GALT1 TRMT10C PTPRK SVIL RAB2A NSF RBBP6 ZNFX1 AZI2 TMF1	1.39e-05	844	414	31	M41129
Coexpression	CHIBA_RESPONSE_TO_TSA_DN	BIRC3 PTK2 BRCA2 DMD LIG3	1.59e-05	21	414	5	M12459
Coexpression	GSE42021_CD24INT_VS_CD24LOW_TREG_THYMUS_UP	PLA2G2F F13A1 DYRK2 IKZF3 GAS7 NOX3 SCYL2 MRPL48 GFM1 ITGAE ITIH3 TDRD3 IPO5	1.65e-05	197	414	13	M9589
Coexpression	GSE9037_WT_VS_IRAK4_KO_BMDM_UP	AKAP7 RC3H2 MEAK7 PDP1 PDE4DIP PTK2 STT3A CDC73 DMD PRUNE2 AZI2 KIF3A GPCPD1	1.94e-05	200	414	13	M5812
Coexpression	GSE27786_CD4_TCELL_VS_MONO_MAC_UP	ZC3H14 ADH5 PIK3R1 ARIH2 CHD6 KBTBD2 IGBP1 RAB40C SMG1 ERAP1 UBXN4 RBM4 AZI2	1.94e-05	200	414	13	M4833
Coexpression	GSE2770_UNTREATED_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_DN	WDFY2 DNAJC10 RXFP2 SLC15A2 PRKAB1 CNPY3 B4GALT1 MAST4 PID1 ZNF629 MFSD9 HUWE1 DENND11	1.94e-05	200	414	13	M6056
Coexpression	GSE36888_STAT5_AB_KNOCKIN_VS_WT_TCELL_IL2_TREATED_6H_DN	CEMIP2 PSAT1 COPS3 ATP5F1A EMC1 ARHGAP11A PDCD4 BCLAF3 SGO2 ADSS1 GPD2 RFX3 CDC42EP1	1.94e-05	200	414	13	M8745
Coexpression	GSE339_EX_VIVO_VS_IN_CULTURE_CD8POS_DC_DN	PIK3R1 ARIH2 BAIAP2 MMP11 PTPN23 APOB ATP5F1A PTK2 UBXN4 GPD2 LARP1 LAMC2 ZNFX1	1.94e-05	200	414	13	M5132
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HNBGABA	PDZD7 CSMD2 CSMD3 LRP1B AKAP7 ENC1 GABBR2 SLC4A1 ANKRD36B PPP2R2C PDP1 PDE4DIP CACNG4 RAB11FIP4 ATP1A3 ATP2B1 CCDC144A FRMPD4 MYCBP2 PLPPR4 NUAK1 PTPRK GRIN3A DOCK3 L1CAM KIF3A ARFGEF3	2.33e-05	703	414	27	M39070
Coexpression	RODWELL_AGING_KIDNEY_NO_BLOOD_DN	ADH5 AMT PPP2R1B ATP5F1A CYB5A PTGER3 KNG1 DSG2 ARFGEF3 FAM171A1 EGF	2.47e-05	148	414	11	M11837
Coexpression	BLANCO_MELO_SARS_COV_1_INFECTION_MCR5_CELLS_UP	ASPM CCDC144A BRCA2 SGO2	2.75e-05	12	414	4	M34000
Coexpression	DODD_NASOPHARYNGEAL_CARCINOMA_UP	ADH5 ASPM SEMA6A ZNF81 ARHGAP8 SLC25A17 COL6A3 PSAT1 NAA15 DIABLO ZNF618 PRPF40A SCYL2 TET1 DOCK7 TTI1 GFM1 SMG1 MCM8 DHX33 ARHGAP11A ZSCAN32 C5orf34 UBXN4 NF1 BRCA1 BRCA2 NUAK1 SPIN1 SGO2 MTCL1 DMD CAMTA1 IPO5 GCFC2 DSG2 RBM4 CEP192 RFC1 ANKRD46 FAM171A1 KLHL5 ZNF532	2.91e-05	1407	414	43	M14427
Coexpression	GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP	BIRC6 FANCC RIC1 PPM1E SMG1 MYO9B NF1 BRCA1 ADSS1 RALGAPA2 ZNF106 CELSR2	3.15e-05	180	414	12	M8239
Coexpression	NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN	ABCA1 MIER3 PLAA PIK3CA PIK3R1 ARIH2 RAB11FIP2 ENC1 KBTBD2 WDR26 VIRMA RBM39 PPM1B PDP1 UNK ATP2B1 CDS2 PDCD4 CDC73 RBBP6 RFC1 RALGAPA2 TEX30 GPCPD1 TMF1 SPATA13	3.56e-05	680	414	26	M41089
Coexpression	GEORGES_TARGETS_OF_MIR192_AND_MIR215	ERCC6 CEMIP2 CREBZF ASPM CCDC15 AKAP7 ZNF823 RAB11FIP2 ENC1 CEP295 ZNF85 KDM1B CADPS2 LYPD6 EMC1 ARHGAP11A C5orf34 BRCA1 BRCA2 SGO2 RAB40B RAB2A UACA NSF LARP1B DENND11 TEX30 OVOL1 TMTC4 BBS7 SPATA13	3.98e-05	892	414	31	M18120
Coexpression	NICK_RESPONSE_TO_PROC_TREATMENT_DN	PRKAB1 ERAP1 ITPRID2 ZSCAN32 TLK1	5.82e-05	27	414	5	M8801
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	TRRAP FAT1 NMT2 ENC1 RBM39 PPM1B STAU2 ANKRD17 ATP2B1 MYCBP2 CDS2 PTK2 TLK1 BRCA1 NUAK1 PTPRK MTCL1 FAM171A1 TIAM1 KAT6B	6.04e-05	466	414	20	M13522
Coexpression	PHONG_TNF_RESPONSE_VIA_P38_COMPLETE	MECOM KMT2A DYRK2 ATP2B1 SNX2 ERAP1 B4GALT1 PTPRK SVIL PSD3 LARP1 CDC42EP1 KAT6B	6.30e-05	224	414	13	M2500
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HDA1	PDZD7 CSMD2 CSMD3 PIK3R1 FGD1 MACROH2A2 ENC1 GABBR2 ANKRD36B CADPS PDE4DIP RAB11FIP4 SSH2 ATP1A3 CADPS2 FRMPD4 PLPPR4 GPC2 GRIN3A PID1 DOCK3 L1CAM KIF3A	6.44e-05	584	414	23	M39068
Coexpression	NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_NEGATIVE	MIER3 CREBZF PIK3R1 NMT2 DYRK2 RAB11FIP2 VIRMA RBM39 PDP1 UNK GFM1 SMG1 PTK2 LUZP1 B4GALT1 RBBP6 RBM4 AZI2 DENND11 KAT6B	7.62e-05	474	414	20	M40991
Coexpression	GSE2770_UNTREATED_VS_ACT_CD4_TCELL_48H_UP	KCNH8 PLAA DNAJC10 ZNF81 SHLD2 ITGA11 NAA15 RAB11FIP2 PPP2R1B PDE4DIP BPNT2 LIG3	7.94e-05	198	414	12	M6069
Coexpression	GSE11961_MARGINAL_ZONE_BCELL_VS_GERMINAL_CENTER_BCELL_DAY7_UP	HIF1A AKAP7 HSD17B7 IFT74 BIRC3 STAU2 UNK MYCBP2 SPNS3 GCFC2 NSF RFC1	8.33e-05	199	414	12	M9320
Coexpression	GSE43260_BTLA_POS_VS_NEG_INTRATUMORAL_CD8_TCELL_DN	ZC3H14 ERCC6 PATZ1 CDIPT ENC1 SLC4A2 IGBP1 ZNF35 ATP5F1A ITPRID2 NSF ANKRD46	8.33e-05	199	414	12	M9954
Coexpression	GSE24726_WT_VS_E2_2_KO_PDC_DAY6_POST_DELETION_DN	IKZF1 ADCY7 PHKA2 BAIAP2 ENC1 ARHGAP6 RAB40C SSH2 ATP2B1 CDS2 PDCD4 PNPLA7	8.74e-05	200	414	12	M8056
Coexpression	GSE29164_UNTREATED_VS_CD8_TCELL_TREATED_MELANOMA_DAY3_DN	ZBP1 ARHGAP6 PDE4DIP SSH2 CTNND2 CTSD IFT140 MYCBP2 SPNS3 COQ8A L1CAM HDAC10	8.74e-05	200	414	12	M8486
Coexpression	GSE17721_LPS_VS_POLYIC_4H_BMDC_UP	TUFM CEMIP2 PIK3CA ARHGAP8 NAA15 GAS7 SLC15A2 PDCD4 FAM20C KDR CDC73 AZI2	8.74e-05	200	414	12	M3803
Coexpression	GSE31082_CD4_VS_CD8_SP_THYMOCYTE_UP	F13A1 PHEX BIRC3 WDR26 SFMBT2 PPM1B TET1 PCNX1 AVL9 IL21 DLG3 DENND11	8.74e-05	200	414	12	M5069
Coexpression	GSE9601_UNTREATED_VS_NFKB_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_DN	LRRC66 IKZF1 DNAJC10 IKZF3 SFMBT2 GFM1 CCDC125 DHX33 NF1 UACA ZNF106	1.08e-04	174	414	11	M6881
Coexpression	AIZARANI_LIVER_C9_LSECS_1	HIF1A CEMIP2 SEMA6A BAIAP2 FLT4 DENND4C NR5A2 CTSD LUZP1 PTPRB NUAK1 KDR NPR1 UACA EPAS1	1.11e-04	304	414	15	M39113
Coexpression	DE_YY1_TARGETS_DN	HIF1A NAA15 ENC1 ERAP1 TDRD3 RBBP6 EGF EPAS1	1.14e-04	93	414	8	M3278
Coexpression	JAK2_DN.V1_DN	MYO15B KMT2A AMT ETNPPL ANKRD36B SLC15A2 CEP295 CTTNBP2NL DIP2A RFX3	1.21e-04	147	414	10	M2872
Coexpression	LAKE_ADULT_KIDNEY_C14_DISTAL_CONVOLUTED_TUBULE	MECOM LRP1B WDFY2 PKHD1 ARHGAP6 CADPS2 PTGER3 SVIL NHS KNG1 EGF VPS13B	1.27e-04	208	414	12	M39233
Coexpression	RODWELL_AGING_KIDNEY_DN	WDFY2 ADH5 AMT SLC4A1 ATP5F1A PTGER3 NF1 KNG1 ARFGEF3 EGF	1.28e-04	148	414	10	M5408
Coexpression	CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP	ERBB3 ABCA3 PATZ1 CRACD SFMBT2 PPP2R2C P4HTM RAB40C CACNG4 CTNND2 RUBCN MYO5B AVL9 DLG3 KATNIP ARFGEF3 KAT6B	1.52e-04	385	414	17	M2840
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HNBML5	KCNH8 PDZD7 CRACD MACROH2A2 USH2A ENC1 IGBP1 CADPS PDP1 RAB11FIP4 ATP1A3 PROX1 NUAK1 DLG3 GPC2 L1CAM LARP1B GRIP1 ARFGEF3	1.73e-04	465	414	19	M39066
Coexpression	DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN	ABCA1 MECOM ENC1 GABBR2 SFMBT2 PDP1 CTNND2 ATP2B1 BCLAF3 NUAK1 PTPRK KCNJ3 MTCL1 UACA PARP8 L1CAM PSD3 KIF3A KLHL5 EPAS1	1.73e-04	504	414	20	M2157
Coexpression	BROWNE_HCMV_INFECTION_4HR_DN	ERCC6 PATZ1 CREBZF SHC2 ERI3 DYRK2 GABBR2 PRKAB1 AVL9 MPRIP ABCC10 RBM4B ZNF629	2.04e-04	252	414	13	M789
Coexpression	TCGA_GLIOBLASTOMA_MUTATED	PIK3CA PIK3R1 NF1	2.07e-04	8	414	3	M19387
Coexpression	GRESHOCK_CANCER_COPY_NUMBER_UP	PATZ1 MECOM IKZF1 FANCC PIK3CA KMT2A FLT4 BIRC3 GAS7 TET1 PDE4DIP NF1 BRCA1 BRCA2 KAT6B	2.15e-04	323	414	15	M9150
Coexpression	LAKE_ADULT_KIDNEY_C13_THICK_ASCENDING_LIMB	MECOM LRP1B PKHD1 ARHGAP6 ATP1A1 PTGER3 NHS KNG1 EGF	2.43e-04	131	414	9	M39232
Coexpression	DESCARTES_FETAL_THYMUS_VASCULAR_ENDOTHELIAL_CELLS	MECOM STXBP6 PROX1 PTPRB NUAK1 KDR HIF3A EGF EPAS1	2.43e-04	131	414	9	M40316
Coexpression	NIKOLSKY_BREAST_CANCER_8Q12_Q22_AMPLICON	VIRMA PDP1 STAU2 NKAIN3 SPAG1 NECAB1 RAB2A ANKRD46 VPS13B	2.58e-04	132	414	9	M13954
Coexpression	GSE29949_MICROGLIA_BRAIN_VS_CD8_NEG_DC_SPLEEN_UP	ABCA1 UBA1 NCR1 SLC25A17 JCAD ATP2B1 MTCL1 ABCC10 ZNF629 KLHL25 CELSR2	2.91e-04	195	414	11	M8421
Coexpression	MULLIGHAN_NPM1_SIGNATURE_3_UP	ETFDH PLPPR3 ADCY7 ARIH2 CCDC15 MRE11 GABBR2 CRP SLC15A2 PRKAB1 STAG2 ARHGAP11A TLK1 MTCL1 KIF3A	3.17e-04	335	414	15	M10277
Coexpression	DAZARD_RESPONSE_TO_UV_NHEK_DN	ERBB3 FAT1 FAT2 DYRK2 KBTBD2 PCF11 ATP2B1 PTK2 TLK1 MAST4 MTCL1 PSD3 KAT6B VPS13B	3.29e-04	300	414	14	M8702
Coexpression	GSE37301_LYMPHOID_PRIMED_MPP_VS_CD4_TCELL_DN	PATZ1 CDIPT AKAP7 HSD17B7 MEAK7 PCF11 PDE4DIP RUBCN ITGAE PDCD4 ITPK1	3.32e-04	198	414	11	M8859
Coexpression	GSE33292_DN3_THYMOCYTE_VS_TCELL_LYMPHOMA_FROM_TCF1_KO_DN	ENC1 GAS7 KBTBD2 STAU2 C15orf39 ITPRID2 ARHGAP11A DLG3 KNG1 DMXL2 LAMA5	3.46e-04	199	414	11	M9423
Coexpression	GSE23502_BM_VS_COLON_TUMOR_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_UP	PRSS54 HIF1A PLA2G6 JCAD SFMBT2 CRP ZNF841 ABCC10 EDA C4orf54 PCDH8	3.46e-04	199	414	11	M8082
Coexpression	GSE17721_LPS_VS_PAM3CSK4_1H_BMDC_DN	XIRP1 PIK3CA BIRC3 CADPS2 ITPRID2 FAM20C UBXN4 BRCA2 KDR GPD2 PARP8	3.46e-04	199	414	11	M3912
Coexpression	GSE21546_ELK1_KO_VS_SAP1A_KO_AND_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_UP	ERBB3 KIAA0319L TRRAP SHPRH CHD6 AVL9 DLG3 RFX3 TGM4 TIAM1 VPS13B	3.46e-04	199	414	11	M7530
Coexpression	GSE5589_UNSTIM_VS_180MIN_LPS_AND_IL10_STIM_MACROPHAGE_DN	KMT2A NCR1 IKZF3 ENC1 CNPY3 CTNND2 ATP2B1 B4GALT1 SELENOO TEX30 TIAM1	3.46e-04	199	414	11	M6605
Coexpression	GSE5455_HEALTHY_VS_TUMOR_BEARING_MOUSE_SPLEEN_MONOCYTE_24H_INCUBATION_UP	PATZ1 MMP11 TPST1 HSD17B7 MYO5B PTK2 RBM4B ZNF629 PSD3 DENND11 BBS7	3.46e-04	199	414	11	M6577
Coexpression	GSE8621_UNSTIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_DN	PRSS54 IKZF1 BIRC6 DYRK2 RNF169 HSD17B7 ENC1 TET1 CDH23 DHX33 TIAM1	3.46e-04	199	414	11	M6987
Coexpression	GSE4590_SMALL_VS_VPREB_POS_LARGE_PRE_BCELL_UP	SHPRH TET1 CCDC125 LUZP1 TDRD3 NF1 SVIL PARP8 RALGAPA2 PNPLA7	3.56e-04	168	414	10	M6874
Coexpression	GSE41867_NAIVE_VS_DAY8_LCMV_EFFECTOR_CD8_TCELL_DN	ABCA1 RAB11FIP2 PCNX1 AVL9 MYO9B CDS2 C15orf39 PDCD4 AZI2 GPCPD1 SPATA13	3.62e-04	200	414	11	M9469
Coexpression	GSE16385_ROSIGLITAZONE_IL4_VS_IFNG_TNF_STIM_MACROPHAGE_UP	CEMIP2 DYRK2 COL6A3 WDR26 PRPF40A PPM1B NAXD PTK2 ABCC10 TIAM1 VPS13B	3.62e-04	200	414	11	M8030
Coexpression	GSE28737_BCL6_HET_VS_BCL6_KO_MARGINAL_ZONE_BCELL_UP	PHEX RXFP2 MOGAT2 PRPF40A STX19 ARHGAP6 ATP1A3 SNX2 MYCBP2 MUC16 EDA	3.62e-04	200	414	11	M9348
Coexpression	GSE13484_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_UP	ZC3H14 ADCY7 CREBZF DDX41 SHLD2 COPS3 ATP5F1A MYO9B NACC2 TMF1 KAT6B	3.62e-04	200	414	11	M3277
Coexpression	GSE14908_RESTING_VS_HDM_STIM_CD4_TCELL_NONATOPIC_PATIENT_DN	AP3B1 RAB40C STAG2 SNX2 ERAP1 ITPRID2 COQ8A SPIN1 SVIL RAB2A DYNC1H1	3.62e-04	200	414	11	M7080
Coexpression	GSE33424_CD161_INT_VS_NEG_CD8_TCELL_DN	ABCA3 WDFY2 AFMID MMP11 ITGA10 STAU2 MPRIP CAMTA1 RFC1 ARFGEF3 ZW10	3.62e-04	200	414	11	M8553
Coexpression	GSE46606_IRF4HIGH_VS_WT_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_UP	ERBB3 ETFDH TRRAP ADCY7 PHKA2 SHPRH RNF169 CTTNBP2NL ABCD4 ZNF629 ANKRD46	3.62e-04	200	414	11	M9847
Coexpression	GSE16522_MEMORY_VS_NAIVE_ANTI_CD3CD28_STIM_CD8_TCELL_DN	ABCA3 ZBP1 SLC25A17 ITGAE C5orf34 PTPRK SPIN1 IL21 IPO5 RFC1 TMTC4	3.62e-04	200	414	11	M3662
Coexpression	GSE17721_PAM3CSK4_VS_GADIQUIMOD_8H_BMDC_DN	BIRC6 PIK3R1 NMT2 KMT2A RC3H2 PSAT1 AP3B1 TBC1D13 BRCA1 CDC73 TMTC4	3.62e-04	200	414	11	M3973
Coexpression	GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_48H_DN	WDFY2 DYRK2 ENC1 SMPD4 PDE4DIP CTSD SMG1 EMC1 SGO2 TGM4 ZNF532	3.62e-04	200	414	11	M6042
Coexpression	GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_48H_UP	IKZF1 ENC1 DENND4C SLC15A2 CNPY3 CTSD STAG2 SMG1 IFT140 MYO9B AZI2	3.62e-04	200	414	11	M6044
Coexpression	GSE22103_UNSTIM_VS_GMCSF_AND_IFNG_STIM_NEUTROPHIL_UP	TRRAP NAA15 ENC1 VIRMA MEAK7 KDM1B CTTNBP2NL TIAM1 CBX6 MFSD5 SPATA13	3.62e-04	200	414	11	M7789
Coexpression	GSE6259_FLT3L_INDUCED_33D1_POS_DC_VS_BCELL_DN	ABCA1 IKZF1 PHKA2 PANK2 CLN5 SFMBT2 ATP2B1 IFT140 ZNF841 RFX3 GPCPD1	3.62e-04	200	414	11	M6745
Coexpression	GRUETZMANN_PANCREATIC_CANCER_DN	CDO1 ABCA3 PPP2R1B IGBP1 NR5A2 CTNND2 CYB5A ITPRID2 DMD DPEP1 RFC1	3.62e-04	200	414	11	M10431
Coexpression	LAKE_ADULT_KIDNEY_C11_THIN_ASCENDING_LIMB	HIF1A MECOM TPST1 ATP1A1 PTK2 MAST4 SVIL RALGAPA2 RFX3 VPS13B	3.74e-04	169	414	10	M39230
Coexpression	CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP	ERBB3 PATZ1 KIAA0319L ARHGAP8 P4HTM RAB40C CACNG4 RAB11FIP4 CTNND2 CADPS2 CYB5A MYO5B PDCD4 ITPK1 DLG3 KATNIP ARFGEF3 OVOL1	3.75e-04	455	414	18	M17299
Coexpression	SENESE_HDAC3_TARGETS_UP	ABCA3 MIER3 ENC1 BIRC3 KBTBD2 MEAK7 SCYL2 PDP1 KDM1B ATP2B1 SMG1 ITPRID2 B4GALT1 NF1 PTPRB ADGRL3 PARP8 RFX3 ANKRD46	3.78e-04	495	414	19	M8451
Coexpression	BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_DN	ABCA1 KBTBD2 SLC15A2 AVL9 ZW10 SPATA13	3.99e-04	61	414	6	M6023
Coexpression	LIU_SOX4_TARGETS_DN	AKAP17A KIAA0319L ERI3 ARIH2 RC3H2 SMPD4 WDR26 STAG2 PDCD4 ITPK1 RBBP6 LARP1 ARFGEF3 TMF1	4.57e-04	310	414	14	M17287
CoexpressionAtlas	dev gonad_e12.5_M_SertoliCell_Sox9_k-means-cluster#1_top-relative-expression-ranked_1000	CDO1 ERBB3 ERCC6 CEMIP2 PICK1 PSAT1 CARMIL1 PDP1 RAB40C BRCA1 LARP1 RALGAPA2	1.62e-06	114	399	12	gudmap_dev gonad_e12.5_M_SertoliCell_Sox9_k1_1000
CoexpressionAtlas	dev gonad_e13.5_M_SertoliCell_Sox9_top-relative-expression-ranked_1000	ERBB3 ERCC6 TRRAP CEMIP2 FAT1 NMT2 MMP11 JCAD PSAT1 ITGA11 CARMIL1 BIRC3 GAS7 SLC4A2 STXBP6 CADPS PDP1 DOCK7 RAB40C ATP1A1 CCDC125 ERAP1 CDH23 C15orf39 ZNF275 BRCA1 PLPPR4 SVIL KATNIP MTCL1 NPR1 DSG2 FZD3 RALGAPA2 TEX30 TIAM1	1.12e-05	880	399	36	gudmap_dev gonad_e13.5_M_SertoliCell_Sox9_1000
CoexpressionAtlas	dev gonad_e12.5_M_SertoliCell_Sox9_top-relative-expression-ranked_1000	CDO1 ERBB3 ABCA1 ERCC6 TRRAP CEMIP2 FAT1 MMP11 PICK1 JCAD PSAT1 ITGA11 ZNF618 CARMIL1 GAS7 SLC4A2 CADPS PDP1 DOCK7 RAB40C ATP1A1 ERAP1 CDH23 C15orf39 ZNF275 BRCA1 PLPPR4 SVIL MTCL1 NPR1 KBTBD6 DSG2 FZD3 LARP1 RALGAPA2 TIAM1	1.23e-05	884	399	36	gudmap_dev gonad_e12.5_M_SertoliCell_Sox9_1000
CoexpressionAtlas	DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_1000	MECOM BIRC6 CREBZF PIK3CA NMT2 SHPRH PKHD1 RC3H2 ENC1 PRPF40A SLC4A1 P4HTM STXBP6 SLC15A2 ATP1A1 SMG1 LZTS3 MYCBP2 C15orf39 PTGER3 CTTNBP2NL TACR3 KNG1 HUWE1 FAM171A1 LIG3 OVOL1 CELSR2 TMTC4 GPCPD1 VPS13B SPATA13	4.75e-05	795	399	32	gudmap_developingKidney_e15.5_anlage of loop of Henle_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000	ABCA2 MECOM IKZF1 CEMIP2 CRACD DNAJC10 ASPM CCDC15 NAA15 IFT74 PPM1E AP3B1 NECAB3 TTI1 CEP295 CACNG4 CTNND2 ATP1A3 ATP2B1 PROX1 MYO5B LUZP1 BRCA1 BRCA2 MTCL1 DMD FZD3 RBBP6 GRIK4 AZI2 KIF3A GRIP1 KLHL5 TEX30 CELSR2 LRP11 SPATA13	5.72e-05	989	399	37	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000
CoexpressionAtlas	dev gonad_e12.5_M_SertoliCell_Sox9_k-means-cluster#2_top-relative-expression-ranked_500	CDO1 ERBB3 ERCC6 CARMIL1 DSG2 RALGAPA2	9.48e-05	40	399	6	gudmap_dev gonad_e12.5_M_SertoliCell_Sox9_k2_500
CoexpressionAtlas	facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4	ABCA2 CEMIP2 CRACD FAT1 ASPM CCDC15 RC3H2 PSAT1 IFT74 PPM1E ENC1 ZNF7 KBTBD4 STXBP6 CADPS DOCK7 TTI1 CEP295 CACNG4 KDM1B CADPS2 PROX1 LYPD6 MCM8 TLK1 BRCA1 BRCA2 NUAK1 NHS DMD CAMTA1 SHANK1 DOCK3 GPD2 GCFC2 FZD3 NSF PARP8 L1CAM PSD3 AZI2 RFC1 RALGAPA2 RFX3 CELSR2 SPATA13	9.74e-05	1370	399	46	facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4
CoexpressionAtlas	dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_1000	CREBZF MEX3A PIK3R1 RXFP2 ASPM SEMA6A AKAP7 DYRK2 ZNF823 RGS5 ZNF618 RAB11FIP2 CACHD1 SCYL2 PCF11 ZNF35 PDP1 ATP2B1 LYPD6 MYO5B PDCD4 TDRD3 BRCA2 PTPRK KDR ADGRL3 KBTBD6 PSD3 MUC16 DNAH7 KLHL5 KAT6B	1.08e-04	831	399	32	gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_1000
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Gen_Cap\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MECOM SEMA6A JCAD RGS5 CACHD1 SFMBT2 STXBP6 NR5A2 CTNND2 PTK2 PTPRB MAST4 KDR ADGRL3 UACA GRIK4 FAM171A1 EPAS1	3.53e-13	193	415	18	6e1982d089a9de628e6006d23ff78a223fbd9f47
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MECOM SEMA6A RGS5 CACHD1 SFMBT2 NR5A2 CTNND2 PTK2 PTPRB MAST4 PTPRK KDR ADGRL3 UACA GRIK4 FAM171A1 EPAS1	4.41e-12	194	415	17	0b9cd96fa0b616da7cc90e92ff71157e9bba518f
ToppCell	COVID-19-lung-Capillary_Aerocytes\|lung / Disease (COVID-19 only), tissue and cell type	LRP1B SHC2 SEMA6A JCAD FLT4 ARHGAP6 STXBP6 CADPS2 PTK2 KDR UACA LAMA5 HIF3A RALGAPA2 EDA KLHL5 EPAS1	5.20e-12	196	415	17	4ac4073380d939a73cec7413e9f3f5ef616d2924
ToppCell	nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SEMA6A JCAD FLT4 ITGA10 STXBP6 CADPS2 IFT140 KDR ADGRL3 UACA HIF3A EDA KLHL5 EPAS1 SPATA13	3.27e-10	189	415	15	b6b4da51bc7f2c13a2f940540fdc61027d084835
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CSMD3 PIK3R1 CARMIL1 ENC1 GAS7 GABBR2 PPP2R2C MLIP PDP1 CADPS2 ATP2B1 FRMPD4 NUAK1 NECAB1 FZD3	5.06e-10	195	415	15	2e1df01bf6e4e98e6cd9fb50926e34c5077b8666
ToppCell	Endothelial\|World / Lineage, Cell type, age group and donor	SHC2 SEMA6A JCAD FLT4 RGS5 STXBP6 NR5A2 PROX1 PTPRB KDR ADGRL3 UACA HIF3A RALGAPA2 EPAS1	5.43e-10	196	415	15	96c6d78482a130ce4e29f6629972a06d10d7530e
ToppCell	LPS_IL1RA-Endothelial\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	JCAD STXBP6 ITPRID2 PTK2 LUZP1 PTPRB KDR DYNC1H1 ADGRL3 NPR1 UACA RALGAPA2 CDC42EP1 FAM171A1 EPAS1	7.20e-10	200	415	15	5c092b2ecc081b5d04476c56333c338cd89ab984
ToppCell	LPS_IL1RA-Endothelial-Endothelial\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	JCAD STXBP6 ITPRID2 PTK2 LUZP1 PTPRB KDR DYNC1H1 ADGRL3 NPR1 UACA RALGAPA2 CDC42EP1 FAM171A1 EPAS1	7.20e-10	200	415	15	72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5
ToppCell	pdx-Tumor_cells-T0\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	ERBB3 ABCA1 KIAA0319L AFMID PKHD1 SHLD2 MLIP CTNND2 ALDH1L1 PTK2 FAM20C PTPRK DMD PID1	2.37e-09	185	415	14	1d874608aa2062024323512f68889219471b2f00
ToppCell	LPS_only-Endothelial-Endothelial-Gen_Cap\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MECOM SEMA6A RGS5 CACHD1 SFMBT2 STXBP6 NR5A2 CTNND2 PTPRB KDR ADGRL3 UACA FAM171A1 EPAS1	4.10e-09	193	415	14	af5108260783e69a7d67896c5bf64f862525926d
ToppCell	nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SEMA6A JCAD ITGA10 STXBP6 CADPS2 PTK2 PTPRB KDR UACA HIF3A RALGAPA2 KLHL5 EPAS1 SPATA13	4.10e-09	193	415	14	f582e939e3e08a8a3f71deec78c33715be8faa51
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial-Gen_Cap\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MECOM SEMA6A JCAD RGS5 SFMBT2 STXBP6 NR5A2 CTNND2 PTPRB KDR ADGRL3 UACA FAM171A1 EPAS1	4.10e-09	193	415	14	e09387af84d2a0a526e54d4793e6e06c6739db53
ToppCell	LPS-antiTNF-Endothelial-Endothelial\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SEMA6A JCAD FLT4 RGS5 STXBP6 NR5A2 CTNND2 PTPRB KDR ADGRL3 NPR1 UACA FAM171A1 EPAS1	4.10e-09	193	415	14	02f633b016ab19bfa65bfd0cf32f000549a62148
ToppCell	LPS-antiTNF-Endothelial\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SEMA6A JCAD FLT4 RGS5 STXBP6 NR5A2 CTNND2 PTPRB KDR ADGRL3 NPR1 UACA FAM171A1 EPAS1	4.10e-09	193	415	14	5122b1ffba42de190061be34ecdc6176f84e56a3
ToppCell	LPS_only-Endothelial\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SEMA6A RGS5 CACHD1 SFMBT2 STXBP6 NR5A2 CTNND2 PTPRB MAST4 KDR ADGRL3 UACA FAM171A1 EPAS1	4.38e-09	194	415	14	58f069efdefa0366033764446b9d6ffd4a17807e
ToppCell	LPS_only-Endothelial-Endothelial\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SEMA6A RGS5 CACHD1 SFMBT2 STXBP6 NR5A2 CTNND2 PTPRB MAST4 KDR ADGRL3 UACA FAM171A1 EPAS1	4.38e-09	194	415	14	bfd92ec75facb0ba55c31e5f2e089d983b3d0169
ToppCell	Children_(3_yrs)-Endothelial\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SHC2 SEMA6A JCAD FLT4 STXBP6 NR5A2 PROX1 PTPRB KDR ADGRL3 UACA HIF3A FAM171A1 EPAS1	4.68e-09	195	415	14	094cf6591daa5ffad36e44122b6f524a3a34c2fd
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MECOM LRP1B PKHD1 ARHGAP6 ATP1A1 MYO5B PTGER3 MAST4 KCNJ3 NHS DNAH7 GRIP1 FAM171A1 EGF	4.68e-09	195	415	14	6477e6e7be5bd8eb99119a12ae16334ccddecd43
ToppCell	COVID-19-kidney-TAL\|kidney / Disease (COVID-19 only), tissue and cell type	MECOM LRP1B PKHD1 TPST1 PPM1E ARHGAP6 ATP1A1 ITPRID2 NHS KNG1 LAMC2 ARFGEF3 EGF ZNF532	5.00e-09	196	415	14	04f5eb206ed3016a737609a3ebac0c1fcabb94ef
ToppCell	COVID-19-lung-Capillary_Aerocytes\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SHC2 SEMA6A JCAD FLT4 ITGA10 STXBP6 CADPS2 KDR UACA LAMA5 HIF3A RALGAPA2 KLHL5 EPAS1	5.00e-09	196	415	14	49cc0a2b9739abad61dff7292ea0b14d28ff35c4
ToppCell	Fetal_29-31_weeks-Endothelial\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	SHC2 SEMA6A JCAD FLT4 RGS5 STXBP6 NR5A2 PROX1 PTPRB KDR ADGRL3 RALGAPA2 KLHL5 EPAS1	5.00e-09	196	415	14	3981f6c7487598f4f7ce4650ac0ac5bd41481d66
ToppCell	COVID-19-lung-Capillary_1\|lung / Disease (COVID-19 only), tissue and cell type	CEMIP2 SEMA6A JCAD STXBP6 NR5A2 CADPS2 PTPRB PTPRK KDR UACA HIF3A RALGAPA2 FAM171A1 EPAS1	5.34e-09	197	415	14	7e86ff9dafcbaaa7464d61484dd48bfeb7eae6e4
ToppCell	Parenchymal-NucSeq-Endothelial-Endothelia_vascular-VE_alveolar_capillary_Car4_aerocyte\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SHC2 SEMA6A FLT4 ITGA10 ARHGAP6 STXBP6 IFT140 KDR ADGRL3 UACA HIF3A EDA KLHL5 EPAS1	6.08e-09	199	415	14	dc88ce36cc066eb6c28cfd5b9b60fe07f8cc7b53
ToppCell	Control-Endothelial_cells-Capillary_endothelial_cells\|Control / group, cell type (main and fine annotations)	LRP1B SEMA6A JCAD FLT4 ITGA10 STXBP6 IFT140 KDR ADGRL3 HIF3A EDA KLHL5 EPAS1	1.55e-08	180	415	13	b043f9ffb9a4cd427a15bebb86a711c7b08866e8
ToppCell	PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MECOM CEMIP2 STXBP6 ATP2B1 LYPD6 ITPRID2 LUZP1 PTPRB NUAK1 IL21 NPR1 UACA EPAS1	1.89e-08	183	415	13	3427f3cbe6ea81709750e7dd3ff378f03ae65eab
ToppCell	COVID-19-Endothelial_cells-Pulmonary_venous_endothelial_cells\|COVID-19 / group, cell type (main and fine annotations)	MECOM SEMA6A RGS5 ITGA10 STXBP6 NR5A2 PTK2 PTPRB NUAK1 HIF3A RALGAPA2 FAM171A1 EPAS1	2.44e-08	187	415	13	2d20193a6cacdfa4877457c97b0077408942186c
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Alv_Gen_Intermediate\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SEMA6A JCAD FLT4 RGS5 STXBP6 NR5A2 CTNND2 PTPRB KDR ADGRL3 NPR1 UACA FAM171A1	2.60e-08	188	415	13	789d1be574e693d7bdd488f3c72c6df788e47b47
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Alv_Gen_Intermediate\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SEMA6A JCAD FLT4 RGS5 STXBP6 CTNND2 PTPRB KDR ADGRL3 NPR1 UACA CDC42EP1 FAM171A1	2.95e-08	190	415	13	106ea0bb7b99c697ffc5443d72343df2484250c7
ToppCell	Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SHC2 SEMA6A JCAD ITGA10 STXBP6 CADPS2 KDR ADGRL3 UACA HIF3A EDA KLHL5 EPAS1	2.95e-08	190	415	13	0e9847d7f49b2236b8a191e1a7df37556351ba9e
ToppCell	Control-Endothelial-Endothelial-Gen_Cap\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SEMA6A SFMBT2 STXBP6 NR5A2 CTNND2 CADPS2 PTPRB KDR ADGRL3 UACA RALGAPA2 FAM171A1 GPCPD1	3.55e-08	193	415	13	e1d546165dcc2392f540162206852c4717d7306f
ToppCell	Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CEMIP2 SEMA6A JCAD ITGA10 STXBP6 NR5A2 CTTNBP2NL PTPRB UACA LAMA5 HIF3A FAM171A1 EPAS1	3.78e-08	194	415	13	68004855b23fe1e31e8452d70effabc78a4a0bd3
ToppCell	Fetal_29-31_weeks-Endothelial-capillary_endothelial_cell_(Cap1)\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	SEMA6A JCAD FLT4 RGS5 STXBP6 NR5A2 PTPRB KDR ADGRL3 DPEP1 RALGAPA2 KLHL5 EPAS1	4.53e-08	197	415	13	6a3c647af41fea923311562575a0d656fbc13cbe
ToppCell	control-Epithelial-Secretory\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	MECOM FAT2 PIK3R1 CARMIL1 LRIG3 SLC15A2 ATP1A1 MYCBP2 ITPRID2 PTPRK PTPRS DSG2 EPAS1	5.10e-08	199	415	13	3d01f90ffd271ca00129192787e4921bdca7e01e
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Activated_Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	HIF1A CEMIP2 KMT2A RGS5 KBTBD2 NR5A2 ITPRID2 LUZP1 NF1 MAST4 KDR RALGAPA2 EPAS1	5.41e-08	200	415	13	2d07237022b409c4fac6fcf99b68c8affb3007cd
ToppCell	Neuronal-Excitatory\|Neuronal / cells hierarchy compared to all cells using T-Statistic	PIK3R1 BAIAP2 CARMIL1 ENC1 PPP2R2C MLIP CADPS2 ATP2B1 PTK2 NUAK1 PTPRK NECAB1 PSD3	5.41e-08	200	415	13	4409065bc7aa995354c71e0f9d6f3726cf393d6b
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	MECOM BIRC6 KMT2A NR5A2 ITPRID2 PTPRB MAST4 KDR ADGRL3 UACA RALGAPA2 FAM171A1 EPAS1	5.41e-08	200	415	13	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	Control-Epithelial_cells-Airway_club\|Control / group, cell type (main and fine annotations)	MECOM FAM149A CACHD1 ATP1A1 CADPS2 CYB5A PTK2 MAST4 PTPRK SVIL GRIP1 ARFGEF3	1.42e-07	181	415	12	c755d23dd9aabc717dc73e2b3fa99a1f751e6507
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CSMD3 LRP1B FAT1 PKHD1 USH2A COL9A1 APOB XIRP2 FRMPD4 DMD ADGRL3 ARFGEF3	1.70e-07	184	415	12	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	LPS-IL1RA\|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HIF1A SEMA6A BIRC3 AP3B1 LUZP1 B4GALT1 PTPRB KDR CAMTA1 IPO5 LARP1B RALGAPA2	1.70e-07	184	415	12	c066c2ec4f0f1d6eb183fca5c7bb0cd45c9950dc
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CSMD3 LRP1B FAT1 PKHD1 USH2A COL9A1 APOB XIRP2 FRMPD4 DMD ADGRL3 ARFGEF3	1.70e-07	184	415	12	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CSMD3 LRP1B FAT1 PKHD1 USH2A COL9A1 APOB XIRP2 FRMPD4 DMD ADGRL3 ARFGEF3	1.70e-07	184	415	12	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	COVID-19-Epithelial_cells-Airway_club\|COVID-19 / group, cell type (main and fine annotations)	ERBB3 MECOM ARHGAP8 FAM149A CACHD1 CADPS2 CYB5A PTK2 MAST4 PTPRK GRIP1 ARFGEF3	1.80e-07	185	415	12	cfe6fd73d817e173fe803bc1683c291d9bcb8608
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MECOM LRP1B WDFY2 PPM1E ARHGAP6 ATP1A1 ALDH1L1 PTGER3 MAST4 KNG1 FAM171A1 EGF	2.02e-07	187	415	12	b93cf4dfe8ffb89348ee7bccc9f284189f7240a2
ToppCell	Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D175\|Adult / Lineage, Cell type, age group and donor	CEMIP2 FAT1 SEMA6A JCAD ITGA10 STXBP6 NR5A2 PTK2 PTPRB UACA HIF3A EPAS1	2.02e-07	187	415	12	f3548817f2fded5978137bb252cb628ac199e4f6
ToppCell	LA-03._Atrial_Cardiomyocyte\|World / Chamber and Cluster_Paper	PPM1E MLIP CADPS PDE4DIP CTNND2 KCNJ3 SVIL DMD PRUNE2 NRAP PSD3 GRIP1	2.14e-07	188	415	12	6d249fe92d51a19da19ec14bb2262d394255d577
ToppCell	COVID-19-lung-Vein_EC\|lung / Disease (COVID-19 only), tissue and cell type	CEMIP2 SEMA6A RGS5 CACHD1 STXBP6 NR5A2 CADPS2 PTPRB NUAK1 RALGAPA2 FAM171A1 EPAS1	2.14e-07	188	415	12	d582b76fc2faac526c9bf97503041129e1a6a211
ToppCell	Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)\|Adult / Lineage, Cell type, age group and donor	SHC2 SEMA6A JCAD FLT4 ITGA10 STXBP6 KDR ADGRL3 UACA HIF3A EDA EPAS1	2.14e-07	188	415	12	e5cad03f4a64147fe8174e7f614cf45233ffb9b7
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial-Alv_Gen_Intermediate\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SEMA6A FLT4 RGS5 STXBP6 NR5A2 CTNND2 PTPRB KDR ADGRL3 NPR1 UACA FAM171A1	2.40e-07	190	415	12	a3c6eec6df052105ab78b7e3c78f94218d5912eb
ToppCell	PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CEMIP2 RGS5 STXBP6 LUZP1 PTPRB NUAK1 RPS6KL1 NPR1 RALGAPA2 FAM171A1 KLHL5 EPAS1	2.40e-07	190	415	12	9b0ad888eb20acc011904d8593bc32bdef18d050
ToppCell	COVID-19-Endothelial_cells-Endothelial_cells_(general)\|COVID-19 / group, cell type (main and fine annotations)	SEMA6A STXBP6 NR5A2 CADPS2 PTK2 PTPRB PTPRK KDR ADGRL3 HIF3A RALGAPA2 EPAS1	2.40e-07	190	415	12	812e11314c76c0179fbe5a9bea29b41ce5cbc93d
ToppCell	Control-Endothelial-VE_Capillary_B\|World / Disease state, Lineage and Cell class	SEMA6A JCAD ITGA10 STXBP6 NR5A2 CADPS2 PTPRB PTPRK KDR HIF3A RALGAPA2 EPAS1	2.54e-07	191	415	12	c672c8e28d06d555335976b3f8bd2ea6d3b34aae
ToppCell	LPS_only-Endothelial-Endothelial-Activated_Alv_Cap\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SEMA6A RGS5 CACHD1 STXBP6 NR5A2 CTNND2 MAST4 PTPRK KDR ADGRL3 FAM171A1 EPAS1	2.54e-07	191	415	12	a7b18bcf27c38ad2353c239ecb309c80f3ef3359
ToppCell	Control-Endothelial-VE_Capillary_B\|Control / Disease state, Lineage and Cell class	SEMA6A JCAD ITGA10 STXBP6 NR5A2 CADPS2 PTPRB PTPRK KDR HIF3A RALGAPA2 EPAS1	2.54e-07	191	415	12	322237793a1278bafb14e63cab688b353e352dcc
ToppCell	Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)\|World / Lineage, Cell type, age group and donor	SHC2 SEMA6A JCAD FLT4 ITGA10 STXBP6 KDR ADGRL3 UACA EDA KLHL5 EPAS1	2.69e-07	192	415	12	1e156bab5ecf64627890d2de9b27603d9a01f28d
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SEMA6A JCAD RGS5 STXBP6 NR5A2 CTNND2 PTPRB KDR ADGRL3 UACA FAM171A1 EPAS1	2.69e-07	192	415	12	c07d7b40b2aa4eb27ac85801c014a656e2fd01dc
ToppCell	PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CEMIP2 RGS5 STXBP6 LUZP1 PTPRB NUAK1 RPS6KL1 NPR1 RALGAPA2 FAM171A1 KLHL5 EPAS1	2.69e-07	192	415	12	c157981b9a179925edcaabc0cb3b8805f0929004
ToppCell	LPS-IL1RA+antiTNF-Endothelial\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SEMA6A JCAD RGS5 STXBP6 NR5A2 CTNND2 PTPRB KDR ADGRL3 UACA FAM171A1 EPAS1	2.69e-07	192	415	12	04f5a2e3dd6beff027b89d66eefdd92036e041af
ToppCell	PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	KCNH8 ADCY7 PKHD1 FAM149A CTNND2 CCDC125 MYO5B DMD DOCK3 DNAH7 GRIP1 ARFGEF3	2.69e-07	192	415	12	b99f8236ef4ccdc75c02abea381cae6453205f6f
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6\|TCGA-Prostate / Sample_Type by Project: Shred V9	BIRC6 DENND4C PCNX1 KDM1B STAG2 AVL9 PTPRK DYNC1H1 HUWE1 ARFGEF3 KLHL11 VPS13B	2.84e-07	193	415	12	abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCell	Control-Endothelial-Endothelial\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SEMA6A JCAD STXBP6 CTNND2 CADPS2 PTPRB KDR ADGRL3 NPR1 UACA RALGAPA2 FAM171A1	2.84e-07	193	415	12	aff0649c73c634bc6ff0dc7759b4693a9236bf05
ToppCell	Control-Endothelial\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SEMA6A JCAD STXBP6 CTNND2 CADPS2 PTPRB KDR ADGRL3 NPR1 UACA RALGAPA2 FAM171A1	2.84e-07	193	415	12	c5f9fe03e64c211d4bcd4959e5b32f14841e336a
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FAT1 PKHD1 ARHGAP6 ATP1A1 MYO5B ALDH1L1 PTGER3 MAST4 NHS PRUNE2 DNAH7 GRIP1	2.84e-07	193	415	12	3866667dd221612589ae50f5c52f73a183a49ce6
ToppCell	IPF-Endothelial-VE_Venous\|IPF / Disease state, Lineage and Cell class	RGS5 ITGA10 STXBP6 NR5A2 CADPS2 PTPRB NUAK1 NPR1 HIF3A RALGAPA2 FAM171A1 EPAS1	2.84e-07	193	415	12	29a655fa80feaabe846c90a28363b037e22d24ae
ToppCell	LPS-IL1RA-Endothelial\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SEMA6A JCAD RGS5 STXBP6 NR5A2 CTNND2 PTPRB KDR ADGRL3 UACA FAM171A1 EPAS1	3.01e-07	194	415	12	43f92b0533e26633dc94cce554045d641ef8fd76
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MECOM FAT1 PKHD1 ARHGAP6 ATP1A1 MYO5B PTGER3 MAST4 KCNJ3 NHS DNAH7 GRIP1	3.01e-07	194	415	12	5eaaa81f4b2535f983c424aaef00077089526a5c
ToppCell	IPF-Endothelial-VE_Capillary_B\|IPF / Disease state, Lineage and Cell class	JCAD RGS5 ITGA10 STXBP6 CADPS2 PTPRB PTPRK KDR NPR1 HIF3A RALGAPA2 EPAS1	3.01e-07	194	415	12	169a304d5c13f08c39fad4116f093bc4a0765e9d
ToppCell	RA-03._Atrial_Cardiomyocyte\|World / Chamber and Cluster_Paper	MLIP CADPS PDE4DIP MAST4 KCNJ3 SVIL DMD PRUNE2 NRAP PSD3 EDA GRIP1	3.01e-07	194	415	12	89812fb164065041357bb37a3c2d87028ec3de4e
ToppCell	LPS-IL1RA-Endothelial-Endothelial\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SEMA6A JCAD RGS5 STXBP6 NR5A2 CTNND2 PTPRB KDR ADGRL3 UACA FAM171A1 EPAS1	3.01e-07	194	415	12	1d39d968730a7e85b6161c1c8a6bd38afe9bcad7
ToppCell	Adult-Endothelial\|Adult / Lineage, Cell type, age group and donor	SEMA6A JCAD FLT4 STXBP6 NR5A2 PROX1 PTPRB KDR UACA HIF3A FAM171A1 EPAS1	3.01e-07	194	415	12	963b3fbee0575af8379baa397ace65949eaf34f7
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CRACD CACNG4 ATP1A3 PROX1 LYPD6 MYO5B NHS GRIN3A MYRFL GRIP1 KLHL5 TIAM1	3.01e-07	194	415	12	02a9cc821c2b14aa7d0e55661a5fab66364474e1
ToppCell	Endothelial-endothelial_cell_of_vein\|World / Lineage, Cell type, age group and donor	SEMA6A JCAD RGS5 STXBP6 NR5A2 PTPRB NUAK1 NPR1 HIF3A RALGAPA2 FAM171A1 EPAS1	3.01e-07	194	415	12	3cbd9622a68e89add90e589867d88c83c5a33476
ToppCell	Fetal_29-31_weeks-Endothelial-endothelial_cell_of_vein\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	SEMA6A JCAD RGS5 STXBP6 NR5A2 PTPRB NUAK1 KDR ADGRL3 NPR1 FAM171A1 EPAS1	3.01e-07	194	415	12	fc2e0081005c0c496e41197a2d06e4a37708221f
ToppCell	COVID-19-kidney-Technical/muscle_(Mes)\|kidney / Disease (COVID-19 only), tissue and cell type	CSMD2 CSMD3 USH2A GABBR2 XIRP2 CADPS CTNND2 NKAIN3 DMD ADGRL3 GRIK4	3.07e-07	159	415	11	5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PIK3R1 AKAP7 COL6A3 ITPRID2 PTGER3 ITIH3 SVIL PID1 UACA ZNF106 GPCPD1 PCDH8	3.36e-07	196	415	12	308fa54385ca34e9e590967d4553b84aad96c92f
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CRACD FAT1 CACNG4 ATP1A3 PROX1 LYPD6 MYO5B NHS GRIN3A GRIP1 KLHL5 TIAM1	3.36e-07	196	415	12	7af6c5147ac859353504d19727dbe24f63a29dd4
ToppCell	10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like-C\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MECOM JCAD FLT4 RGS5 NR5A2 CADPS2 PTPRB SVIL KDR DPEP1 UACA EPAS1	3.36e-07	196	415	12	ed818de15f84f7f28bd06fd69d7876710da232a0
ToppCell	COVID-19-lung-Capillary_1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CEMIP2 SEMA6A JCAD STXBP6 NR5A2 CADPS2 PTPRB PTPRK KDR HIF3A RALGAPA2 EPAS1	3.36e-07	196	415	12	ac28e9be288af6f00a841aea4ce4b99aed6b4505
ToppCell	10x3'2.3-week_17-19-Endothelial-stroma-tip_EC\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	MECOM SHC2 JCAD LRIG3 NR5A2 PTPRB MAST4 KDR NPR1 UACA CDC42EP1 EPAS1	3.54e-07	197	415	12	b212ff28ca2d1fea4140f186ab90941bdca21249
ToppCell	nucseq-Endothelial\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SEMA6A JCAD FLT4 STXBP6 NR5A2 PROX1 PTK2 PTPRB KDR HIF3A RALGAPA2 EPAS1	3.54e-07	197	415	12	ebf9be068eaa658493fa7884fd19f34642922acb
ToppCell	356C-Endothelial_cells\|356C / Donor, Lineage, Cell class and subclass (all cells)	SEMA6A JCAD FLT4 RGS5 STXBP6 NR5A2 PTPRB NUAK1 KDR UACA RALGAPA2 EPAS1	3.54e-07	197	415	12	f20eda534b2b28986790b28ce150ca3ba067593a
ToppCell	343B-Endothelial_cells\|343B / Donor, Lineage, Cell class and subclass (all cells)	SEMA6A JCAD FLT4 RGS5 STXBP6 PTPRB NUAK1 KDR UACA HIF3A FAM171A1 EPAS1	3.74e-07	198	415	12	fab32347580c7a81ef1fe4fe7b325d9105a947d9
ToppCell	COVID-19-lung-Capillary_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CEMIP2 SEMA6A JCAD STXBP6 NR5A2 CADPS2 PTPRB KDR LAMA5 HIF3A RALGAPA2 EPAS1	3.74e-07	198	415	12	45419f2804b4be79bae6632e71c54e1af482d115
ToppCell	COVID-19-kidney-Technical/muscle_(Imm)\|kidney / Disease (COVID-19 only), tissue and cell type	IKZF1 CSMD3 USH2A IKZF3 GABBR2 CADPS CTNND2 NKAIN3 DMD ADGRL3 GRIK4	3.94e-07	163	415	11	19c28ce16a588a7f4a035c32726f6ccd67702b5b
ToppCell	Bronchial-NucSeq-Endothelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SHC2 SEMA6A FLT4 STXBP6 NR5A2 PROX1 PTPRB KDR UACA HIF3A FAM171A1 EPAS1	3.95e-07	199	415	12	36a230b80096455df26c2e2c8c05fd6b231508c5
ToppCell	Parenchymal-NucSeq-Endothelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SHC2 SEMA6A FLT4 STXBP6 NR5A2 PROX1 PTPRB KDR UACA HIF3A FAM171A1 EPAS1	3.95e-07	199	415	12	a4a9a1c2a34b5a8318a55d1211d6c8661ca9793e
ToppCell	NS-control-d_0-4-Epithelial-Secretory\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	MECOM FAT2 CARMIL1 LRIG3 SLC15A2 ATP1A1 MYCBP2 ITPRID2 PTPRK PTPRS DSG2 EPAS1	3.95e-07	199	415	12	32bdfff40fd442b88489c8b0f79af3927a51a03c
ToppCell	COVID-19-lung-Capillary_2\|lung / Disease (COVID-19 only), tissue and cell type	CEMIP2 SEMA6A JCAD STXBP6 NR5A2 CADPS2 PTPRB KDR LAMA5 HIF3A RALGAPA2 EPAS1	3.95e-07	199	415	12	793ce71b78a68033ef4419ed571e1dd86b40124f
ToppCell	ASK452-Endothelial\|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq	CEMIP2 JCAD FLT4 BIRC3 STXBP6 NR5A2 CTTNBP2NL LUZP1 PTPRB KDR RALGAPA2 EPAS1	3.95e-07	199	415	12	0bc97a9a78aaafd1554ae6a61356ed9ea4983fa5
ToppCell	control-Epithelial-Secretory\|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	MECOM FAT2 CARMIL1 LRIG3 SLC15A2 ATP1A1 MYCBP2 ITPRID2 PTPRK PTPRS DSG2 EPAS1	3.95e-07	199	415	12	262e5b8a52c8ddb0b47048c786e8bdb7158e1b9a
ToppCell	Control_saline-Endothelial-Endothelial-Gen_Cap\|Control_saline / Treatment groups by lineage, cell group, cell type	RGS5 NR5A2 PTK2 PTPRB KDR ADGRL3 NPR1 UACA FAM171A1 KLHL5 GPCPD1 EPAS1	4.17e-07	200	415	12	3b97920e1e6e2f09ddba2a861baa9c00c2970f4c
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Alv_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	JCAD FLT4 CARMIL1 ARHGAP6 STXBP6 PTK2 LUZP1 KDR NPR1 UACA CDC42EP1 EPAS1	4.17e-07	200	415	12	7034f57e282982c19c13ee8ab78eabaffa069e30
ToppCell	LPS_IL1RA_TNF-Endothelial\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	FLT4 RGS5 STXBP6 LUZP1 PTPRB KDR ADGRL3 NPR1 UACA CDC42EP1 FAM171A1 EPAS1	4.17e-07	200	415	12	d01cec331be3b03cef80e9536fc531285bcf00f6
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	MECOM JCAD RGS5 NR5A2 PTK2 PTPRB KDR ADGRL3 NPR1 UACA FAM171A1 EPAS1	4.17e-07	200	415	12	b2d4e6f3e8e4da62e6b02758ab2ed8f505269f9a
ToppCell	Parenchyma_Control_(B.)-Endothelial-TX\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	SEMA6A FLT4 RGS5 STXBP6 NR5A2 PROX1 PTPRB NUAK1 KDR HIF3A FAM171A1 EPAS1	4.17e-07	200	415	12	9e5627e11288713aa9b622aae40e849dd6eacd29
ToppCell	LPS_only-Endothelial-Endothelial\|LPS_only / Treatment groups by lineage, cell group, cell type	STXBP6 NR5A2 ITPRID2 LUZP1 PTPRB MAST4 NUAK1 KDR NPR1 UACA FAM171A1 EPAS1	4.17e-07	200	415	12	4bb609a284d4e6066f17470a1736076aa4a1f84c
ToppCell	LPS_only-Endothelial\|LPS_only / Treatment groups by lineage, cell group, cell type	STXBP6 NR5A2 ITPRID2 LUZP1 PTPRB MAST4 NUAK1 KDR NPR1 UACA FAM171A1 EPAS1	4.17e-07	200	415	12	81e76508c9050d533853d5fd2f3097b27613d836
ToppCell	Control_saline-Endothelial-Endothelial\|Control_saline / Treatment groups by lineage, cell group, cell type	JCAD FLT4 STXBP6 PTK2 LUZP1 PTPRB KDR NPR1 UACA CDC42EP1 FAM171A1 EPAS1	4.17e-07	200	415	12	e77eba6172cabf85b8028638ed35299f2f079cd8
ToppCell	distal-Endothelial-Capillary_Intermediate_1-2\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	SEMA6A BAIAP2 JCAD FLT4 ITGA10 ARHGAP6 STXBP6 LUZP1 PTPRB KDR LAMA5 HIF3A	4.17e-07	200	415	12	43bc48413b100a06f8edd9acd812296788fcbf5b
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	FLT4 RGS5 STXBP6 LUZP1 PTPRB KDR ADGRL3 NPR1 UACA CDC42EP1 FAM171A1 EPAS1	4.17e-07	200	415	12	a1fa6bae5a688faf488d6925cd3fad725dfa916b
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	MECOM NR5A2 ITPRID2 PTK2 PTPRB MAST4 KDR ADGRL3 NPR1 UACA FAM171A1 EPAS1	4.17e-07	200	415	12	a2b9d1cd291d17abddc3ee2e242121412c864b8b
Drug	Loxapine succinate [27833-64-3]; Up 200; 9uM; PC3; HT_HG-U133A	TRPC5 MECOM FER BIRC3 GAS7 GABBR2 PDE4DIP CTNND2 EMC1 ITPK1 ZSCAN32 NF1 NPR1 LAMC2 EDA	1.80e-06	189	409	15	6694_UP
Drug	Clorsulon [60200-06-8]; Up 200; 10.6uM; MCF7; HT_HG-U133A	ABCA2 IKZF1 KMT2A PICK1 GABBR2 AP3B1 TBC1D13 ACTL8 PTPRS HPS4 IPO5 MFSD9 AZI2 LIG3 ZW10	2.82e-06	196	409	15	7025_UP
Drug	SB 203580; Down 200; 1uM; MCF7; HT_HG-U133A	ADCY7 BAIAP2 RAB40C LZTS3 AVL9 C15orf39 STT3A ZSCAN32 TLK1 PTPRS SVIL HUWE1 LIG3 KLHL25 CELSR2	3.01e-06	197	409	15	7061_DN
Drug	Gentamicine sulfate [1405-41-0]; Down 200; 2.6uM; PC3; HT_HG-U133A	CHRNA5 PIK3R1 ARIH2 BAIAP2 SLC25A17 AMT SCYL2 PDE4DIP ERAP1 ZSCAN32 TDRD3 SVIL MFSD9 KIF3A EGF	3.01e-06	197	409	15	2082_DN
Drug	Ethopropazine hydrochloride [1094-08-2]; Down 200; 11.4uM; HL60; HT_HG-U133A	ABCA2 ELOA2 KIAA0319L CLN5 FLT4 IFT74 ENC1 PDE4DIP NECAB3 PCNX1 RUBCN ERAP1 PTPRS HPS4 DMXL2	3.20e-06	198	409	15	3038_DN
Drug	PF-01378883-00 [351320-41-7]; Down 200; 10uM; MCF7; HT_HG-U133A	PHEX MMP11 COL9A1 NOX3 ETNPPL PPP2R1B PROX1 EMC1 PTGER3 ACTL8 ABCD4 NPR1 EDA BRF1 VPS13B	3.20e-06	198	409	15	6363_DN
Drug	Chlorambucil [305-03-3]; Up 200; 13.2uM; PC3; HT_HG-U133A	CDO1 MECOM AMT APBB1 SLC15A2 CACNG4 ZNF85 PROX1 NF1 ACTL8 IMPG2 PRUNE2 HUWE1 RHAG TGM4	3.20e-06	198	409	15	3788_UP
Drug	irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A	MRPS31 MECOM KIF16B WDR26 ATP2B1 AVL9 ARHGAP11A PTK2 TLK1 NF1 MAST4 PTPRK SVIL TIAM1	3.38e-06	174	409	14	7530_DN
Drug	Furazolidone [67-45-8]; Up 200; 17.8uM; MCF7; HT_HG-U133A	ELOA2 F13A1 KMT2A MMP11 BIRC3 GABBR2 PTGER3 MAST4 HIF3A RFX3 EDA FAM171A1 KLHL25 BRF1 PCDH8	3.41e-06	199	409	15	4178_UP
Drug	Bromopride [4093-35-0]; Down 200; 11.6uM; MCF7; HT_HG-U133A	ETFDH CEMIP2 KMT2A BAIAP2 RAB11FIP2 ENC1 GABBR2 EMC1 LZTS3 ERAP1 CABYR NF1 KCNJ3 CDC42EP1 LIG3	3.41e-06	199	409	15	4741_DN
Drug	Parthenolide [20554-84-1]; Down 200; 16.2uM; MCF7; HT_HG-U133A	PATZ1 MECOM CREBZF PIK3R1 NMT2 AKAP7 ENC1 ZNF85 C15orf39 BRCA1 SVIL DLG3 KATNIP LAMA5	6.07e-06	183	409	14	5530_DN
Drug	(-)-Isoproterenol hydrochloride [5984-95-2]; Down 200; 16.2uM; MCF7; HT_HG-U133A	PATZ1 PHEX ARIH2 PCNX1 MYO9B CDS2 C15orf39 TDRD3 PNPLA6 MAST4 KCNJ3 PSD3 KLHL25 CBX6	1.18e-05	194	409	14	6833_DN
Drug	Tolnaftate [2398-96-1]; Down 200; 13uM; PC3; HT_HG-U133A	ABCA1 KIAA0319L FANCC PIK3R1 PLA2G6 SLC25A17 RC3H2 RGS5 PCNX1 ZSCAN32 PLPPR4 BRCA2 RBM4 EGF	1.18e-05	194	409	14	4221_DN
Drug	Simvastatin [79902-63-9]; Down 200; 9.6uM; HL60; HT_HG-U133A	ABCA1 PDZD7 ARIH2 PLA2G6 RGS5 PPM1E ENC1 RUBCN IFT140 PTGER3 TLK1 PTPRB RAB2A PRUNE2	1.33e-05	196	409	14	3002_DN
Drug	Lysergol [602-85-7]; Down 200; 15.8uM; MCF7; HT_HG-U133A	ABCA1 CLN5 ARIH2 BAIAP2 AMT IFT74 ITGA10 PDP1 CACNG4 MYO9B TDRD3 ACTL8 COQ8A KAT6B	1.41e-05	197	409	14	4966_DN
Drug	troglitazone; Down 200; 10uM; MCF7; HT_HG-U133A_EA	ABCA3 PIK3R1 SLC25A17 RC3H2 ENC1 PPP2R1B SLC15A2 PCNX1 ZNF85 ZSCAN32 DIP2A BRCA2 KCNJ3 NACC2	1.49e-05	198	409	14	1070_DN
Drug	Nitrendipine [39562-70-4]; Down 200; 11uM; MCF7; HT_HG-U133A	PLAA PLA2G6 BAIAP2 SLC25A17 ZNF35 PCNX1 MYO9B PDCD4 NF1 HPS4 DLG3 PSD3 BRF1 BBS7	1.49e-05	198	409	14	6464_DN
Drug	Chlormezanone [80-77-3]; Down 200; 14.6uM; PC3; HT_HG-U133A	PIK3R1 NMT2 AKAP7 AMT IFT74 ARHGAP6 IFT140 PTGER3 B4GALT1 PTPRB ABCD4 CELSR2 TIAM1 CBX6	1.49e-05	198	409	14	4636_DN
Drug	Niridazole [61-57-4]; Up 200; 18.6uM; PC3; HT_HG-U133A	CREBZF KMT2A ZNF81 FLT4 STXBP6 PDE4DIP PCNX1 CTNND2 ERAP1 PTGER3 B4GALT1 NF1 PLPPR4 NPR1	1.49e-05	198	409	14	4621_UP
Drug	minocycline; Down 200; 10.5uM; MCF7; HT_HG-U133A_EA	MECOM KMT2A CARMIL1 TBC1D13 SLC15A2 ZNF85 RUBCN AVL9 ARHGAP11A CABYR GCFC2 LAMA5 AZI2 KIF3A	1.49e-05	198	409	14	1135_DN
Drug	Nadide [53-84-9]; Up 200; 6uM; MCF7; HT_HG-U133A	ABCA2 KIAA0319L IKZF1 ALX4 BAIAP2 FLT4 BIRC3 AP3B1 ERAP1 PTGER3 NF1 PSD3 EDA CDC42EP1	1.49e-05	198	409	14	7227_UP
Drug	Meclofenoxate hydrochloride [3685-84-5]; Up 200; 13.6uM; PC3; HT_HG-U133A	ELOA2 KIAA0319L RGS5 GABBR2 SLC15A2 PROX1 FRMPD4 ERAP1 ITIH3 TLK1 NF1 MAST4 GPD2 TIAM1	1.58e-05	199	409	14	3707_UP
Drug	Sulfanilamide [63-74-1]; Up 200; 23.2uM; HL60; HT_HG-U133A	CDO1 ERBB3 ABCA1 ABCA2 KMT2A PLA2G6 GABBR2 PTGER3 NF1 ACTL8 KCNJ3 EDA KIF3A BRF1	1.58e-05	199	409	14	2709_UP
Drug	(S)-(-)-Cycloserine [339-72-0]; Down 200; 39.2uM; MCF7; HT_HG-U133A	KIAA0319L ADRA1D FER BAIAP2 PICK1 RAB40C CTNND2 CROCC ALDH1L1 ZSCAN32 DLG3 PSD3 CDC42EP1 VPS13B	1.58e-05	199	409	14	4346_DN
Drug	Delsoline [509-18-2]; Down 200; 8.6uM; MCF7; HT_HG-U133A	KIAA0319L CREBZF BAIAP2 AMT FLT4 PDE4DIP PCNX1 LZTS3 ALDH1L1 PDCD4 NF1 MAST4 LAMC2 BRF1	1.58e-05	199	409	14	6075_DN
Drug	ICI 182,780; Down 200; 1uM; MCF7; HT_HG-U133A_EA	MECOM PIK3R1 KMT2A DYRK2 NAA15 PRPF40A STAG2 MYCBP2 UBXN4 SPIN1 RBBP6 CBX6 KAT6B	2.01e-05	177	409	13	985_DN
Drug	4,4'-diaminodibenzyl	SEMA6A DOCK3 EDA	2.27e-05	4	409	3	CID000012138
Drug	Terbutaline hemisulfate [23031-32-5]; Up 200; 7.2uM; PC3; HT_HG-U133A	ABCA1 APBB1 GAS7 SLC15A2 B4GALT1 PID1 NPR1 RBBP6 HUWE1 DNAH7 KLHL25 BRF1 EPAS1	2.86e-05	183	409	13	5764_UP
Drug	Harmine hydrochloride [343-27-1]; Down 200; 16uM; MCF7; HT_HG-U133A	MRPS31 PLAA BAIAP2 DYRK2 PPM1B PDE4DIP AVL9 TLK1 BRCA1 DLG3 KIF3A TIAM1 VPS13B	3.20e-05	185	409	13	7209_DN
Drug	Neostigmine bromide [114-80-7]; Down 200; 13.2uM; PC3; HT_HG-U133A	KMT2A DYRK2 RC3H2 NAA15 ENC1 PRPF40A SCYL2 PDP1 UBXN4 SPIN1 GPD2 RBM4 KAT6B	3.79e-05	188	409	13	6735_DN
Drug	Melphalan	FANCC MEX3A PIK3R1 ZNF618 DENND4C LRIG3 TET1 ATP2B1 TRMT10C NUAK1 NHS DLG3 MTCL1 PRUNE2 PSD3 TEX30	4.37e-05	276	409	16	ctd:D008558
Drug	orthovanadate	ERBB3 ABCA1 ADCY7 PIK3CA PIK3R1 ENPP7 KIF16B SLC4A1 ATP1A1 ATP1A3 CTSD ATP2B1 ATP5F1A PTK2 STT3A PTPRB ACTL8 PTPRS DYNC1H1 NSF EGF	4.52e-05	435	409	21	CID000061672
Drug	thioridazine hydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A_EA	ABCA3 PIK3R1 NMT2 CCDC15 RC3H2 ENC1 PPP2R1B SLC15A2 AVL9 BRCA1 KCNJ3 IPO5 NACC2	4.71e-05	192	409	13	1068_DN
Drug	Loperamide hydrochloride [34552-83-5]; Down 200; 7.8uM; PC3; HG-U133A	MRPS31 PHKA2 MACROH2A2 RC3H2 MEAK7 SLC4A2 PCF11 TTI1 ERAP1 BRCA1 IPO5 RBBP6 NACC2	5.53e-05	195	409	13	1949_DN
Drug	Hydrastine hydrochloride [5936-28-7]; Up 200; 9.6uM; PC3; HT_HG-U133A	ABCA2 ARIH2 AKAP7 AMT ZNF85 CADPS2 AVL9 B4GALT1 MAST4 BRCA2 ADGRL3 GCFC2 DNAH7	5.53e-05	195	409	13	7309_UP
Drug	dimethylphosphinate	SEMA6A PDP1 CTSD	5.60e-05	5	409	3	CID000076777
Drug	felodipine; Down 200; 10uM; MCF7; HT_HG-U133A_EA	ERI3 DYRK2 IFT74 AP3B1 IGBP1 CTNND2 EMC1 AVL9 ITPRID2 TDRD3 BRCA1 TIAM1 KAT6B	5.82e-05	196	409	13	848_DN
Drug	Terconazole [67915-31-5]; Down 200; 7.6uM; MCF7; HT_HG-U133A	CEMIP2 CREBZF PHEX PCNX1 LZTS3 ERAP1 MYO9B TDRD3 TLK1 BRCA2 KCNJ3 IPO5 GPD2	5.82e-05	196	409	13	2844_DN
Drug	Fluspirilen [1841-19-6]; Down 200; 8.4uM; HL60; HT_HG-U133A	KIAA0319L PDZD7 ERI3 ARIH2 AKAP7 ENC1 KBTBD4 PCNX1 CDS2 ADGRL3 LIG3 BBS7 KAT6B	5.82e-05	196	409	13	3086_DN
Drug	manganese tetroxide	CDO1 FER STT3A DOCK3 LAMC2	5.85e-05	24	409	5	CID000014825
Drug	Estriol [50-27-1]; Up 200; 13.8uM; PC3; HT_HG-U133A	GAS7 PDE4DIP CACNG4 MYO9B NF1 KCNJ3 HPS4 DLG3 PID1 HUWE1 RHAG KLHL25 EGF	6.14e-05	197	409	13	5866_UP
Drug	Doxazosin mesylate [77883-43-3]; Up 200; 7.4uM; HL60; HT_HG-U133A	CDO1 CREBZF FGD1 RGS5 PDE4DIP CACNG4 ALDH1L1 ITIH3 DLG3 KNG1 DSG2 LAMA5 LIG3	6.14e-05	197	409	13	3024_UP
Drug	Glycopyrrolate [596-51-0]; Up 200; 10uM; HL60; HT_HG-U133A	CDO1 CREBZF RAB40C CTNND2 PROX1 LZTS3 CDS2 PTGER3 NF1 DLG3 PSD3 RHAG TIAM1	6.14e-05	197	409	13	2565_UP
Drug	Piperacillin sodium salt [59703-84-3]; Down 200; 7.4uM; MCF7; HT_HG-U133A	IKZF1 ADCY7 MACROH2A2 FLT4 ZNF35 PDE4DIP EMC1 PDCD4 NF1 GPD2 LAMC2 OVOL1 ZW10	6.14e-05	197	409	13	3939_DN
Drug	Moxisylyte hydrochoride [964-52-3]; Up 200; 12.6uM; MCF7; HT_HG-U133A	ABCA2 IKZF1 BAIAP2 PICK1 IFT74 GAS7 SLC15A2 PDE4DIP NF1 ACTL8 RAB2A EDA KAT6B	6.14e-05	197	409	13	1682_UP
Drug	Josamycin [16846-24-5]; Down 200; 4.8uM; HL60; HG-U133A	ARIH2 AMPD2 NECAB3 CACNG4 CTSD C15orf39 PDCD4 LUZP1 DIP2A SPIN1 RAB2A LARP1 ANKRD46	6.14e-05	197	409	13	2034_DN
Drug	PF-00539745-00 [351321-33-0]; Down 200; 10uM; PC3; HT_HG-U133A	PHEX AKAP7 SCYL2 PDE4DIP PRKAB1 PCNX1 ATP12A AVL9 TDRD3 BRCA2 KATNIP TGM4 TIAM1	6.14e-05	197	409	13	5939_DN
Drug	Dioxybenzone [131-53-3]; Down 200; 16.4uM; PC3; HT_HG-U133A	TRPC5 AMT RGS5 GABBR2 AP3B1 ATP1A3 PTGER3 PDCD4 PTPRB RAB2A PID1 GPD2 L1CAM	6.14e-05	197	409	13	4638_DN
Drug	A-32686	HIF1A ATP1A1 ATP1A3 EDA	6.45e-05	13	409	4	CID000004951
Drug	Azathioprine [446-86-6]; Down 200; 14.4uM; MCF7; HT_HG-U133A	TRPC5 KIAA0319L IKZF1 ADRA1D FER BAIAP2 GABBR2 LZTS3 MYO9B ALDH1L1 IPO5 DMXL2 OVOL1	6.46e-05	198	409	13	5627_DN
Drug	2-propylpentanoic acid; Down 200; 500uM; MCF7; HT_HG-U133A_EA	ABCA2 PATZ1 FANCC CLN5 KBTBD4 TDRD3 MAST4 BRCA1 BRCA2 KCNJ3 LIG3 TIAM1 KAT6B	6.46e-05	198	409	13	1020_DN
Drug	Harmane hydrochloride [21655-84-5]; Up 200; 18.2uM; PC3; HT_HG-U133A	KIAA0319L PLA2G6 SLC4A1 PDE4DIP PCNX1 ERAP1 PTGER3 PDCD4 B4GALT1 ZSCAN32 NF1 IMPG2 EDA	6.46e-05	198	409	13	4584_UP
Drug	Yohimbine hydrochloride [65-19-0]; Up 200; 10.2uM; PC3; HT_HG-U133A	ABCA3 CEMIP2 FER GAS7 PDE4DIP PRKAB1 CTNND2 AVL9 MAST4 RAB2A GCFC2 MFSD9 CBX6	6.46e-05	198	409	13	7130_UP
Drug	Fenspiride hydrochloride [5053-08-7]; Down 200; 13.4uM; MCF7; HT_HG-U133A	ABCA2 KIAA0319L CREBZF AKAP7 DYRK2 IFT74 ENC1 CACNG4 ITPRID2 LUZP1 NF1 IPO5 BRF1	6.46e-05	198	409	13	6001_DN
Drug	Clioquinol [130-26-7]; Down 200; 13uM; MCF7; HT_HG-U133A	ARIH2 PLA2G6 SEMA6A SLC25A17 IFT74 AP3B1 PDE4DIP PCNX1 AVL9 ITPRID2 PDCD4 PTK2 NF1	6.80e-05	199	409	13	6461_DN
Drug	Diclofenac sodium [15307-79-6]; Down 200; 12.6uM; MCF7; HT_HG-U133A	CLN5 ARIH2 BAIAP2 TPST1 IFT74 RAB11FIP2 ENC1 ZNF7 PDE4DIP CTNND2 PDCD4 ABCC10 TIAM1	6.80e-05	199	409	13	7215_DN
Drug	rapamycin, Streptomyces hygroscepicus; Up 200; 0.1uM; MCF7; HT_HG-U133A	TRPC5 ADRA1D PLAA PLA2G6 AKAP7 PPP2R1B TDRD3 TAS2R9 PTPRS HUWE1 DNAH7 KLHL25 BRF1	6.80e-05	199	409	13	5927_UP
Drug	Dipyridamole [58-32-2]; Down 200; 8uM; MCF7; HT_HG-U133A	ABCA2 TRPC5 IKZF1 CREBZF SEMA6A SLC15A2 PDE4DIP IFT140 LZTS3 ALDH1L1 DMXL2 PSD3 OVOL1	6.80e-05	199	409	13	5617_DN
Drug	Mafenide hydrochloride [138-37-4]; Up 200; 18uM; PC3; HT_HG-U133A	ABCA1 ABCA2 PLA2G6 DYRK2 GABBR2 CRP PROX1 IFT140 PTPRS PID1 ADGRL3 PRUNE2 BRF1	6.80e-05	199	409	13	5079_UP
Drug	NSC89595	PIK3CA PIK3R1 DIABLO ATP1A1 ATP1A3 ATP12A TIAM1	6.99e-05	57	409	7	CID000002464
Drug	Trimethoprim [738-70-5]; Down 200; 13.8uM; MCF7; HT_HG-U133A	TRPC5 ADRA1D AKAP7 GABBR2 PCNX1 CADPS2 IFT140 ERAP1 PTGER3 PDCD4 LUZP1 PTPRS PSD3	7.16e-05	200	409	13	4701_DN
Drug	Loperamide hydrochloride [34552-83-5]; Down 200; 7.8uM; MCF7; HT_HG-U133A	ABCA1 KIAA0319L IKZF1 FGD1 SEMA6A FLT4 PDE4DIP NF1 ACTL8 PSD3 BRF1 ZW10 KAT6B	7.16e-05	200	409	13	5632_DN
Drug	Methylergometrine maleate [113-42-8]; Up 200; 8.8uM; MCF7; HT_HG-U133A	PHEX MMP11 GAS7 NOX3 GABBR2 PCNX1 CROCC EMC1 TLK1 ADGRL3 EDA BRF1 VPS13B	7.16e-05	200	409	13	3222_UP
Drug	AC1N9YT9	HIF1A TUFM GFM2 GFM1 EDA	8.80e-05	26	409	5	CID000014973
Drug	Helveticoside [630-64-8]; Down 200; 7.4uM; MCF7; HT_HG-U133A	MRPS31 PATZ1 PIK3R1 CCDC15 DYRK2 PCF11 PDE4DIP MYO9B TDRD3 BRCA1 HPS4 ANKRD46	9.54e-05	178	409	12	6047_DN
Drug	Etifenin [63245-28-3]; Down 200; 12.4uM; PC3; HT_HG-U133A	KMT2A DYRK2 RC3H2 NAA15 ENC1 PRPF40A SCYL2 PDP1 MYCBP2 SPIN1 RBBP6 KAT6B	9.54e-05	178	409	12	3998_DN
Drug	Digoxigenin [1672-46-4]; Down 200; 10.2uM; MCF7; HT_HG-U133A	MRPS31 ZC3H14 PATZ1 PLAA PIK3R1 MEAK7 PDE4DIP ZSCAN32 CABYR BRCA1 HPS4 ANKRD46	1.01e-04	179	409	12	5640_DN
Drug	P-320	KMT2A FLT4 KDR	1.11e-04	6	409	3	CID000203773
Drug	Azaguanine-8 [134-58-7]; Down 200; 26.2uM; PC3; HT_HG-U133A	ERBB3 MECOM ASPM DYRK2 MEAK7 PCF11 PPP2R1B ANKRD17 TTI1 RBBP6 RBM4B KAT6B	1.12e-04	181	409	12	1791_DN
Drug	Methylcholanthrene	HIF1A ABCA1 ERCC6 CSMD3 PTER ADCY7 PHEX PHKA2 PIK3R1 ASPM BAIAP2 DYRK2 TPST1 DIABLO ITGA10 WDR26 RBM39 SLC4A2 STAU2 PRKAB1 CTSD ATP5F1A ARHGAP11A PDCD4 PTK2 ITIH3 BRCA1 KNG1 LAMA5 LAMC2 GRIK4 RALGAPA2 GDPD4 LRP11 GPCPD1 EPAS1	1.26e-04	1034	409	36	ctd:D008748
Drug	Rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA	ABCA2 ERCC6 PHEX ERI3 AMT SLC15A2 PDCD4 COQ8A ABCD4 DMXL2 LAMC2 BRF1	1.38e-04	185	409	12	1022_UP
Drug	Sulfaphenazole [526-08-9]; Down 200; 12.8uM; MCF7; HT_HG-U133A	PTER PIK3R1 CCDC15 DYRK2 RC3H2 NAA15 TRIM66 UBXN4 BRCA2 SPIN1 KIF3A KAT6B	1.38e-04	185	409	12	1673_DN
Drug	2,4,4'-trichlorobiphenyl	HIF1A PLPPR3 CSMD3 FAT2 MEX3A TMEM38A ASPM FGD1 SEMA6A DYRK2 COL6A3 PPM1E ENC1 BIRC3 GAS7 ETNPPL ZNF7 MLIP PDE4DIP DOCK7 KNDC1 CEP295 FRMPD4 CDH23 ARHGAP11A PTGER3 IGSF10 BRCA2 NECAB1 PTPRS SPIN1 KDR GPC2 DMD SHANK1 PRUNE2 NSF RBM4B PSD3 MYRFL RALGAPA2 TEX30 EGF CELSR2 SPATA13	1.38e-04	1411	409	45	ctd:C081766
Drug	17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A_EA	MRPS31 PATZ1 PIK3R1 MACROH2A2 MEAK7 PCF11 C15orf39 BRCA1 RBBP6 RBM4B KIF3A KAT6B	1.45e-04	186	409	12	831_DN
Drug	GBR 12909 dihydrochloride [67469-78-7]; Up 200; 7.6uM; MCF7; HT_HG-U133A	PHEX SEMA6A GABBR2 ALDH1L1 PTGER3 NF1 PTPRS DMXL2 NPR1 PSD3 LIG3 KLHL25	1.52e-04	187	409	12	3240_UP
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HG-U133A	CREBZF PCF11 CNPY3 PCNX1 CACNG4 STAG2 EMC1 PDCD4 DIP2A LARP1 AZI2 KAT6B	1.60e-04	188	409	12	1421_DN
Drug	3-isoreserpine	ABCA1 ABCA2 ABCA3 ADCY7 ADRA1D PIK3CA PIK3R1 MRE11 AMT CLEC4F ABCD4 ABCC10	1.77e-04	190	409	12	CID000005052
Drug	Tetrahydrozoline hydrochloride [522-48-5]; Down 200; 16.8uM; MCF7; HT_HG-U133A	PHEX ADRA1D CLN5 NMT2 DYRK2 FLT4 SCYL2 CNPY3 LZTS3 LUZP1 GPD2 LAMC2	1.77e-04	190	409	12	6769_DN
Drug	Tubocurarine chloride pentahydrate (+) [6989-98-6]; Up 200; 5.2uM; MCF7; HT_HG-U133A	KIAA0319L MECOM BAIAP2 MMP11 RAB40C PCNX1 ALDH1L1 NF1 KCNJ3 DMXL2 LAMC2 KLHL25	1.77e-04	190	409	12	2887_UP
Drug	Imipenem [74431-23-5]; Down 200; 13.4uM; MCF7; HT_HG-U133A	ABCA2 CREBZF NMT2 ARIH2 BAIAP2 ZNF35 PCNX1 IFT140 MYO9B CABYR RAB2A BRF1	1.85e-04	191	409	12	5997_DN
Drug	SSFSB	ERBB3 AP3B1 EGF	1.91e-04	7	409	3	CID003035734
Drug	0317956-0000 [391210-11-0]; Down 200; 1uM; MCF7; HT_HG-U133A	ABCA1 ADRA1D MYO9B C15orf39 ALDH1L1 ITPK1 ACTL8 LAMC2 CDC42EP1 BRF1 TIAM1 EPAS1	1.95e-04	192	409	12	3858_DN
Drug	Mebeverine hydrochloride [2753-45-9]; Up 200; 8.6uM; PC3; HT_HG-U133A	ABCA3 KIAA0319L CEMIP2 PCNX1 ERAP1 C15orf39 TRIM66 ZSCAN32 MAST4 RAB2A LAMC2 EGF	2.04e-04	193	409	12	7147_UP
Drug	CP-320650-01 [172079-28-6]; Down 200; 1uM; MCF7; HT_HG-U133A	ABCA2 ZNF85 LZTS3 ITPRID2 TDRD3 KCNJ3 CDC73 RBBP6 LARP1 LIG3 BBS7 EPAS1	2.04e-04	193	409	12	3908_DN
Drug	phenanthridinone; Up 200; 51.2uM; MCF7; HT_HG-U133A_EA	MECOM IFT74 CNPY3 CTNND2 EMC1 PDCD4 DIP2A COQ8A KCNJ3 SVIL DLG3 KIF3A	2.04e-04	193	409	12	1115_UP
Drug	Albendazole [54965-21-8]; Up 200; 15uM; MCF7; HT_HG-U133A	PLAA BAIAP2 FLT4 RGS5 BIRC3 GABBR2 CROCC EMC1 PTGER3 LUZP1 MAST4 BRF1	2.14e-04	194	409	12	7164_UP
Drug	2,4,5,2',5'-pentachlorobiphenyl	HIF1A PLPPR3 CSMD3 FAT2 MEX3A TMEM38A ASPM FGD1 SEMA6A DYRK2 COL6A3 PPM1E ENC1 BIRC3 GAS7 ETNPPL ZNF7 MLIP PDE4DIP DOCK7 KNDC1 CEP295 FRMPD4 CDH23 ARHGAP11A PTGER3 IGSF10 BRCA2 NECAB1 PTPRS SPIN1 KDR GPC2 DMD SHANK1 PRUNE2 NSF RBM4B PSD3 MYRFL RALGAPA2 TEX30 EGF CELSR2 SPATA13	2.20e-04	1441	409	45	ctd:C009828
Drug	Betulin [473-98-3]; Down 200; 9uM; MCF7; HT_HG-U133A	ABCA1 PLAA ARIH2 MACROH2A2 AMT GABBR2 PDCD4 ITPK1 B4GALT1 TRIM66 IPO5 BRF1	2.25e-04	195	409	12	3513_DN
Drug	Gallamine triethiodide [65-29-2]; Up 200; 4.4uM; MCF7; HT_HG-U133A	IKZF1 FGD1 PPP2R1B PDE4DIP PCNX1 IFT140 ERAP1 ITPK1 NF1 PRUNE2 LIG3 KLHL25	2.25e-04	195	409	12	6215_UP
Drug	Iproniazide phosphate [305-33-9]; Down 200; 14.4uM; PC3; HT_HG-U133A	PHKA2 PIK3R1 AMPD2 ITGA10 TBC1D13 CACNG4 ARHGAP11A MAST4 IPO5 LAMC2 LIG3 ZW10	2.25e-04	195	409	12	2125_DN
Drug	leukotoxin B (12,13-EODE); Up 200; 0.2uM; MCF7; HT_HG-U133A_EA	ARIH2 CCDC15 MACROH2A2 DYRK2 RAB11FIP2 PDCD4 KCNJ3 IPO5 RFC1 TMF1 KAT6B EPAS1	2.25e-04	195	409	12	1108_UP
Drug	Pyrithyldione [77-04-3]; Down 200; 24uM; HL60; HT_HG-U133A	ABCA2 KIAA0319L F13A1 CREBZF PIK3R1 NMT2 PLA2G6 ENC1 PDE4DIP RUBCN SPAG1 TLK1	2.25e-04	195	409	12	2740_DN
Drug	Picotamide monohydrate [80530-63-8]; Up 200; 10.2uM; PC3; HT_HG-U133A	ABCA2 IFT74 GABBR2 CTNND2 AVL9 C15orf39 ZSCAN32 BRCA2 ABCD4 PSD3 MFSD9 TIAM1	2.25e-04	195	409	12	7140_UP
Drug	Lisuride (S)(-) [18016-80-3]; Up 200; 11.8uM; MCF7; HT_HG-U133A	PLAA FGD1 KMT2A AKAP7 JCAD BIRC3 PPP2R1B ALDH1L1 B4GALT1 SVIL PRUNE2 OVOL1	2.25e-04	195	409	12	5028_UP
Drug	Pimethixene maleate [13187-06-9]; Up 200; 9.8uM; MCF7; HT_HG-U133A	IKZF1 SEMA6A SLC25A17 AKAP7 CNPY3 PCNX1 LZTS3 ERAP1 NF1 ACTL8 EDA TIAM1	2.25e-04	195	409	12	7468_UP
Drug	Methoxy-6-harmalan [3589-73-9]; Down 200; 18.6uM; HL60; HG-U133A	MRPS31 ERCC6 CREBZF DDX41 PPP2R1B NECAB3 CYB5A NF1 SPIN1 RAB2A ZNF629 ZW10	2.25e-04	195	409	12	1743_DN
Drug	Calcifediol	PSAT1 APOB PPM1B ATP1A1 ATP1A3 CYB5A KDR NSF	2.35e-04	91	409	8	ctd:D002112
Drug	Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA	CLN5 NMT2 ARIH2 TPST1 PCNX1 RUBCN ITPRID2 KCNJ3 DLG3 ABCC10 BBS7 KAT6B	2.36e-04	196	409	12	987_DN
Drug	Ranitidine hydrochloride [66357-59-3]; Down 200; 11.4uM; MCF7; HT_HG-U133A	IKZF1 SEMA6A IFT74 PPP2R1B EMC1 ZSCAN32 TDRD3 NF1 KCNJ3 RAB2A LIG3 VPS13B	2.36e-04	196	409	12	5425_DN
Drug	Norcyclobenzaprine [303-50-4]; Down 200; 15.4uM; MCF7; HT_HG-U133A	PIK3R1 PCNX1 CACNG4 ERAP1 PDCD4 NF1 MAST4 BRCA2 KCNJ3 HPS4 IPO5 BRF1	2.36e-04	196	409	12	4776_DN
Disease	Schizophrenia	ERBB3 ABCA1 CSMD2 TRRAP ADCY7 CHRNA5 PANK2 PLAA PIK3CA KMT2A PLA2G6 PICK1 ANKK1 PSAT1 RGS5 ETNPPL CRP TET1 CTNND2 CADPS2 MYO5B MYO9B PTGER3 ITIH3 BRCA1 KCNJ3 HPS4 DLG3 KDR TACR3 GRIN3A SHANK1 IPO5 FZD3 PSD3 GRIK4 PCDH8	1.84e-09	883	402	37	C0036341
Disease	Colorectal Carcinoma	CDO1 ABCA1 ABCA3 ELOA2 ERCC6 ETFDH CSMD3 FAT1 PIK3CA PKHD1 NCR1 MMP11 PPM1E APOB PPP2R1B CTNND2 ALDH1L1 SPNS3 CABYR NF1 PTPRS ABCD4 DLG3 KDR DMD SHANK1 DPEP1 PARP8 EDA LIG3 BRF1 TIAM1	3.30e-09	702	402	32	C0009402
Disease	lung non-small cell carcinoma (is_implicated_in)	ERBB3 HIF1A ERCC6 LRP1B CHRNA5 FAT1 BIRC3 PTPRB BRCA1 KDR EGF EPAS1	4.89e-07	139	402	12	DOID:3908 (is_implicated_in)
Disease	breast angiosarcoma (is_implicated_in)	PIK3CA PTPRB KDR	2.51e-06	3	402	3	DOID:4511 (is_implicated_in)
Disease	Glioblastoma Multiforme	HIF1A FAT1 PIK3CA PIK3R1 DYRK2 CTNND2 STAG2 PTK2 NF1 EGF	2.99e-06	111	402	10	C1621958
Disease	hippocampal atrophy	IKZF1 ZBP1 CHD6 TLK1 PRUNE2 GCFC2 VPS13B	1.08e-05	56	402	7	EFO_0005039
Disease	lung non-small cell carcinoma (is_marker_for)	ERBB3 IKZF3 DIABLO BIRC3 NF1 PTPRB BRCA1 KDR L1CAM LAMC2 EGF	2.21e-05	169	402	11	DOID:3908 (is_marker_for)
Disease	Neoplasm of uncertain or unknown behavior of ovary	ERCC6 PIK3CA PIK3R1 BRCA1 BRCA2	4.15e-05	29	402	5	C0496920
Disease	Ovarian Carcinoma	ERCC6 PIK3CA PIK3R1 BRCA1 BRCA2	4.93e-05	30	402	5	C0029925
Disease	response to radiation, Urinary retention	LRP1B COL6A3 PTPRS CAMTA1	7.02e-05	17	402	4	GO_0009314, HP_0000016
Disease	familial hemiplegic migraine (implicated_via_orthology)	ATP1A1 ATP1A3 ATP12A	8.43e-05	7	402	3	DOID:0060178 (implicated_via_orthology)
Disease	cancer (implicated_via_orthology)	CDIPT FLT4 TTI1 PROX1 CDS2 BRCA2 DLG3 KDR IPO5 RBBP6 HIF3A CBX6 EPAS1	8.86e-05	268	402	13	DOID:162 (implicated_via_orthology)
Disease	Arthrogryposis	ERCC6 GFM2 DYNC1H1 L1CAM	1.69e-04	21	402	4	C0003886
Disease	dystonia 12 (is_implicated_in)	PLA2G6 ATP1A3	1.85e-04	2	402	2	DOID:0090056 (is_implicated_in)
Disease	Usher syndrome type 2A (is_implicated_in)	PDZD7 USH2A	1.85e-04	2	402	2	DOID:0110838 (is_implicated_in)
Disease	ductal carcinoma in situ (biomarker_via_orthology)	BRCA1 BRCA2	1.85e-04	2	402	2	DOID:0060074 (biomarker_via_orthology)
Disease	Hereditary site-specific ovarian cancer syndrome	BRCA1 BRCA2	1.85e-04	2	402	2	C4749652
Disease	USHER SYNDROME, TYPE IIA	PDZD7 USH2A	1.85e-04	2	402	2	C1848634
Disease	lymphangioma (is_marker_for)	FLT4 KDR	1.85e-04	2	402	2	DOID:1475 (is_marker_for)
Disease	Autosomal recessive polycystic kidney disease	PKHD1 DZIP1L	1.85e-04	2	402	2	cv:C0085548
Disease	HEMANGIOMA, CAPILLARY INFANTILE, SOMATIC	FLT4 KDR	1.85e-04	2	402	2	C4016109
Disease	USHER SYNDROME, TYPE IIA	PDZD7 USH2A	1.85e-04	2	402	2	276901
Disease	Usher syndrome type 2A	PDZD7 USH2A	1.85e-04	2	402	2	cv:C1848634
Disease	Autosomal Recessive Polycystic Kidney Disease	PKHD1 SLC4A2 DZIP1L	1.98e-04	9	402	3	C0085548
Disease	isovalerate measurement	NMT2 USH2A FAM171A1	1.98e-04	9	402	3	EFO_0021051
Disease	cardiovascular disease	MECOM ADRA1D PIK3R1 RXFP2 PKHD1 APOB DOCK7 PCNX1 CADPS2 ATP2B1 ERAP1 MYO9B ABCC10 DPEP1 NPR1 OVOL1 CELSR2	2.04e-04	457	402	17	EFO_0000319
Disease	colorectal carcinoma (is_implicated_in)	ERCC6 PIK3CA BIRC3 PTPRB	2.04e-04	22	402	4	DOID:0080199 (is_implicated_in)
Disease	Conventional (Clear Cell) Renal Cell Carcinoma	CSMD3 LRP1B PIK3CA FLT4 CTSD KDR SHANK1 L1CAM EPAS1	2.05e-04	148	402	9	C0279702
Disease	colorectal cancer (is_implicated_in)	ERCC6 IKZF1 LRP1B ALX4 FAT1 PIK3CA BRCA1 KDR	2.61e-04	121	402	8	DOID:9256 (is_implicated_in)
Disease	Head and Neck Carcinoma	ERBB3 PIK3CA CDC73	2.81e-04	10	402	3	C3887461
Disease	Fanconi anemia (is_implicated_in)	FANCC BRCA1 BRCA2	2.81e-04	10	402	3	DOID:13636 (is_implicated_in)
Disease	uric acid measurement	ABCA1 FSIP1 MECOM BIRC6 SHLD2 FLT4 CARMIL1 MLIP SLC15A2 NR5A2 CCDC125 PCNX3 ITPK1 B4GALT1 SPIN1 SELENOO DPEP1 KLHL5 OVOL1 EPAS1	3.07e-04	610	402	20	EFO_0004761
Disease	Malignant Head and Neck Neoplasm	ERBB3 FANCC FAT1 PIK3CA CDC73	3.21e-04	44	402	5	C0278996
Disease	breast cancer (implicated_via_orthology)	PIK3CA MRE11 BRCA1 BRCA2	3.42e-04	25	402	4	DOID:1612 (implicated_via_orthology)
Disease	atopic eczema, childhood onset asthma, atopic march	IKZF3 KIF3A OVOL1	3.82e-04	11	402	3	EFO_0000274, EFO_0007755, MONDO_0005405
Disease	autosomal recessive polycystic kidney disease (biomarker_via_orthology)	PIK3CA PKHD1 SLC4A2	3.82e-04	11	402	3	DOID:0110861 (biomarker_via_orthology)
Disease	Malignant Neoplasms	ERBB3 BIRC6 DNAJC10 PIK3CA PIK3R1 MRE11 BRCA1 KDR	3.82e-04	128	402	8	C0006826
Disease	selective IgA deficiency disease	IKZF3 CDH23 MAST4 IL21 FAM171A1	3.96e-04	46	402	5	EFO_1001929
Disease	Antiglaucoma preparations and miotics use measurement	ABCA1 MECOM KMT2A GAS7	4.00e-04	26	402	4	EFO_0009944
Disease	Malignant neoplasm of breast	ERBB3 XIRP1 HIF1A ABCA3 ERCC6 MECOM PIK3CA MRE11 PPM1E KIF16B IGBP1 ARHGAP11A PDCD4 C5orf34 NF1 BRCA1 BRCA2 NHS KDR GPC2 DMD PGBD3 MFSD9 EGF TMTC4 ZNF532 KAT6B PCDH8 VPS13B	4.11e-04	1074	402	29	C0006142
Disease	Intellectual Disability	ZC3H14 TRRAP NAA15 PTPN23 WDR26 P4HTM ATP1A1 STAG2 FRMPD4 STT3A NF1 BRCA1 DYNC1H1 NSF BRF1 BBS7	4.75e-04	447	402	16	C3714756
Disease	nervous system disease (implicated_via_orthology)	ATP1A1 ATP1A3 ATP12A	5.04e-04	12	402	3	DOID:863 (implicated_via_orthology)
Disease	thyroid gland carcinoma (is_marker_for)	FLT4 PTPRB KDR	5.04e-04	12	402	3	DOID:3963 (is_marker_for)
Disease	lung adenocarcinoma (is_implicated_in)	ERBB3 LRP1B ALX4 CHRNA5 EGF	5.33e-04	49	402	5	DOID:3910 (is_implicated_in)
Disease	lung small cell carcinoma (is_implicated_in)	FAT1 PIK3R1 PTK2 LAMC2	5.36e-04	28	402	4	DOID:5409 (is_implicated_in)
Disease	Usher syndrome type 2	PDZD7 USH2A	5.50e-04	3	402	2	C0339534
Disease	Nephrocalcinosis	PHEX SLC26A1	5.50e-04	3	402	2	C0027709
Disease	HEMANGIOMA, CAPILLARY INFANTILE	FLT4 KDR	5.50e-04	3	402	2	602089
Disease	HEMANGIOMA, CAPILLARY INFANTILE	FLT4 KDR	5.50e-04	3	402	2	C1865871
Disease	Capillary infantile hemangioma	FLT4 KDR	5.50e-04	3	402	2	cv:C1865871
Disease	Alzheimer disease, APOE carrier status, age at onset	TACR3 NSF	5.50e-04	3	402	2	EFO_0004847, EFO_0007659, MONDO_0004975

Protein segments in the cluster

Peptide	Gene	Start	Entry
HSMISRKVTIAGFDL	TPST1	191	O60507
HTEADIFKNGSKRMI	nan	6	A8MVM7
QHVKSALASVIMGLS	PPP2R1B	351	P30154
SSIAALRMKAKEHSA	ALX4	391	Q9H161
LGRDSTKLHLMNFTA	AZI2	266	Q9H6S1
RTHGSNIAKMTNTGL	CTTNBP2NL	321	Q9P2B4
LKLNGRTMEIESTFH	ERI3	171	O43414
DKSGRQSFQAVTDHM	ERBB3	746	P21860
SVSSHLDKASIMRLA	EPAS1	46	Q99814
SVTHANALTVMSKAV	SLC4A2	1061	P04920
MGEDTDTRKINHSFL	PPP2R2C	1	Q9Y2T4
FDRIAHTKETMLSDG	B4GALT1	356	P15291
HTKETMLSDGLNSLT	B4GALT1	361	P15291
NLTESIKAMHISGSD	BBS7	106	Q8IWZ6
IKAMHISGSDLFLSA	BBS7	111	Q8IWZ6
KTFRGMTLLHLAAAQ	CAMTA1	1061	Q9Y6Y1
VTGHTSQKEAMEVSL	BIRC6	491	Q9NR09
VANSKVNATMIDHSG	CSMD2	3301	Q7Z408
SKLPERIESSSNTMH	CSMD3	1661	Q7Z407
KHSETFTRDNNMGLV	COPS3	281	Q9UNS2
SESVLRTQIRHMKFG	CBX6	216	O95503
HGMTLKSVTEGASAR	CDC73	316	Q6P1J9
SVTHANALTVMGKAS	SLC4A1	731	P02730
LFRELMGDHVSSTKA	ACTL8	311	Q9H568
NKAFELMHSGKSIRT	ADH5	356	P11766
LAKAMVSDGSFHITL	AKAP7	116	Q9P0M2
MANGSLEKVLSTHSL	ANKK1	101	Q8NFD2
KLSLTQSDISHIGSM	MACROH2A2	196	Q9P0M6
VKEGRSVVLTSHSME	ABCA1	2091	O95477
NASMKLGTEALSTNH	ADGRL3	746	Q9HAR2
NTLRSHLIDKGMLTS	CDS2	426	O95674
GLKFSVRNEVMATSH	CACHD1	696	Q5VU97
RESGKAIIITSHSME	ABCA3	1561	Q99758
TVSNLSMQTHAARFK	BIRC3	246	Q13489
AAQMLGKVSSIHSDQ	CABYR	176	O75952
GKVSSIHSDQSDVLM	CABYR	181	O75952
EHSKSASLLFGMRNS	APBB1	201	O00213
GALNEHMTSLASVLK	ARIH2	71	O95376
DTSMIEKLLSHGTNI	ANKRD36B	131	Q8N2N9
MEKHRSNSTELSGTL	CCDC144CP	481	Q8IYA2
TSSTEVFMHQLRKLS	DMXL2	401	Q8TDJ6
TSTGASVLMKRNLHN	DMXL2	2751	Q8TDJ6
RDKGSNAVVHYSIMS	CELSR2	426	Q9HCU4
QKSEPHSLSSEALMR	DIABLO	61	Q9NR28
HTTGFKDQNEMLSSL	DMD	586	P11532
MTFISVGHRQSLEKF	ABCD4	571	O14678
LMSKLDGINRHSFNS	ADCY7	971	P51828
ELARNSVLMSGFSHK	AMPD2	796	Q01433
TASRMESNGEALKIH	NPR1	1001	P16066
THRLKDGSTMLIEAA	ANKRD17	691	O75179
RGTHSKLETMQTAES	ANKRD46	141	Q86W74
SSVVRGSESHKMIDL	CDIPT	111	O14735
LNSTTGKIRTTHAML	CDH23	826	Q9H251
HTSRKDAMTAQNTGI	CTNND2	1106	Q9UQB3
HSAVILQAAFRGMKT	ASPM	2386	Q8IZT6
GLEKPESRSSIHNFM	ATP2B1	1131	P20020
DSGIHLTIEMNKSAT	ATP2B1	1191	P20020
HNSGRKIAAFIAESM	ETNPPL	201	Q8TBG4
THLQKTGTAEMSSIL	ATP5F1A	41	P25705
AAKTVHSGSLMLVTV	AP3B1	1046	O00203
MNDVSSRSHAIFTIK	KIF16B	216	Q96L93
ATIDKVLQDSLSMHS	MLIP	266	Q5VWP3
MRSHKAESSELVRNS	P4HTM	261	Q9NXG6
SAGNLILKTHVMSED	RC3H2	1161	Q9HBD1
HGLIFMETSAKTASN	RAB2A	141	P61019
IALRSHLKSFSMANG	RAB40B	216	Q12829
VTIKSHLKSFSMANG	RAB40C	216	Q96S21
MKVGHVTERTDASSA	RBM39	321	Q14498
FQGKRMHVQLSTSRL	RBM4	136	Q9BWF3
KVVVHMRSVFANSST	PAAT	161	Q9H8K7
RKISSTAFGRQLMHS	RAB11FIP4	301	Q86YS3
NSTGAMLLSHKLELT	RIC1	281	Q4ADV7
KGTLDHMVDQVTRSV	AFMID	131	Q63HM1
HKGNLQRAVSVSSMS	MTCL1	1376	Q9Y4B5
EKASFTNSELHRAMN	PTPN23	506	Q9H3S7
SVETDQRKMSAGNHS	OR8G2P	6	Q6IF36
QRKMSAGNHSSVTEF	OR8G2P	11	Q6IF36
QIASKGHISMRTKSA	KAT6B	1916	Q8WYB5
GQMFSTTSSLNKHRR	MECOM	411	Q03112
RMNGSHFKDEKALVT	MECOM	1046	Q03112
LSAAHTLVMKINATD	DSG2	171	Q14126
QSHSVMESKLGSLRD	DZIP1L	296	Q8IYY4
IALLDKLSSMGHQAT	ERCC6	826	P0DP91
KRSHNASIIDMGEES	CADPS	371	Q9ULU8
GISSMAKLTVHIEQA	FAT1	236	Q14517
LTSGRRKTIDMLDTH	MUC16	5961	Q8WXI7
RIEMESTFSLAHGLK	MUC16	6646	Q8WXI7
VLMGHQLTATKVFTA	ABCC10	526	Q5T3U5
MGVKNHSTVTEFLLS	OR8D4	1	Q8NGM9
TDITASAMRVHKDGS	PNPLA6	1091	Q8IY17
MAAGSTTLHAVEKLQ	ELOA2	1	Q8IYF1
RTGNHTSRAKMSAEL	LARP1	661	Q6PKG0
KDTDLMTFNISVHRS	NKAIN3	91	Q8N8D7
KMVIVTHSGELSNES	PTPRB	1151	P23467
SDPRAEQAMTAIKSH	PARP8	346	Q8N3A8
LAETLMAKESTQGHR	FAM86B2	96	P0C5J1
MAKESTQGHRSYLLS	FAM86B2	101	P0C5J1
SKRDQSTSMSHINLL	FAM171A1	351	Q5VUB5
NLSIKMDLTRHSGTI	KIAA0100	1256	Q14667
AATISAIEAMKNAHR	MPRIP	766	Q6WCQ1
RSMAEDTINAAVKTH	GPD2	441	P43304
AMAATGDVALLRHSK	ITPK1	326	Q13572
NLGLDRKMVTHTAAS	LRP11	346	Q86VZ4
GHKNDATETITMRTG	LRP1B	2111	Q9NZR2
HAQEFAMKSVGTRTG	LZTS3	46	O60299
VKFSHLSRNMTLQRT	NMT2	311	O60551
SMFLLLKEGRSSHVQ	NCR1	151	O76036
GSSVEATRAVMKHLA	NLRC4	496	Q9NPP4
HGSGMSNRSTAKRFI	MCM8	766	Q9UJA3
VAIFIMSLNKRHSSG	MFSD9	451	Q8NBP5
DRRTLHAMKVGSLAS	NRAP	426	Q86VF7
TPRKSSLTQMEFAAH	FAM149A	726	A5PLN7
ASSMSHLQSLREVKL	LRIG3	91	Q6UXM1
AATARMKTAALGHDL	GPC2	476	Q8N158
QKGLLLSSSLMHSES	KIAA0319L	991	Q8IZA0
SSHLDKASVMRLTIS	HIF1A	51	Q16665
SRIHSFRGVKDITML	KATNIP	1081	O60303
DKTGTLTQNRMTVAH	ATP12A	391	P54707
DKTGTLTQNRMTVAH	ATP1A1	376	P05023
STSAEKRHLEVSNGM	JCAD	951	Q9P266
TMESELKRIHGSFTL	KIAA1109	2796	Q2LD37
SHKIQITMGSTEARV	KIAA1109	4491	Q2LD37
SALKENATGHVESMA	HPS4	291	Q9NQG7
RSKTAIGLSHIMSAG	FSIP2	2706	Q5CZC0
GSVTKTASAMQHVLD	ITGAE	276	P38570
ASSKLGITMTVAHEL	ERAP1	341	Q9NZ08
VQKFELGSSSIAHMV	ERAP1	861	Q9NZ08
MKSDGRIHSNSSSEE	PID1	226	Q7Z2X4
SEKIAMEASTNSGVH	PCNX1	451	Q96RV3
SAKTHARVLSMDGAG	PCNX3	496	Q9H6A9
SLALEGKASHREMTS	PDCD4	206	Q53EL6
LTAATFTVMGLKRAH	SLC25A17	291	O43808
RTGLITTTKLMDFHD	FAT2	411	Q9NYQ8
RLSAMKSAVESGQAD	IGBP1	171	P78318
IHMGSGESRRKAFTT	OR2M4	226	Q96R27
HQMTSAEGRKKAFAT	OR2T6	226	Q8NHC8
LSMRSEEARHKAVTT	OR2Z1	226	Q8NG97
ASMAKARSTLTAHIT	OR4K15	231	Q8NH41
EDLHMKVSGDTSFRL	PCDH8	51	O95206
MGSAVKVLTSSSRLH	PDZD7	146	Q9H5P4
ASHMKTRATRAVLLG	PTGER3	166	P43115
LAETLMAKESTQGHR	EEF2KMT	96	Q96G04
VGHSTDAREMSKTFI	CYB5A	66	P00167
MSGLSESKQTHVHLR	KBTBD2	61	Q8IY47
GRLHFSETTANNMRK	MYRFL	341	Q96LU7
FQKHGRSTTTSDMIA	NAXD	321	Q8IW45
SGHRKLIASMSSDSL	F13A1	701	P00488
ASNKLGTAMSHEIRL	L1CAM	116	P32004
RAAQSTAMNRHIKAS	NSF	446	P46459
TRTDTQSGNLHIAMK	GDPD4	506	Q6W3E5
SKNIRTVVTGIEMFH	TUFM	296	P49411
TGKVILFTMHNNRSL	ITGA11	451	Q9UKX5
VSLDRTLQFGHMSVT	LAMA5	2831	O15230
KMNGSHRDQGSSALS	IKZF1	91	Q13422
FTASMSHLLKGNSEE	MEAK7	91	Q6P9B6
SEKIMDRISAGTHTR	MIER3	231	Q7Z3K6
ADGTFLVRDASTKMH	PIK3R1	351	P27986
ALLKTDTAMHFGNLV	PRSS54	131	Q6PEW0
VSNIGRKDYLAHSSM	DDX41	606	Q9UJV9
DMTSATHVLGSRDKN	LIG3	971	P49916
LSETAAAMLRKHTNI	IPO5	286	O00410
EMRGTITVHKTDSSN	KIF3A	41	Q9Y496
EGRNKALSTCTSHML	OR4D6	231	Q8NGJ1
STAHGSLLNLKAMVE	PLA2G2F	16	Q9BZM2
FQGKRMHVQLSTSRL	RBM4B	136	Q9BQ04
MFSRRSHGDVKKSTQ	RALGAPA2	1	Q2PPJ7
HLVSLRMSGSRKEFD	KLHL5	41	Q96PQ7
HTMEKVVRSAATSGA	HUWE1	1836	Q7Z6Z7
RVMEHDGQSLVKSTI	ITPRID2	786	P28290
VSRSHSGMVKQVALQ	BPNT2	241	Q9NX62
LRMHSAEGRQKAFST	OR8U9	226	P0C7N5
EFGTVDHERLSKMLS	PDP1	491	Q9P0J1
MLQSVKRAFAIDSSH	NAA15	691	Q9BXJ9
LGVAHTVVKRMSSFV	PNPLA7	571	Q6ZV29
LKSEMHNKTVSQRFG	PIK3CA	671	P42336
MLTHAEAQRTGDSKE	LRRC66	591	Q68CR7
ASAMTLLTERGKLHQ	SMPD4	851	Q9NXE4
TDPQSRDHGFLRTKM	OVOL1	91	O14753
HSKGTSSIAITALME	RBBP6	446	Q7Z6E9
RSFAVTETLQMGIKH	GRIN3A	916	Q8TCU5
LQEAGADISKTVMSH	PTER	216	Q96BW5
HVTGMELEFKRLANS	PTPRS	1676	Q13332
SSMVAHKLVASARDA	PPM1E	461	Q8WY54
VAGSLITKSNLHAMI	PRPF40A	226	O75400
GTSGDHDNSFMKTLR	POTEB3	81	A0JP26
IRQSGAKQSHMEEFT	PCF11	521	O94913
SRELEMHTISSKVFG	PATZ1	101	Q9HBE1
IQMGRDKNFSSLHTV	PANK2	296	Q9BZ23
GQFMLVGHLSSSKSR	ARHGAP6	701	O43182
MSAGLVTSEKESAAH	MOGAT2	156	Q3SYC2
VMLKTAESHRDALAG	MYO15B	436	Q96JP2
FLIGSSKQMRHQSES	BRCA1	1316	P38398
INMSKHTTFFGAIRL	EDA	371	Q92838
HTAMKSGILAAESIF	ETFDH	401	Q16134
SSSTHNAMAPLVRKI	CHRNA5	341	P30532
SMKLTTNGRFREHNA	APOB	1681	P04114
LRTMSLEDSLSSGHK	CEFIP	876	Q711Q0
EKLMGTRHSLATISL	CROCC	1076	Q5TZA2
IRGKEAAALSMFHVS	HDAC10	531	Q969S8
GLMTNTVVKLHESSR	IGSF10	1496	Q6WRI0
ERLATVKSGMSDVHA	IGSF22	511	Q8N9C0
SHRDQMIAEDKSIGS	IFT74	286	Q96LB3
DDRVSPTVLHKMSNS	GPCPD1	171	Q9NPB8
VCSLMTRKHSFGLTE	KLHL11	436	Q9NVR0
HSVLMSVIAGEAVAS	KDM1B	706	Q8NB78
HETRKSRSSTGSMNV	KLHL25	6	Q9H0H3
MSHDLVAVGRKSENF	BCLAF3	436	A2AJT9
MAILGKATSHTQAVL	CCDC125	151	Q86Z20
LTIMSKSHAQEAVRG	DOCK3	916	Q8IZD9
ASFEAMASIINRLHK	DOCK7	816	Q96N67
SATRNEKMRHLITTG	BRCA2	2386	P51587
GSHKASIKMSAQAVV	LINC01555	51	Q8NAE3
LKEGFHVSMLNRRTT	CACNG4	311	Q9UBN1
VQHTSSISGMKRESE	GCFC2	161	P16383
TGKDMVRINLHSSFV	EGF	276	P01133
EEAATLFPRKMTSHN	CHD6	66	Q8TD26
LSRIMKTHAEDLNSG	FER	81	P16591
HDLSSQRITSVAMKS	FAM20C	251	Q8IXL6
AFDQRTGHKNKVTMT	CDO1	166	Q16878
AKRMSSLQSEGHFSL	FRMPD4	1196	Q14CM0
LLDSDSHTGKAMRST	FNIP1	711	Q8TF40
VEFKSMASGSHKIQS	DENND11	106	A4D1U4
SVSDMKLRFSHSVQN	AVL9	571	Q8NBF6
RSQSREHMGESLSLK	ARFGEF3	1966	Q5TH69
LHKFTSIRRTMSEVG	CTSD	26	P07339
RFAKGMSETFETLHN	CNPY3	121	Q9BT09
MLQSRHSLDGSKLTE	CRACD	1066	Q6ZU35
MQSHLTKAAGSRAGD	COL6A3	126	P12111
MINSIHKVTGDATFA	DNAH7	1151	Q8WXX0
VKAVLGHLLAMSRSS	FANCC	446	Q00597
MVIFLGTLVHKSSSQ	IL21	16	Q9HBE4
SSQGKRRLTADMISH	CDC42EP1	26	Q00587
MEKHRSNSTELSGTL	CCDC144B	531	Q3MJ40
FAAASIGQVHLARMK	COQ8A	336	Q8NI60
TSLSHAFGQTDMSRK	CRP	11	P02741
KFISSEGDHMTLLNI	DHX33	551	Q9H6R0
LGSKSSSMELHREEN	DENND4C	1246	Q5VZ89
LIKTGRSVVLTSHSM	ABCA2	2231	Q9BZC7
TSNSSKSAELHRMVV	CADPS2	451	Q86UW7
KEGDMLRLTSDATVH	CEMIP2	136	Q9UHN6
KTVKFHARTGMIESN	DLG3	576	Q92796
RKVIHMFSTAEGLLT	HSD17B7	111	P56937
FTNRRAAKASHMGVS	LUZP1	426	Q86V48
HTMEVTGNSISVTKR	LYPD6	81	Q86Y78
ALHKQASVRASEGAM	MAST4	1606	O15021
EMSQIGFSTHRLKDG	ITGA10	371	O75578
RDLQTMHFLAKVASS	CEP192	1651	Q8TEP8
DKTGTLTQNRMTVAH	ATP1A3	366	P13637
AMVDDQRSKAGSIHS	FZD3	566	Q9NPG1
AKTLQRAMETLHASS	GABBR2	366	O75899
KALTGHNMSEALVTE	FSIP1	486	Q8NA03
GSNMTEFHSQISKSR	DYNC1H1	1136	Q14204
HSTSSIGSMLAQADK	KMT2A	1001	Q03164
QKADSLSSLVTRHMD	LAMC2	876	Q13753
HFLNSRALGVMDKST	KNDC1	1491	Q76NI1
TQHSSLFMLNEVKRA	KNG1	171	P01042
SSSLALMHINLSGTK	CARMIL1	421	Q5VZK9
HKIMIGVERSSATLF	COL9A1	181	P20849
MSVSVHENRKSRASS	ENC1	1	O14682
PDSSFKLMVQRTTAH	EMC1	566	Q8N766
TRNTLKSMEGSDGHA	CCDC158	711	Q5M9N0
SKESLVSFAMQHVRS	DNAJC10	221	Q8IXB1
ILAGVKMSHAATSAL	DIP2A	1161	Q14689
VSHMLQTKILGSDRV	AMT	81	P48728
MEKHRSNSTELSGTL	CCDC144A	531	A2RUR9
MATSHRVAKLVASSL	FAM161A	1	Q3B820
LIITSDHGMTTVDKR	ENPP7	241	Q6UWV6
ASMSHTILLKAAELG	GRIK4	221	Q16099
LLGTTHAEAMSILKQ	GRIP1	211	Q9Y3R0
TASAEARHIKAEMGS	IKZF3	236	Q9UKT9
AKHEGDMSLRVSTAA	C4orf54	546	D6RIA3
CSTKHQLESRKESMG	CEP295	2266	Q9C0D2
SNMSKIDAHITQSRF	C5orf34	266	Q96MH7
DLAHVSVATMKATLQ	DPEP1	211	P16444
FTDKANSGLSMESIH	GFM1	431	Q96RP9
LHSTSAEAVAMGLLK	RUBCN	621	Q92622
TNGMTTVRFVNTLHK	SLC15A2	511	Q16348
HRRQGSSTSLKSMEG	DYRK2	131	Q92630
RTDMHISGVFATKDA	IFT140	441	Q96RY7
VMGTRTFSNIHSERK	PRSS51	96	A0A1B0GVH4
EKNSGSKCVISMHSR	KIF28P	21	B7ZC32
LHDSDRKTGTRNMFS	MFSD5	396	Q6N075
KQLSHMGSIREETLA	KBTBD6	201	Q86V97
RTGTHMSRAKITSEL	LARP1B	466	Q659C4
SAIHSTRDILSVMAK	PHKA2	691	P46019
MIRIDSQTNSSHLKD	PTPRK	1161	Q15262
GIRHSKRASTMAATT	ODF3L2	261	Q3SX64
GTSGDHDNSFMKTLR	POTEC	81	B2RU33
TSIALLDKLSSMGHQ	PGBD3	356	Q8N328
AGKHRSEISVMTATI	OR10P1	191	Q8NGE3
ANRSKHEKLSTFGLM	NR5A2	331	O00482
LGLQHTTAAKALMSA	MMP11	221	P24347
LRMHSAEGRQKAFST	OR8U1	226	Q8NH10
TSAAAIMLLTVRHGT	MRPS31	26	Q92665
FISASVNGLMKHASE	USH2A	1811	O75445
MRKHPDSVNASLRST	ARHGAP11A	931	Q6P4F7
KSAAMLGNSEDHTAL	SNX2	346	O60749
MAHIDAGKTTTTERI	GFM2	76	Q969S9
HMVNGFTALALTKLD	ADSS1	351	Q8N142
HITEMGFSKEASRQA	TDRD3	201	Q9H7E2
EKHLMSQRNSGETTE	PRUNE2	1431	Q8WUY3
GTMDTHSLESKAERI	SVIL	91	O95425
QSKHTEARELMYSGA	GET4	56	Q7L5D6
STAGVLLSSHMDQKD	NHS	611	Q6T4R5
MAIETLQKSDGLSTH	RFX3	161	P48380
GAASSVSTKHALIMD	RFC1	706	P35251
PSLSSFDMAQKRIHA	RGS5	146	O15539
SQKSFTGMHRTEAII	IQCA1L	151	A6NCM1
NSKVTSRFAHNVVTM	ITIH3	51	Q06033
RSMFTSNLKEAHNRV	KBTBD4	71	Q9NVX7
LANSEKQGMRTHAVS	PTK2	376	Q05397
KQGMRTHAVSVSETD	PTK2	381	Q05397
HMSVRKSTGDSQNLG	GAS7	146	O60861
GVSAHLDKASIMRLT	HIF3A	46	Q9Y2N7
SQGQKTKHRMFSLIS	PRORY	166	Q9H606
MPDHDSTALLSRQTK	PROX1	1	Q92786
EMSHRSSDFAKIINN	PSAT1	41	Q9Y617
VTVRHGFDLLTEMKT	SMG1	1046	Q96Q15
IATAAEHSNAAIRKM	FGD1	551	P98174
HISRVGQAMASTEEK	STT3A	551	P46977
SKLLETMHLTGADFT	SELENOO	441	Q9BVL4
KIHSSRLSDITSSNM	SHLD2	106	Q86V20
GSHSTKVEAVVRTLM	SHPRH	1506	Q149N8
VIGMRSFIKAENTTH	RXFP2	436	Q8WXD0
METGSLFTSGIKRHL	SGO2	6	Q562F6
GSKMLLDSVLTTHER	MRPL48	141	Q96GC5
VSEGLSFLHSSVKMV	SCYL2	161	Q6P3W7
NSSRNMLTSTAVKHD	SPATA31D4	446	Q6ZUB0
HMVGIIFSRSKLTNL	MYCBP2	3951	O75592
HRSTGLQADTEAKMK	NUAK1	336	O60285
ELHVISMETTSIGKN	TGM4	406	P49221
LSGKNRSHILASMET	PKHD1	2531	P08F94
VDTCLHKGSRDNMSI	PPM1B	276	O75688
IISMDSSQIHSKDPR	PLA2G6	271	O60733
RGQMTQTHRSAFVSK	RNF169	256	Q8NCN4
KDTAGSRVAQMHSLF	SOWAHD	291	A6NJG2
MGTNFSESVEHRSLI	IMPG2	151	Q9BZV3
NHFGRSMSVEKIDIS	MRE11	151	P49959
ELKTTRFHPNRQSSM	TACR3	386	P29371
LLSLETRMSEQGKTH	NOX3	456	Q9HBY0
RLRHSKSIDEGMFSA	SHANK1	1281	Q9Y566
SVATDMSCDHLKGRS	TET1	806	Q8NFU7
ALSIKDGVMVLSATH	PRKAB1	241	Q9Y478
DRLHMSLQQGKSSST	BAIAP2	441	Q9UQB8
NHQFSTLRISKSTMD	AKAP17A	61	Q02040
TLALKTHVGMSIQTF	ALDH1L1	516	O75891
MRSAKGHTFRSSLSV	ADRA1D	321	P25100
QKEGSIAMQSSATHL	CCDC15	111	Q0P6D6
MHDAIGFRSTLTGKN	CLN5	116	O75503
RELIQTFKGHMENSS	CLEC4F	101	Q8N1N0
SRSVEHAKPTAAMDV	C15orf39	591	Q6ZRI6
RKHTGMFTVAQLATI	SPATA13	271	Q96N96
NRTFDSIMEAHKGIT	XIRP2	1321	A4UGR9
RNASIHASMDSARSK	PLPPR4	431	Q7Z2D5
HASMDSARSKQLLTQ	PLPPR4	436	Q7Z2D5
DHSLMFSLANVLGKS	TMTC4	651	Q5T4D3
EKSMQDRLRLGHFTT	TLK1	291	Q9UKI8
GDIVRKSMSHQAAIA	VPS26B	296	Q4G0F5
KSMSHQAAIASQRFE	VPS26B	301	Q4G0F5
NSSRNMLTSTAVKHD	SPATA31D3	446	P0C874
KTFSSLGNLRRHMAA	ZNF823	171	P16415
TLAKSEILETHGTMN	ZNF35	96	P13682
KTFETEAALNTHMRT	ZNF532	1271	Q9HCE3
RQETTDSKSSLHLMQ	TMF1	276	P82094
SKIMGGNSILHSAAD	STXBP6	146	Q8NFX7
SVLSKRTLQARSMHE	ZNF618	646	Q5T7W0
QRVLFSGSSDHSVIM	WDFY2	211	Q96P53
TVHMKAVLSSQEGRD	ZSCAN32	681	Q9NX65
LETMTLGNRSHKAAE	ZBP1	396	Q9H171
ISHSNSMQGRRAKTT	TIAM1	306	Q13009
NVGSFTDRMTPEKHL	SPATA31A1	346	Q5TZJ5
HSKMFSVQLSLGEQT	STAU2	36	Q9NUL3
QEMEASRHKVISGTT	STAU2	421	Q9NUL3
HCKMGVSRSASTVIA	SSH2	391	Q76I76
DRHSRKATMSFGILL	SPNS3	106	Q6ZMD2
GKSNLRFAGMSISIH	SHC2	211	P98077
AMGASVTILTSQLKH	SLC26A1	216	Q9H2B4
AKENMVTFSHTLPRA	PLPPR3	366	Q6T4P5
QVRAFRHTSTLAAMK	STAG2	211	Q8N3U4
SSHSFILIMGNSKLR	TAS2R9	276	Q9NYW1
AAEHFSMIRASRNKS	MEX3A	196	A1L020
SRISDAHLADTMIGK	SPIN1	121	Q9Y657
SSVVTRILKSQHAAM	STX19	126	Q8N4C7
SRNMLTSIAVKHDLA	SPATA31D1	451	Q6ZQQ2
SQTGLSKRLEMHHSS	SEMA6A	896	Q9H2E6
KTSELLDMFGISTRH	TKTL2	601	Q9H0I9
QMSTIHKSATTLSRD	ZNF514	136	Q96K75
MISKQAGDSSSHRQQ	SPAG1	601	Q07617
LKEGATASEHRALMS	FLT4	881	P35916
ESLMSHAIELKSGSN	PLAA	681	Q9Y263
RSHFFTVGMKLETVN	SFMBT2	296	Q5VUG0
FKHLNELSASMQRTG	ZBED8	381	Q8IZ13
MRHSLTKLLAASGSN	CREBZF	1	Q9NS37
SVELRNMFGETLHKA	NF1	436	P21359
GANSSRAEHDMKSVL	PHEX	261	P78562
AFSSLVEHRGKLNMV	RHAG	256	Q02094
MSSLHKSRIADFQDV	TBC1D13	1	Q9NVG8
RHSGLSSGSTQERMK	RPS6KL1	236	Q9Y6S9
NHSMAVKGRSTNDVF	TEX30	191	Q5JUR7
PHRRTLSFDTSKMNQ	RAB11FIP2	271	Q7L804
AMISTKGQSHICATR	UBQLNL	361	Q8IYU4
VLGHEAMKRLQTSSV	UBA1	61	P22314
TEHKLEITMLSQGVS	UBA1	981	P22314
FGEKNHEVSMTALRL	BRF1	196	Q92994
LHAVSRESIFNKMNS	ARHGAP8	356	P85298
SSKMDRQSVLHVLGI	ZNFX1	196	Q9P2E3
LGSGSHFSNRKEDML	UACA	381	Q9BZF9
GKAFRVSSSLINHQM	ZNF841	151	Q6ZN19
RRSFHKLSEGLMDGS	VPS13B	1471	Q7Z7G8
ISFRSHIVSQLEMGK	ZNF792	56	Q3KQV3
KSFGMISCLTEHSRI	ZNF85	181	Q03923
AAMIRNSKTHEGLTE	TRPC5	726	Q9UL62
SGLMTKKNSTFVRVH	KDR	311	P35968
ELRTKMSQSHEDSLT	WDR26	436	Q9H7D7
GKSFIMSSTLIRHQR	ZNF629	436	Q9UEG4
STSATRHQMKGEDAQ	ZNF275	46	Q9NSD4
NVVRKHSTSLSIMGF	TRIM66	621	O15016
QMHLLKSETSVANGS	UBXN4	111	Q92575
QSAGAASHAMIEKIL	UNK	186	Q9C0B0
VKHRLVENMSSGTAD	PICK1	121	Q9NRD5
HTSRTMSINAAELKQ	VIRMA	1426	Q69YN4
SGMKTADSLRVLSGH	ZC3H14	486	Q6PJT7
NAGVKTTRLEAHSEM	PSD3	546	Q9NYI0
TADSPNVMTTFRHDK	TRMT10C	291	Q7L0Y3
STLMLEHQAFEKGLS	TRRAP	2706	Q9Y4A5
MQDSKGRLHALTSVS	XIRP1	486	Q702N8
EEAVHKALSSMSSLQ	XIRP1	1551	Q702N8
ATMHLKQEVTPRAAS	ZNF106	906	Q9H2Y7
ETNEILHMSFPTKAS	TMEM38A	176	Q9H6F2
SQRRISGKSTFHSEM	ZNF81	101	P51508
GKAFSMSTQLTIHQR	ZNF7	531	P17097
KRAASFVSVLHALMA	TTI1	751	O43156
MASFVTEVLAHSGRL	ZW10	1	O43264
GHESDVISRLSNKSM	KCNH8	676	Q96L42
FSEHAVISMRDGKLT	KCNJ3	196	P48549
AFTLLGVKESHQMSI	MYO5B	311	Q9ULV0
HIVERGTDLMFKVSS	NACC2	111	Q96BF6
RGHLQRKSFSQMISE	MYO9B	1036	Q13459
EAGFSSVSHIRNTML	PDE4DIP	1036	Q5VU43
EELSSALHLSKGMSI	NECAB1	16	Q8N987
HVSAQKMLDGASFTL	NECAB3	331	Q96P71